Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,41758,-0.0526940198552156,0.00352833852455799,-0.0596095633633493,-0.0457784763470819,5.04563710178627e-50
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LDLR,Low-density lipoprotein receptor,41788,0.0784292805783132,0.00558268894711939,0.0674872102419592,0.0893713509146672,1.64309602379315e-44
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,41812,0.036018541677537,0.00260036696613863,0.0309218224239053,0.0411152609311687,2.50731203198965e-43
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,41836,0.0555643467688445,0.00423804730418276,0.0472577740526463,0.0638709194850428,4.99566501130003e-39
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPA,Apolipoprotein(a),39448,0.261640209606204,0.0200621204922335,0.222318453441426,0.300961965770981,1.38490320499347e-38
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,41911,0.0559672813074805,0.00438297081212168,0.047376658515722,0.064557904099239,4.01956998269099e-37
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFA,Protransforming growth factor alpha,41740,0.0623780041800432,0.00499264774156589,0.0525924146065741,0.0721635937535123,1.28313863121632e-35
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP1,"Fatty acid-binding protein, liver",41744,0.128939240016987,0.0104714947339732,0.1084151103384,0.149463369695575,1.19146461523024e-34
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGA,Fibrinogen alpha chain,39407,0.0420152642903964,0.00341018265191181,0.0353313062926493,0.0486992222881436,1.19918536360225e-34
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA4,Carbonic anhydrase 4,41925,0.0317856405382583,0.00267187313261916,0.0265487691983247,0.0370225118781918,1.80421883069526e-32
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,41848,0.0632369460038147,0.00532086567753079,0.0528080492758544,0.0736658427317751,2.0764613407412e-32
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,41758,0.0389639383498351,0.00342710008122004,0.0322468221906438,0.0456810545090264,8.18523113106037e-30
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLL1,Delta-like protein 1,41802,0.0385100290645046,0.00339099695040423,0.0318636750417123,0.0451563830872969,9.4548120936317e-30
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS4,Galectin-4,41744,0.0700078508966001,0.00623218113746264,0.0577927758671734,0.0822229259260269,3.79960679666518e-29
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,41758,0.0458018235963969,0.00408958207570831,0.0377862427280086,0.0538174044647852,5.53636800323193e-29
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",41802,0.043007756343372,0.0038678946103121,0.0354266829071603,0.0505888297795837,1.35579694311407e-28
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS9,Galectin-9,41750,0.0385065456466146,0.00347113883765629,0.0317031135248082,0.0453099777684209,1.8073867727051e-28
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,41384,0.0474855364270886,0.00432406202323136,0.0390103748615552,0.0559606979926221,6.23838061119812e-28
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNA1,Ephrin-A1,41734,0.0355459987391822,0.003249923143617,0.0291761493776929,0.0419158481006715,1.00457270332531e-27
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRP2,Neuropilin-2,41758,0.0337065855894809,0.00310467556539384,0.027621421481309,0.0397917496976528,2.41957631100801e-27
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSC2,Desmocollin-2,41612,0.0419256585971968,0.00386485703093254,0.034350538816569,0.0495007783778246,2.6697356185917e-27
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST3,Cystatin-C,41803,0.0341595992522388,0.00316502307788538,0.0279561540195834,0.0403630444848941,4.82484489517198e-27
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOC1,Apolipoprotein C-I,39630,-0.0453575037811549,0.00422061477315134,-0.0536299087365316,-0.0370850988257783,8.339554247064e-27
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD14,Monocyte differentiation antigen CD14,41557,0.0486735596528413,0.0045364946638866,0.0397820301116236,0.0575650891940591,9.60063031103539e-27
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDF15,Growth/differentiation factor 15,41925,0.0535656770238537,0.00505068573652303,0.0436663329802686,0.0634650210674389,3.567704068069e-26
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,41556,0.0530395032071359,0.00504634616439621,0.0431486647249193,0.0629303416893525,9.811088422927e-26
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2,Complement C2,41819,0.0258711406889558,0.00249025599813445,0.0209902389326123,0.0307520424452993,3.48014429981466e-25
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,39650,0.0281142777024493,0.00270732106713411,0.0228079284108665,0.0334206269940322,3.80523541598998e-25
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REN,Renin,41765,0.0927650306510147,0.00896511896267024,0.075193397484181,0.110336663817848,5.36512174488836e-25
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMBP,Protein AMBP,41855,0.023037579150513,0.00222771108871179,0.0186712654166379,0.0274038928843881,5.69824911476227e-25
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRP1,Neuropilin-1,41848,0.0310070768707884,0.00300636486483717,0.0251146017357075,0.0368995520058692,7.57762637322109e-25
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,41736,0.049068187169003,0.00478746318093441,0.0396847593343716,0.0584516150036345,1.47468506906374e-24
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",41925,0.0335354093775081,0.00328331886698201,0.0271001043982233,0.0399707143567928,2.11388249361463e-24
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,41764,0.0388398060391665,0.00384734337900826,0.0312990130163103,0.0463805990620227,7.08425165057369e-24
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOM,Apolipoprotein M,41819,-0.0313781245590837,0.00312350349738463,-0.0375001914139576,-0.0252560577042098,1.16544329484931e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,41717,0.0425701348452069,0.00424504945676797,0.0342498379099417,0.0508904317804722,1.39361062901334e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP12,Macrophage metalloelastase,41765,0.060426987471919,0.00602865739485183,0.0486108189780094,0.0722431559658286,1.46278549714683e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLTP,Phospholipid transfer protein,41884,-0.0417762896978613,0.00417196283366127,-0.0499533368518374,-0.0335992425438852,1.60977987477362e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDK,Midkine,41750,0.0563931751087393,0.00565477618862882,0.0453098137790268,0.0674765364384518,2.42991209896533e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,41689,0.0401816197800779,0.00406434719078102,0.0322154992861471,0.0481477402740087,5.74129688914844e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300E,CMRF35-like molecule 2,41849,0.0454194258875979,0.00461542136275375,0.0363732000166006,0.0544656517585953,8.99023505819515e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,41764,0.0343796882676205,0.00349595778316772,0.0275276110126117,0.0412317655226292,9.61290065382727e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,41765,0.0362330775896148,0.00368716731205586,0.0290062296579853,0.0434599255212443,1.03320352859377e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MERTK,Tyrosine-protein kinase Mer,41911,0.0266834134164732,0.00271853241416834,0.0213550898847033,0.0320117369482432,1.15407145612277e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,41758,0.0457069242157692,0.00466456426486761,0.0365643782566287,0.0548494701749097,1.36178293496275e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LBP,Lipopolysaccharide-binding protein,41836,0.0632054086112093,0.00645207369367062,0.0505593441716149,0.0758514730508038,1.39579439700548e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS1,Galectin-1,41765,0.0379725658304808,0.00388669708704697,0.0303546395398687,0.0455904921210928,1.80769752774487e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD4,T-cell surface glycoprotein CD4,41721,0.0311764188167833,0.00319416489565488,0.0249158556212997,0.0374369820122668,1.98419561698649e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,41877,-0.0394661571914562,0.00407192010849618,-0.0474471206041087,-0.0314851937788036,3.85049774266787e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMSB10,Thymosin beta-10,41758,0.0813414823736136,0.00840516336455964,0.0648673621790767,0.0978156025681505,4.44893593036228e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUCA2A,Guanylin,41706,0.0374921177527894,0.00388831442847252,0.0298710214729832,0.0451132140325955,6.26848815875682e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD59,CD59 glycoprotein,41281,0.0251173734539888,0.00261822911781141,0.0199856443830785,0.0302491025248992,1.01128635083145e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,41689,0.0346929793653623,0.00361944961652232,0.0275988581169786,0.0417871006137461,1.08768211205491e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNA4,Ephrin-A4,41614,0.0341370262012367,0.00357348756594152,0.0271329905719913,0.0411410618304821,1.48457246401445e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,41877,0.0337580773700283,0.00355482457234907,0.0267906212082242,0.0407255335318325,2.53877492518824e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C4BPB,C4b-binding protein beta chain,41802,0.0399535483994395,0.0042119564512016,0.0316981137550843,0.0482089830437946,2.81285223485032e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA2,Apolipoprotein A-II,39655,0.0516943679589331,0.0054667688883258,0.0409795009378145,0.0624092349800516,3.84122511820648e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE4,Ribonuclease 4,39320,0.0290517023146979,0.00308588883384243,0.0230033602003668,0.0351000444290291,5.7337648622735e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,41689,0.0423107405242064,0.00450036741827855,0.0334900203843804,0.0511314606640323,6.25441370773006e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,41758,0.0303303933096713,0.00322625176202937,0.0240069398560938,0.0366538467632489,6.27873375093548e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,41636,0.0314164830532554,0.00334483226412317,0.024860611815574,0.0379723542909368,6.81789115400729e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREG1,Protein CREG1,41586,-0.041667399451471,0.004450707138747,-0.0503907854434151,-0.0329440134595268,9.09789104967158e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,39408,0.0300309792129045,0.00320720387680352,0.0237448596143696,0.0363170988114394,9.23433145569713e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,41805,0.0210495436987197,0.00224973867838212,0.0166400558890908,0.0254590315083487,9.55990799174127e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR2,Folate receptor beta,41865,0.0299848794006123,0.0032081398288104,0.0236969253361439,0.0362728334650807,1.04885461974628e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,41744,0.0409608907798513,0.00438497605605217,0.032366337709989,0.0495554438497135,1.10394605960252e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF3,Trefoil factor 3,41762,0.0372917775630833,0.0040011544794636,0.0294495147833347,0.045134040342832,1.34302340864121e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUCB2,Nucleobindin-2,41846,0.0386062258286614,0.00415015873855977,0.0304719147010843,0.0467405369562386,1.58646216722121e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,39650,0.0272296608093909,0.00293519346456152,0.0214766816188503,0.0329826399999315,2.06821300113741e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,41662,0.0290175087819736,0.0031498920788252,0.0228437203074762,0.035191297256471,3.6761536465413e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,41758,0.0365086810833685,0.00398710904879564,0.028693947347729,0.044323414819008,6.13251715401701e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,41802,-0.0335511576987226,0.00367213788159768,-0.040748547946654,-0.0263537674507911,7.36717748040129e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGRN,Agrin,41805,0.0360337695226791,0.00396308550383242,0.0282661219351676,0.0438014171101907,1.10590474404177e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RETN,Resistin,41732,0.0429189362895914,0.00472578683616649,0.0336563940907051,0.0521814784884777,1.21806116931727e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,39488,0.0330374788014459,0.00366782251148677,0.0258485466789318,0.0402264109239599,2.46190331154583e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD72,B-cell differentiation antigen CD72,39408,0.0432670821207229,0.004818167741984,0.0338234733464342,0.0527106908950115,3.15685901463575e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COLEC12,Collectin-12,41744,0.027195914105921,0.00303350535179898,0.021250243616395,0.033141584595447,3.51169699714434e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP2,Retinol-binding protein 2,41689,0.076797108528103,0.0085928914390312,0.0599550413076018,0.0936391757486042,4.516843526448e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,41636,0.0332039788457725,0.00374305436575934,0.0258675922888842,0.0405403654026608,8.19673938554661e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB6A,Ras-related protein Rab-6A,41740,-0.0434942725650155,0.00491241224813729,-0.0531226005713645,-0.0338659445586664,9.51863876476451e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTBDN,Retbindin,41689,0.0292292508835312,0.00331284900261208,0.0227360668384115,0.0357224349286508,1.25424489204922e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGL1,Fibrinogen-like protein 1,39655,0.06232635427528,0.00715345862578306,0.0483055753687452,0.0763471331818148,3.38798671639658e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,41507,0.0515494836369151,0.00592165677779921,0.0399430363524286,0.0631559309214016,3.55046139514996e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWC2,Brorin,41595,0.0389924832094583,0.00451581764073904,0.0301414806336098,0.0478434857853068,6.57184655268256e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,41689,0.0312822070328759,0.00362408105842585,0.0241790081583612,0.0383854059073905,6.73341190445961e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",41765,0.0761606116754589,0.00882614035731394,0.0588613765751236,0.0934598467757942,6.89383166770439e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN5,CCN family member 5,41758,0.0361102723809018,0.00418671458020261,0.0279043118037047,0.0443162329580989,7.13911349641722e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSS,Cathepsin S,39063,0.023083336965709,0.00268038765275062,0.0178297771663178,0.0283368967651003,8.21614739503302e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANG,Angiogenin,41774,0.0309233515195174,0.00361302389672598,0.0238418246819345,0.0380048783571003,1.26513381683431e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INHBB,Inhibin beta B chain,39408,0.0494621801635237,0.0057837915608005,0.0381259487043547,0.0607984116226927,1.37454831364084e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",41689,0.0576046384354542,0.00674194224761,0.0443904316301386,0.0708188452407698,1.43616301645293e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,41636,0.0404824486626948,0.00474953061580504,0.0311733686557169,0.0497915286696727,1.71756314346497e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HYAL1,Hyaluronidase-1,41705,0.0216555667854609,0.00254855377133465,0.0166604013936449,0.0266507321772768,2.1503819128599e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,41810,-0.0319305200803244,0.00378377606210716,-0.0393467211620544,-0.0245143189985944,3.53737888089763e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,41758,0.0281756019987235,0.0033425532863859,0.0216241975574072,0.0347270064400399,3.83428202084023e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL22,C-C motif chemokine 22,41614,0.0482908795575045,0.00573025213410908,0.0370595853746507,0.0595221737403583,3.90450313505216e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSM,Oncostatin-M,41673,0.0641175223791362,0.00761971957523471,0.0491828720116762,0.0790521727465963,4.34616995976625e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREML2,Trem-like transcript 2 protein,41758,0.0319711759907859,0.00381855629203409,0.0244868056583991,0.0394555463231727,6.20287922993328e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNF,Tumor necrosis factor,41502,0.0334700075785265,0.00403871573880651,0.0255541247304657,0.0413858904265872,1.27240360885253e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",41925,0.0459852533686688,0.00555798463845451,0.035091603477298,0.0568789032600397,1.42084358019748e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCN2,Transcobalamin-2,41903,0.027515136200229,0.00333759921300828,0.0209734417427328,0.0340568306577252,1.8207135428909e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,41765,0.0282327403372142,0.00343395953778119,0.0215021796431631,0.0349633010312653,2.19447640300683e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,41805,0.025125514410528,0.00306311812532289,0.0191218028848952,0.0311292259361609,2.56879653179855e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,41877,0.0539107355500635,0.00657951447735442,0.0410148871744488,0.0668065839256782,2.76308512010803e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",41805,0.0252821084411432,0.00308844228771484,0.0192287615572221,0.0313354553250643,2.94575087530233e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RSPO3,R-spondin-3,41877,0.0254411692027602,0.00311488732225989,0.0193359900511308,0.0315463483543896,3.42824127695809e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE6,Ribonuclease K6,39604,0.0292452878781934,0.0035809781712407,0.0222265706625616,0.0362640050938251,3.51139858797295e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,41805,0.0243581896909455,0.00298365002461845,0.0185102356426933,0.0302061437391976,3.53651005021806e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,41534,0.033824284530471,0.00415700356019037,0.0256765575524978,0.0419720115084441,4.43112025725269e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,41783,-0.0591067987679094,0.00727362879249975,-0.0733631112012089,-0.0448504863346099,4.82296887925206e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD160,CD160 antigen,41911,0.0432268625801614,0.00536279255613678,0.0327157891701333,0.0537379359901895,8.24211446283335e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,41740,0.0306700546548037,0.00382508740650324,0.0231728833380574,0.0381672259715501,1.1640168744041e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARB2,Lysosome membrane protein 2,41408,0.0290937095319432,0.00364838514420486,0.0219428746493017,0.0362445444145847,1.66053699208785e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,41465,0.0415602615096975,0.00522880042466412,0.0313118126773558,0.0518087103420392,2.04724250737793e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP5,Fatty acid-binding protein 5,41836,0.0584097345381955,0.00737623834471981,0.0439523073825447,0.0728671616938463,2.59192752304979e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,41877,0.0364358184986901,0.00460463127400115,0.0274107412016478,0.0454608957957323,2.71376609340691e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL23,C-C motif chemokine 23,41805,0.0368626530006773,0.00465857838602166,0.0277318393640749,0.0459934666372798,2.71508027953019e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,41877,0.0290803114744209,0.0036778586869519,0.0218717084479952,0.0362889145008467,2.84720813377434e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL15,C-C motif chemokine 15,41925,0.0380136968818153,0.00481105724324702,0.0285840246850512,0.0474433690785795,2.97526504568045e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG4,Regenerating islet-derived protein 4,41764,0.0444478149495181,0.0056408117837116,0.0333918238534434,0.0555038060455929,3.53885130067963e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,41740,-0.0344259222688812,0.0043747737974982,-0.0430004789119777,-0.0258513656257848,3.8477174557597e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_E,,41740,0.0254636282894969,0.00325153351608693,0.0190906225979665,0.0318366339810273,5.1989022156515e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLUL1,Clusterin-like protein 1,41744,-0.0386489108828447,0.00493741599561848,-0.0483262462342569,-0.0289715755314325,5.34512746153958e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THY1,Thy-1 membrane glycoprotein,41865,0.0253643678183981,0.00324035733897067,0.0190132674340156,0.0317154682027806,5.34643812504807e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,41865,0.0594310106227282,0.00762108445423537,0.0444936850924269,0.0743683361530295,6.74491123072979e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN2,Nectin-2,41750,0.0267126574252585,0.00342796609508609,0.0199938438788898,0.0334314709716272,7.0575313064284e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",41534,0.0620681566177611,0.00798388541480688,0.0464197412047396,0.0777165720307826,8.16642978246813e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,41865,0.0397847813159562,0.0051465129201247,0.0296976159925118,0.0498719466394006,1.1487504463871e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYN,Tyrosine-protein kinase Lyn,41689,0.0723500238848161,0.00937181207975512,0.053981272208496,0.0907187755611361,1.24789084618695e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",41689,0.059036328169984,0.00765707692323162,0.04402845740045,0.074044198939518,1.34841665563708e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHISA5,Protein shisa-5,39633,0.0221780788119204,0.00287612240767803,0.0165408788928714,0.0278152787309693,1.35460388741308e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,41070,0.0357105318827847,0.00464631460340053,0.0266037552601196,0.0448173085054497,1.63439024255019e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGF,Hepatocyte growth factor,41911,0.0292389331757537,0.00381332826866899,0.0217648097691625,0.0367130565823449,1.87426463009764e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPY30,Protein dpy-30 homolog,41832,0.0511108553043878,0.00666827631141452,0.0380410337340153,0.0641806768747602,1.91596286429075e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAV,Integrin alpha-V,41877,-0.0140746623722621,0.00183733595657007,-0.0176758408471394,-0.0104734838973848,1.98222293896006e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,41636,0.0487893409090369,0.00637161032118334,0.0363009846795175,0.0612776971385562,2.03233943470556e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,41786,0.0375860780785043,0.00492143594473272,0.0279400636268282,0.0472320925301805,2.37228890885756e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGN,Mimecan,41758,0.036540756499121,0.00479391097745536,0.0271446909833085,0.0459368220149335,2.6617698495877e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,41534,0.0370093534450834,0.00485665485741574,0.0274903099245485,0.0465283969656183,2.70600092487141e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",41716,0.0571524401649149,0.00750214503515854,0.0424482358960041,0.0718566444338256,2.74957396627599e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EBI3_IL27,Interleukin-27,41862,0.025726168335099,0.00338691196816327,0.019087820877499,0.032364515792699,3.26452341570446e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFH,Complement factor H,39094,0.0196629771553811,0.00259043617417685,0.0145857222539945,0.0247402320567677,3.4545886706211e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,41740,0.0280496299422054,0.00370079315627816,0.0207960753559002,0.0353031845285106,3.70510801267348e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD83,CD83 antigen,41740,0.0289825641222848,0.0038274134441758,0.0214808337717002,0.0364842944728694,3.90927281802687e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",41758,0.0201764346285113,0.00266458698057118,0.0149538441465918,0.0253990251104308,3.917771431818e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,41866,0.0349578118695718,0.00461959588276147,0.0259034039393593,0.0440122197997843,4.06185244116799e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18BP,Interleukin-18-binding protein,41836,0.0262480967753781,0.0034709038553053,0.0194451252189798,0.0330510683317765,4.21989621677914e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD46,Membrane cofactor protein,41732,0.0239520577732064,0.00317187021352954,0.0177351921546885,0.0301689233917243,4.59009750677877e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP9,Matrix metalloproteinase-9,41746,0.0497473730287526,0.00661139039841986,0.0367890478478496,0.0627056982096555,5.63614990173713e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,41758,0.0296758389574471,0.00395392617060146,0.0219261436630682,0.0374255342518259,6.51687486262559e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,41707,0.0262725508768148,0.00350488559782301,0.0194029751050817,0.0331421266485479,7.00261224208974e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,41877,0.0516560073249467,0.00689325767987762,0.0381452222723866,0.0651667923775068,7.11918292453684e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,41863,0.0234725737865921,0.00314094867010719,0.017316314393182,0.0296288331800022,8.32397863346507e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,41903,0.0498588301260939,0.00668096776931718,0.0367641332982322,0.0629535269539555,8.99480899609934e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG1A,Lithostathine-1-alpha,41727,0.0411066037113716,0.00551933488189633,0.0302887073428548,0.0519245000798884,1.00872594930353e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPY,Pro-neuropeptide Y,41877,0.0514996273617335,0.00692499172602169,0.0379266435787309,0.065072611144736,1.09495180132463e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPT,Dermatopontin,41925,0.0207157707426936,0.00279530469234145,0.0152369735457044,0.0261945679396829,1.32982724671136e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B2M,Beta-2-microglobulin,39650,0.0250531900544488,0.00338061805687449,0.0184271786629747,0.0316792014459228,1.34674635271827e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRC1,Macrophage mannose receptor 1,39655,0.0233074755179785,0.0031451683566216,0.0171429455390001,0.0294720054969568,1.34939402729842e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD27,CD27 antigen,41802,0.0350564127328047,0.00473216918166086,0.0257813611367494,0.04433146432886,1.35892724510901e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL9,C-X-C motif chemokine 9,41805,0.0530631199999861,0.00717596060561417,0.0389982372129823,0.0671280027869898,1.5041677100917e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL13,C-X-C motif chemokine 13,41865,0.0468614123600969,0.00635931643209615,0.0343971521531884,0.0593256725670053,1.82161486061349e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,41802,0.030323549418082,0.00411625733211959,0.0222556850471276,0.0383914137890363,1.85176823833217e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS3,Galectin-3,41815,0.0240164363534244,0.00327207655391678,0.0176031663077476,0.0304297063991013,2.26384117045168e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,41534,0.0304954966776087,0.00416236410558014,0.0223372630306716,0.0386537303245457,2.50274873654822e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,41666,0.0327973934204521,0.00450901894025427,0.0239597162975538,0.0416350705433505,3.69616724070724e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,41899,0.030857117115908,0.00424835874777415,0.0225303339702707,0.0391839002615454,3.98767020870963e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",41758,0.0310269026509832,0.00427822817628706,0.0226415754254606,0.0394122298765058,4.32728413365299e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,41840,0.028271209329379,0.00389923560491497,0.0206287075437456,0.0359137111150123,4.38443345202325e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,41752,0.0249917716281697,0.00346199242685296,0.0182062664715379,0.0317772767848015,5.52877465876037e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PENK,Proenkephalin-A,39408,0.0249070495316948,0.00345025253900275,0.0181445545552494,0.0316695445081401,5.59270756520294e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,41640,0.0466825555689834,0.00647555933268923,0.0339904592769125,0.0593746518610543,5.94520347013348e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP7,Matrilysin,41504,0.041397635115662,0.00575296065466863,0.0301218322325115,0.0526734379988125,6.54872487989666e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,41744,0.021779612716191,0.00302833945268436,0.0158440673889297,0.0277151580434524,6.73374253508322e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTN4R,Reticulon-4 receptor,41877,0.0267390796037901,0.0037246995590023,0.0194386684681456,0.0340394907394346,7.40349688045582e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C3,Complement C3,39122,0.036201467400202,0.00506701555262959,0.026270116917048,0.046132817883356,9.62798580815696e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",41740,0.0653320496438787,0.00916170351435526,0.0473751107557424,0.083288988532015,1.04859254167047e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR37,Prosaposin receptor GPR37,41521,0.0512385583883653,0.00719374266143465,0.0371388227719534,0.0653382940047772,1.11473673266007e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,41765,-0.0213070668110666,0.00299175755542215,-0.0271709116196941,-0.0154432220024392,1.1195960534331e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,39633,-0.0404747354204389,0.00568363017117943,-0.0516146505559506,-0.0293348202849272,1.13581505118973e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCAM1,Vascular cell adhesion protein 1,41819,0.0217827222533751,0.00306460984621801,0.0157760869547878,0.0277893575519624,1.23931505396125e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP8,Neutrophil collagenase,41840,0.0561623747304381,0.00790529222133037,0.0406680019766305,0.0716567474842456,1.27023366321278e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR5,Complement factor H-related protein 5,39530,0.0328042203624341,0.00462475544188308,0.0237396996963433,0.041868741028525,1.39169958159355e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",41689,0.02716535261116,0.00383556595923,0.0196476433310692,0.0346830618912508,1.48822812193447e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASN,Vasorin,41604,0.0214377671239508,0.00302988561241602,0.0154991913236154,0.0273763429242862,1.56610050834037e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GH1,Somatotropin,41750,0.138629753416508,0.0196388363621436,0.100137634146706,0.177121872686309,1.76171306601609e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL2,C-C motif chemokine 2,41614,-0.0403906108714992,0.00572466965635905,-0.0516109633979629,-0.0291702583450354,1.80639730328742e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",39308,0.0718987875942062,0.0102110162070224,0.0518851958284423,0.0919123793599702,2.02136983751972e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYMP,Thymidine phosphorylase,41692,0.0518778072292003,0.00737058490295012,0.0374314608194181,0.0663241536389826,2.04012355329645e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FXN,"Frataxin, mitochondrial",41877,0.0566271177686573,0.00804912942427995,0.0408508240970686,0.072403411440246,2.08750848092866e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",39600,0.0688780184607931,0.00980462531705364,0.0496609528393679,0.0880950840822182,2.26627764833789e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,41740,0.0289656420957475,0.00413064617906268,0.0208695755847847,0.0370617086067104,2.45762818607048e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,39655,0.0205485609085164,0.00293439192501605,0.0147971527354849,0.0262999690815478,2.6571524601027e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGF,Placenta growth factor,41911,0.0202730292236006,0.00290129725884171,0.0145864865962709,0.0259595718509304,2.92986584461649e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBI,Acyl-CoA-binding protein,41708,0.0601808897441847,0.00861944486898844,0.0432867778009673,0.077075001687402,3.05045210313537e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFB,Complement factor B,39466,0.0252270795417187,0.00361444417408554,0.0181427689605111,0.0323113901229264,3.13457935751073e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,41636,0.0314502406394464,0.00452056591499451,0.0225899314460572,0.0403105498328357,3.63816777723736e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSBP1,Heat shock factor-binding protein 1,39308,0.0741495249539408,0.0106669321273002,0.0532423379844324,0.0950567119234492,3.82882516166785e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,41750,0.0250208832796448,0.0036177213991473,0.0179301493373161,0.0321116172219735,4.85367835473311e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPI,Mannose-6-phosphate isomerase,41689,0.0652288530547631,0.00943332159619333,0.0467395427262242,0.083718163383302,4.90517392432744e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,41805,0.0208010171646039,0.00301528166787136,0.014891065095576,0.0267109692336317,5.49367372124476e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",41758,0.0290576744191862,0.00421651230450177,0.0207933103023628,0.0373220385360097,5.77618044490551e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6L,Seizure 6-like protein,41802,0.0209969124059367,0.00304733500704778,0.0150241357921231,0.0269696890197504,5.82188800948721e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,41758,0.0406003952012661,0.00589840835707314,0.0290395148214027,0.0521612755811294,6.11411695132418e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,41740,0.0371928903879038,0.00541326256272708,0.0265828957649588,0.0478028850108489,6.67674646740232e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,41911,0.0346843872724276,0.00504865432197212,0.0247890248013623,0.044579749743493,6.70435063495463e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,41911,0.0451255473500721,0.00659306397926079,0.0322031419507209,0.0580479527494232,8.01618561122832e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA4C,Semaphorin-4C,41689,0.0210311933468108,0.00308347196697129,0.014987588291547,0.0270747984020745,9.4630364294297e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",39600,0.0785330607364375,0.0115307392637166,0.0559328117795529,0.101133309693322,1.02151163035269e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",39600,0.0783641250746333,0.0115282590718829,0.0557687372937429,0.100959512855524,1.1190726456174e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,39338,0.0295063042309563,0.00437010354087105,0.0209409012908491,0.0380717071710636,1.53504101879803e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD302,CD302 antigen,41689,0.0231272262275083,0.00344257394141533,0.0163797813023343,0.0298746711526824,1.91848633042586e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,41740,0.028338517038502,0.00421899357337752,0.0200692896346821,0.036607744442322,1.93284917417378e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHB4,Ephrin type-B receptor 4,41925,0.0188054064370754,0.00280556111694712,0.0133065066478591,0.0243043062262918,2.12540362513519e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLIN3,Perilipin-3,41765,0.0317901492258256,0.00475819810724027,0.0224640809356347,0.0411162175160166,2.46639008602319e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR1,Folate receptor alpha,41732,0.0218213029357863,0.00326965215897323,0.0154127847041988,0.0282298211673738,2.59108621264573e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,41740,0.0455840186617883,0.00684321901205385,0.0321713093981627,0.0589967279254138,2.82423821013468e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN4,Nectin-4,41802,0.0247773239195107,0.00373138462416397,0.0174638100561493,0.0320908377828721,3.25407383610153e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,41925,0.0263813637231506,0.00397324591990124,0.0185938017201442,0.0341689257261571,3.26390069434461e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMNB2,Lamin-B2,39598,0.021150330790224,0.00318770776938356,0.0149024235622322,0.0273982380182157,3.39828941685705e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",41675,0.0774937832155733,0.0116879574281027,0.0545853866564919,0.100402179774655,3.48342497253511e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,41686,0.0332569585210541,0.00502945329018246,0.0233992300722965,0.0431146869698118,3.92715158573147e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,41865,0.0328796102762243,0.00498297158442314,0.0231129859707549,0.0426462345816936,4.3141851559687e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,41593,0.0251833828154723,0.00381707030258078,0.0177019250224139,0.0326648406085306,4.34156784600421e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASET2,Ribonuclease T2,41876,0.0195765860112768,0.0029684431892476,0.0137584373603515,0.0253947346622021,4.41654455954935e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,41739,0.0352884725150427,0.00535196703117538,0.024798617133939,0.0457783278961465,4.45844388640449e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,41802,0.0247818341992467,0.00376130796737503,0.0174096705831916,0.0321539978153017,4.60768972857965e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL16,C-C motif chemokine 16,41925,0.037150624683993,0.00564129989044903,0.026093676898713,0.0482075724692732,4.70448214873251e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAYN,Layilin,41617,0.0260026560455227,0.00394999910337592,0.0182606578029059,0.0337446542881395,4.78883756867634e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",41465,0.0600012417569855,0.0091179472325049,0.0421300651812759,0.0778724183326951,4.86827783866643e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE1,Ribonuclease pancreatic,39655,0.0180510479798561,0.00274520304587397,0.0126704500099432,0.0234316459497691,5.06804346401794e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA11,Integrin alpha-11,41740,-0.0245653502194548,0.00375328632341035,-0.031921791413339,-0.0172089090255705,6.16938953696587e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA3G,Semaphorin-3G,39408,0.033005690527854,0.00504994606649635,0.0231077962375211,0.0429035848181868,6.60976921305921e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA7,Thyroxine-binding globulin,39650,0.0132219560341861,0.00202478069927447,0.00925338586360818,0.0171905262047641,6.86240850836585e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA2,Ephrin type-A receptor 2,41245,0.0233926547611637,0.00358682598585895,0.0163624758288802,0.0304228336934472,7.20998988341848e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD7,T-cell antigen CD7,39314,0.0322445572841616,0.00496291070584899,0.0225172523006975,0.0419718622676256,8.55129270673345e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",39308,0.0551687899005386,0.00849444759787001,0.0385196726087134,0.0718179071923638,8.68941141277358e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP3R1,Calcineurin subunit B type 1,41636,0.029003238404225,0.00446677468556904,0.0202483600205097,0.0377581167879403,8.7133375891698e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL21,C-C motif chemokine 21,41805,0.0275399513147776,0.00424752385757948,0.0192148045539218,0.0358650980756334,9.26438527467779e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANSC1,MANSC domain-containing protein 1,41802,0.0199140412536526,0.00307141712104861,0.0138940636963973,0.0259340188109079,9.27062269878069e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL11,C-X-C motif chemokine 11,41865,0.0559088813488694,0.00865252491397056,0.0389499325174871,0.0728678301802517,1.07243588782074e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTN,Pleiotrophin,41521,0.0356447050206863,0.00551769103664122,0.0248300305888695,0.0464593794525031,1.08401772350124e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,41585,0.083694650194495,0.0129677030576905,0.0582779522014216,0.109111348187568,1.12744298880122e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,41877,0.023923051379484,0.00371741652560625,0.0166369149892958,0.0312091877696723,1.27380782351012e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIGR,Polymeric immunoglobulin receptor,41614,0.0263733852939021,0.00410506536470667,0.018327457179077,0.0344193134087272,1.36824122198361e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,41758,0.0303098662074223,0.00472839003547809,0.0210422217378853,0.0395775106769594,1.50300741641937e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAX,Apoptosis regulator BAX,41447,0.0649207726337225,0.010153598678374,0.0450197192241095,0.0848218260433355,1.6733896326703e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNLY,Granulysin,41758,0.0380390222348264,0.0059567125533457,0.0263638656302688,0.049714178839384,1.76110194017642e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK4,Kallikrein-4,41877,0.0438830440594717,0.0068968117128325,0.03036529310232,0.0574007950166234,2.04611296780569e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,41614,0.0181629156023234,0.00285469983870752,0.0125677039184567,0.0237581272861902,2.05198189461417e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISM1,Isthmin-1,41740,-0.0277813663620518,0.00437071300366558,-0.0363479638492363,-0.0192147688748672,2.13563452458989e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEFL,Neurofilament light polypeptide,41424,0.033264018337068,0.00524305605211647,0.0229876284749197,0.0435404081992162,2.30809210905052e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPON2,Spondin-2,41692,0.0244687120227189,0.00386283966810186,0.0168975462732393,0.0320398777721986,2.46087036485621e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,41465,0.0249811283762703,0.00395438767576051,0.0172305285317797,0.0327317282207609,2.7490914866784e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNXB,Tenascin-X,41758,-0.0182157644726386,0.00288469285911353,-0.0238697624765011,-0.0125617664687761,2.79517787714634e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ULBP2,UL16-binding protein 2,41636,0.02746507787227,0.00435470782127626,0.0189298505425686,0.0360003052019715,2.9371343803887e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,39600,0.0839121654854594,0.013317577307849,0.0578097139620754,0.110014617008843,3.07318623442959e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL5,C-C motif chemokine 5,41836,0.0701046217145766,0.0111628615216663,0.0482254131321106,0.0919838302970426,3.48789254578135e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OCLN,Occludin,39600,0.0308039543757196,0.00491677079087448,0.0211670836256057,0.0404408251258336,3.86565461937642e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,41911,0.0268973475059303,0.00429450091955625,0.0184801257036,0.0353145693082605,3.88742198893549e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,41911,0.0193667455930922,0.00309216334357953,0.0133061054396763,0.0254273857465081,3.88833075116522e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BGN,Biglycan,41443,-0.0815589983063043,0.013034638022564,-0.10710688883053,-0.056011107782079,4.04672124827128e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",41466,0.0348324220007316,0.00558553905523203,0.0238847654524768,0.0457800785489864,4.62423040971565e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL18,C-C motif chemokine 18,41646,0.0483889588974322,0.00777456946504206,0.0331508027459497,0.0636271150489146,4.99463954830881e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGRP,Agouti-related protein,41911,0.0349024009404487,0.00560790765483088,0.0239109019369802,0.0458938999439172,4.99869303302611e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY6D,Lymphocyte antigen 6D,41666,0.0273610172178296,0.0044053643325623,0.0187265031260075,0.0359955313096517,5.42999048256695e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL27,C-C motif chemokine 27,41765,0.0428108868260781,0.00689658670997786,0.0292935768745215,0.0563281967776347,5.54341130667246e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP10,Stromelysin-2,41744,0.0395214831414655,0.00637181704258498,0.0270327217379989,0.052010244544932,5.7222962056311e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,41764,0.0262410800530267,0.00423133266589991,0.0179476680278629,0.0345344920781905,5.75600892925617e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFD,Complement factor D,39650,0.0139095752031542,0.00224338987821328,0.00951253104185619,0.0183066193644523,5.83864899747862e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIP,Gastric inhibitory polypeptide,39308,-0.0348699887655349,0.00563481766296618,-0.0459142313849487,-0.0238257461461212,6.30376310992749e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINC1,Antithrombin-III,39630,0.00990688820668523,0.00160660847180291,0.00675793560195152,0.0130558408114189,7.23361590946485e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,41840,0.0206627625808917,0.00336241385135586,0.0140724314322342,0.0272530937295492,8.21452401553856e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG1B,Lithostathine-1-beta,41925,0.038780734007783,0.00632130586563544,0.0263909745111375,0.0511704935044284,8.76121456732969e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC39A14,Zinc transporter ZIP14,41466,0.0228890055118447,0.00373553427161127,0.0155673583394867,0.0302106526842028,9.1951257091061e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PODXL2,Podocalyxin-like protein 2,41802,0.0193794607098695,0.00316533762902203,0.0131753989569863,0.0255835224627527,9.47901645378164e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,41764,0.0235370618998157,0.00384543499968729,0.0160000093004286,0.0310741144992028,9.57634635407136e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,39600,0.0777464422492981,0.0127155642287423,0.0528239363609633,0.102668948137633,1.00288949806849e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA4D,Semaphorin-4D,41865,0.0203527779646562,0.00333113893803777,0.0138237456461022,0.0268818102832102,1.02512384162758e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",39600,0.0627636623329979,0.0102893521886957,0.0425965320431542,0.0829307926228415,1.09726567588567e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO1,Alpha-enolase,41740,0.0530513314836916,0.00870849533721086,0.0359826806227583,0.0701199823446249,1.14690937321931e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",39308,0.048104643453601,0.00791344087237994,0.0325942993437364,0.0636149875634657,1.25170269306351e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,41715,0.0354603989464014,0.00583547610213284,0.024022865786221,0.0468979321065818,1.26085734522756e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL3,C-C motif chemokine 3,41740,0.039035691792042,0.0064251475354761,0.0264424026225088,0.0516289809615751,1.27053700985263e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,41865,0.0232719321934848,0.00383502271158504,0.0157552876787782,0.0307885767081915,1.32822453328032e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARF1,Scavenger receptor class F member 1,41925,0.0285592362648238,0.00470824802071119,0.0193310701442299,0.0377874023854178,1.34863209069097e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRG2,Bone marrow proteoglycan,39633,0.0343522522298359,0.00566434080193337,0.0232501442580465,0.0454543602016253,1.36571746170205e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",39308,0.065037217570667,0.0107294554850499,0.0440074848199693,0.0860669503213647,1.39351674861187e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAT,Linker for activation of T-cells family member 1,41911,0.0507050712967022,0.00837221711480806,0.0342955257516784,0.067114616841726,1.42996562868158e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JAM2,Junctional adhesion molecule B,41865,0.0183253079748024,0.00302789655225529,0.012390630732382,0.0242599852172228,1.46771298941457e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAB2,Disabled homolog 2,41877,0.0740757946469989,0.0122613548900417,0.0500435390625172,0.0981080502314805,1.56865495916382e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",39308,0.0419944272198383,0.00695026672171596,0.028371904445275,0.0556169499944015,1.57151295317292e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,41547,-0.0191780907671344,0.00317841087487531,-0.02540777608189,-0.0129484054523788,1.64457940735134e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F2R,Proteinase-activated receptor 1,41786,0.0379953569109258,0.00634874473368953,0.0255518172328944,0.0504388965889573,2.22409450902661e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,41875,0.0538119645242005,0.00901404333727515,0.0361444395831412,0.0714794894652598,2.43618948395988e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNB2,Plexin-B2,41871,0.0161424517872146,0.00270564261416405,0.0108393922634531,0.0214455113109762,2.49001211838775e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHGB,Secretogranin-1,41827,0.0278908186015088,0.00467864613599001,0.0187206721749684,0.0370609650280492,2.5661133465729e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITM2A,Integral membrane protein 2A,41740,0.0409255310360226,0.00687905839034896,0.0274425765909386,0.0544084854811065,2.76154826530051e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,41925,0.0416262586659757,0.00700583860643302,0.027894814997367,0.0553577023345845,2.89204641083324e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRK1,Protein BRICK1,41466,0.0299262297447089,0.00503796031106832,0.020051827535015,0.0398006319544028,2.92120439742516e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTDH,Protein LYRIC,39334,0.0630309618639484,0.0106099088789005,0.0422355404613033,0.0838263832665934,2.92503464727044e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TST,Thiosulfate sulfurtransferase,41437,0.0496336654551225,0.00835618642601781,0.0332555400601276,0.0660117908501174,2.92843824096621e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,41925,0.0185662153793804,0.00313409016291637,0.0124233986600643,0.0247090320986965,3.22037314290375e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,41790,0.0176814386589455,0.00298693384898642,0.0118270483149321,0.0235358290029589,3.30754486061391e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAG1,Dystroglycan,41805,0.0311182660995276,0.00525847680558761,0.0208116515605759,0.0414248806384793,3.34498630248944e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17RB,Interleukin-17 receptor B,41559,0.0353826046553273,0.00598310310393198,0.0236557225716206,0.047109486739034,3.42821293563472e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL7,C-C motif chemokine 7,41740,0.0368276628711021,0.00623293241573034,0.0246111153362706,0.0490442104059336,3.53653492142051e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12A_IL12B,Interleukin-12,41689,0.050291889128864,0.00852841759836168,0.0335761906360751,0.0670075876216529,3.79351657149876e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,39600,0.035151535488653,0.00596371506407114,0.0234626539630736,0.0468404170142324,3.87472085866243e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRDL1,Chordin-like protein 1,41786,0.0213020897413168,0.00361739358219095,0.0142119983202226,0.0283921811624111,3.98493812613584e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MESD,LRP chaperone MESD,41758,0.079467240138539,0.0134988662311993,0.0530094623253883,0.10592501795169,4.02959107281449e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,41534,-0.0262973415944283,0.0044751418124905,-0.0350686195469097,-0.0175260636419469,4.29829632882883e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,41354,0.0806587564966352,0.0137340703439728,0.0537399786224485,0.107577534370822,4.38919539750652e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERMAP,Erythroid membrane-associated protein,39334,0.0290955630541078,0.00496134377774413,0.0193713292497293,0.0388197968584863,4.63909704503568e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL20,C-C motif chemokine 20,41911,0.0559718136880644,0.00957725705536471,0.0372003898595496,0.0747432375165793,5.20790290508429e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,39655,0.0140346296319755,0.00240699611110956,0.00931691725420075,0.0187523420097502,5.67178410627926e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMP,Cartilage oligomeric matrix protein,41666,-0.0214683344604814,0.00368598027648427,-0.0286928558023905,-0.0142438131185722,5.869460293416e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALB2,Calretinin,41466,0.0189369755795731,0.0032593397549743,0.0125486696598235,0.0253252814993228,6.39270214313893e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOLM2,Protein GOLM2,41865,0.0146016134034001,0.00251514319167284,0.00967193274772131,0.0195312940590788,6.56506020849301e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,41823,0.0205845581190905,0.00354782640155349,0.0136308183720457,0.0275382978661354,6.70215740461178e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP6,Gastrotropin,41502,0.0364619558249556,0.00628595091188422,0.0241414920376625,0.0487824196122486,6.76491885632213e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYBB1,Beta-crystallin B1,39625,0.0425715590133848,0.00734057063844011,0.0281840405620421,0.0569590774647274,6.83448663069189e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,41911,0.0354425428675151,0.00611349487694193,0.023460092908709,0.0474249928263213,6.88671639971906e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",39308,0.0565281803219695,0.00974919080192432,0.0374197663501978,0.0756365942937411,6.89079400486415e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,39334,0.0558951164614626,0.00965669990314432,0.0369679846512998,0.0748222482716255,7.31283999104178e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROK1,Prokineticin-1,41740,0.0318348406700896,0.00551094322407163,0.0210333919509092,0.04263628938927,7.79247737731727e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPCAL1,Hippocalcin-like protein 1,41911,0.0469021713159315,0.0081388416249585,0.0309500417310128,0.0628543009008501,8.45836637904332e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,41636,0.0367173194768639,0.00637796560114441,0.0242165068986209,0.049218132055107,8.76023402215629e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,P4HB,Protein disulfide-isomerase,41694,0.0246127474429268,0.00427732487387171,0.0162291906901383,0.0329963041957154,8.89820293014811e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,41657,0.0183301690858751,0.00318775830842006,0.0120821628013717,0.0245781753703784,9.11473614472201e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,41740,0.0241459956785236,0.00420201001625161,0.0159100560466705,0.0323819353103767,9.32435834508212e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,41750,0.0321909647101524,0.00560606836542999,0.0212030707139096,0.0431788587063952,9.55410676496498e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAX,Protein max,41466,0.0674750375197902,0.0117524049745563,0.0444403237696599,0.0905097512699204,9.60290354327209e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,41722,0.0304247367857081,0.00529972607819822,0.0200372736724396,0.0408121998989766,9.6309084219021e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,41521,0.0216702184215117,0.00377488976927698,0.0142714344737288,0.0290690023692946,9.64498666324298e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,41783,0.0326696250288941,0.00569145068606811,0.0215143816842006,0.0438248683735876,9.66917945751888e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NID1,Nidogen-1,41810,0.0228278176261381,0.00398006701952023,0.0150268862678785,0.0306287489843978,9.93343154488388e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,39622,0.00943953094412354,0.00164576429353706,0.00621383292879089,0.0126652289594562,9.96938470736701e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP5,Platelet glycoprotein V,39408,0.0232095945714766,0.00404957167961609,0.0152724340794291,0.0311467550635241,1.0228836695526e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTRK3,NT-3 growth factor receptor,41865,-0.0134010426250945,0.00235040807006499,-0.0180078424424219,-0.00879424280776711,1.21231452269936e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GM2A,Ganglioside GM2 activator,39406,0.0243811027714587,0.00427888769881498,0.0159944828817813,0.032767722661136,1.24391639073905e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,41747,0.0140244522332427,0.00246455385347969,0.00919392668042249,0.0188549777860629,1.29399857775079e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1RL,Complement C1r subcomponent-like protein,39629,0.0124484892875152,0.00219032714386119,0.00815544808554729,0.0167415304894831,1.35397941200889e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN10,Ataxin-10,41466,0.0459472337150374,0.00811696984754413,0.0300379728138509,0.0618564946162239,1.54033605146563e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATOX1,Copper transport protein ATOX1,41802,0.0444306323430343,0.00786724500337074,0.0290108321364276,0.0598504325496409,1.66112058726297e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFI,Complement factor I,39650,0.0121159447415212,0.00214621694517164,0.00790935952898474,0.0163225299540576,1.69001804223366e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBS4,Thrombospondin-4,41810,-0.0283290068694849,0.00502370178541155,-0.0381754623688916,-0.0184825513700783,1.7447583675164e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIT,Vitrin,39625,-0.024033753980551,0.00426208088893322,-0.0323874325228601,-0.0156800754382419,1.75277415905502e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK14,Kallikrein-14,41877,0.0288733708997616,0.005125131565143,0.0188281130320814,0.0389186287674419,1.79984700025997e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLPS,Colipase,41736,0.0458899660970386,0.00815572218541272,0.0299047506136297,0.0618751815804475,1.87422636161696e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPIND1,Heparin cofactor 2,39630,0.018089456618851,0.00322518573479256,0.0117680925786576,0.0244108206590445,2.08627131272766e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACRBP,Acrosin-binding protein,39589,0.0248853018980261,0.00444443483548222,0.0161742096204809,0.0335963941755712,2.20506887603728e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1R1,Interleukin-1 receptor type 1,41734,0.0147734756119938,0.00264051021666341,0.00959807558733351,0.0199488756366541,2.25121003035189e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F9,Coagulation factor IX,41819,0.0113420591086068,0.00202819916733521,0.00736678874062978,0.0153173294765838,2.28679280463616e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHCHD6,MICOS complex subunit MIC25,39589,0.0179965699963189,0.00321913963932967,0.0116870563032327,0.024306083689405,2.31831964940632e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNPY4,Protein canopy homolog 4,41689,0.0464182228669167,0.00831923029609333,0.0301125314865738,0.0627239142472596,2.45815871037333e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,41636,0.0358087180138787,0.0064353959804925,0.0231953418921134,0.048422094135644,2.68338378505998e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100P,Protein S100-P,41521,0.0329870025762104,0.0059323285543705,0.0213596386096443,0.0446143665427766,2.74263694451341e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,41689,0.0415552015349508,0.00747898570653955,0.0268963895501333,0.0562140135197683,2.80995334738984e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSL,Cathepsin L1,41765,0.0150764787869597,0.00271601455488579,0.00975309025938356,0.0203998673145359,2.89605456722692e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSAP,Prosaposin,39553,0.017586616658015,0.00317192001512872,0.0113696534283627,0.0238035798876673,3.01678932301119e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLG,Plasminogen,39416,0.0134346226141902,0.00242404447049543,0.00868349545201918,0.0181857497763613,3.05635250228273e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,41521,0.0212037606066891,0.00382869054909133,0.0136995271304701,0.0287079940829081,3.11700974137119e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA6,Carbonic anhydrase 6,41726,-0.0382479503036299,0.00691808936695761,-0.0518074054628668,-0.0246884951443929,3.28797346104887e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADIPOQ,Adiponectin,39650,-0.0420593697771823,0.00760830308950908,-0.0569716438326201,-0.0271470957217445,3.31090634064081e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MIA,Melanoma-derived growth regulatory protein,41802,0.0226385411636144,0.0040960918731868,0.0146102010921683,0.0306668812350605,3.32187256785671e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XG,Glycoprotein Xg,41878,0.0210948322180894,0.00382645743309967,0.013594975649214,0.0285946887869647,3.59580915025326e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,41740,0.0401786548250918,0.00731683486436335,0.0258376584909396,0.054519651159244,4.06485179606386e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BST2,Bone marrow stromal antigen 2,41865,0.0307732235274379,0.00563015601389818,0.0197381177401975,0.0418083293146784,4.69188348215393e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIFBP,KIF-binding protein,41689,0.0498198288797,0.00912228378348633,0.0319401526640668,0.0676995050953332,4.81198813235435e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB6,Serpin B6,41832,0.0352999402496038,0.00649183326715044,0.0225759470459889,0.0480239334532186,5.49640648709618e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MVK,Mevalonate kinase,41534,0.0497598091131184,0.00915723603750453,0.0318116264796095,0.0677079917466272,5.61237565988844e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EREG,Proepiregulin,41617,0.048197133404227,0.00887304727401903,0.0308059607471497,0.0655883060613043,5.67725111545054e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL25,C-C motif chemokine 25,41911,0.0295461727315617,0.00544215051377186,0.0188795577245689,0.0402127877385546,5.76207266904692e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YTHDF3,YTH domain-containing family protein 3,41534,0.05137652634354,0.00949212065640219,0.0327719698569917,0.0699810828300883,6.32436835349661e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,41865,0.028231835191099,0.00523422070395662,0.0179727626113441,0.038490907770854,7.0203965713441e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK6,Kallikrein-6,41779,0.0184360936945346,0.00342108661040892,0.0117307639381331,0.0251414234509361,7.20865903180921e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNM1,Dynamin-1,39600,0.0691724426652348,0.0128371691752058,0.0440115910818314,0.0943332942486382,7.25346069277382e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,41836,0.0256982391957555,0.00477139171743324,0.0163463114295863,0.0350501669619246,7.33152108826423e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF8,SLAM family member 8,41465,0.0320885526993814,0.00596975512438961,0.0203878326555778,0.043789272743185,7.78384069743995e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,41866,0.0205546289302693,0.00382710482738389,0.0130535034685968,0.0280557543919417,7.97088403863564e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12B,Interleukin-12 subunit beta,41911,0.0326146717092122,0.00607557868301315,0.0207065374905064,0.0445228059279179,8.08792205254008e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS8,Galectin-8,41865,0.0362258511861588,0.00674828795937355,0.0229992067857866,0.049452495586531,8.08859235224135e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,41534,0.0254683805216911,0.00475550271756924,0.0161475951952553,0.0347891658481268,8.67515600966966e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,41775,0.0566932346252422,0.0105935933489565,0.0359297916612874,0.077456677589197,8.86144518970866e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKB,Creatine kinase B-type,39633,0.0339742738539224,0.00635212094136602,0.021524116808845,0.0464244308989998,9.04620931820262e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6,Interleukin-6,41689,0.0440032747662137,0.00823510169730707,0.0278624754394919,0.0601440740929356,9.27585309890167e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YAP1,Transcriptional coactivator YAP1,39598,0.0163749908140499,0.00306434004268815,0.0103688843303811,0.0223810972977187,9.28748444064064e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,41786,0.053121826608719,0.00994313061194862,0.0336332906092997,0.0726103626081383,9.316396163764e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMBS,Porphobilinogen deaminase,41877,-0.0236637092422394,0.00444043280249302,-0.0323669575351258,-0.0149604609493531,1.00289803259936e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300A,CMRF35-like molecule 8,39408,0.0180339133477878,0.00339414031715008,0.0113813983261736,0.024686428369402,1.09828876039948e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,41736,0.0200402058998558,0.00377509795271116,0.0126410139125419,0.0274393978871697,1.12314468426522e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1B,Interleukin-1 beta,41447,0.0330615251306738,0.00623710427799643,0.0208368007458008,0.0452862495155468,1.17217046750082e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPD52L2,Tumor protein D54,39408,0.0640561778930583,0.01209798294814,0.0403441313147039,0.0877682244714128,1.21496079758615e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BID,BH3-interacting domain death agonist,41740,0.0386627470485162,0.0073363471807785,0.0242835065741904,0.0530419875228421,1.38561636269251e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,41465,0.0650926956609106,0.0123595546018291,0.0408679686413256,0.0893174226804955,1.41222064266822e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSTB,Cystatin-B,41581,0.0252435310991633,0.00479486557472576,0.0158455945727008,0.0346414676256258,1.42658019133157e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C9orf40,Uncharacterized protein C9orf40,39600,-0.0452938684469777,0.0086035690766658,-0.0621568638372427,-0.0284308730567127,1.43186066235938e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,39308,0.0312102991060611,0.00593357803638788,0.0195804861547408,0.0428401120573813,1.46878434401091e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,39655,0.0429380372253046,0.00816619125829044,0.0269323023590554,0.0589437720915539,1.48327831768719e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",41689,0.0258319764779145,0.00491437815737606,0.0161997952894575,0.0354641576663716,1.49205813674469e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,41911,0.0568708924023346,0.0108215327521928,0.0356606882080368,0.0780810965966324,1.50029084358511e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,39585,0.0510852779060856,0.00973508687392494,0.0320045076331927,0.0701660481789785,1.57014117779548e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",41521,0.0539531573477555,0.0102834398637719,0.0337976152147626,0.0741086994807485,1.57376556271553e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYDGF,Myeloid-derived growth factor,39625,0.057841616487584,0.0110358229713143,0.036211403463808,0.0794718295113599,1.62431027181375e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGES2,Prostaglandin E synthase 2,39258,0.0325251648559501,0.00621790984257607,0.020338061564501,0.0447122681473992,1.71902205397982e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,39600,0.048969999206613,0.00936821838305687,0.0306082911758215,0.0673317072374045,1.75205389362585e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,41819,0.0658743483017817,0.01260852669088,0.0411616359876569,0.0905870606159065,1.77197584192452e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHB6,Ephrin type-B receptor 6,41617,0.0189176690609997,0.00362187079056875,0.0118188023114849,0.0260165358105144,1.78592773813455e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,39600,0.0219700938431208,0.00420605808067417,0.0137262200049995,0.0302139676812422,1.78838986977705e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,39589,-0.0214714697782189,0.0041161863544984,-0.0295391950330358,-0.0134037445234021,1.85803971539115e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,41521,0.0279939588715049,0.00538027488003412,0.0174486201066381,0.0385392976363718,1.99021321631264e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS7_LGALS7B,Galectin-7,41694,0.0252365411459775,0.00485615674364712,0.0157184739284291,0.0347546083635258,2.05781411455059e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,41521,0.0642940030813317,0.0123918370231397,0.0400060025159779,0.0885820036466855,2.15301858856446e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN2,Calsyntenin-2,41911,-0.0229504242610415,0.00442735402932115,-0.031628038158511,-0.0142728103635721,2.20618748294273e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST7,Cystatin-F,41769,0.0541454997519255,0.0104520973186942,0.0336593890072848,0.0746316104965662,2.24742432719215e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CETN2,Centrin-2,41466,0.0390825497259868,0.00754860960046909,0.0242872749090673,0.0538778245429062,2.28331438946112e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,41587,0.0281387643774811,0.00543540938651072,0.0174853619799201,0.0387921667750421,2.28928591666017e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,41728,0.0174350499763463,0.00336981325324596,0.0108302159999842,0.0240398839527083,2.32646521429098e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,41689,0.0610300587976747,0.0117988007150354,0.0379044093962054,0.084155708199144,2.34312736929065e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SULT1A1,Sulfotransferase 1A1,41865,0.073526104276401,0.0142248672954477,0.0456453643773234,0.101406844175479,2.38970469345436e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL10,C-X-C motif chemokine 10,41805,0.0377462838412285,0.00731403304119503,0.0234107790804862,0.0520817886019707,2.49460456954485e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINF2,Alpha-2-antiplasmin,39462,0.00767842579942157,0.00148818498336301,0.00476158323203006,0.0105952683668131,2.51856901032582e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDHB,Succinate dehydrogenase,39600,0.0374657127929055,0.00727225955876667,0.0232120840577228,0.0517193415280881,2.62373273365402e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,39625,0.0351574452269635,0.00683716405306212,0.0217566036829618,0.0485582867709653,2.76331172123505e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,39408,0.0413150927421104,0.00803954734982062,0.025557579936462,0.0570726055477588,2.81053047887492e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRN,Progranulin,41698,0.0143215629398797,0.00278921041078313,0.00885471053474475,0.0197884153450146,2.86754356068642e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,41805,0.0224220123703457,0.00437016298383053,0.0138564929220379,0.0309875318186535,2.92754654814769e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP4,Bone morphogenetic protein 4,41614,-0.0267594578333643,0.00521712911943231,-0.0369850309074517,-0.016533884759277,2.9523131306023e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,41794,-0.0289724496602064,0.00564923820103565,-0.0400449565342363,-0.0178999427861765,2.96106550541121e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,41758,0.0672521338686933,0.0131296952432918,0.0415179311918414,0.0929863365455453,3.06359875755975e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,41765,0.0626545223561559,0.0122396580449889,0.0386647925879777,0.0866442521243342,3.11529714241384e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTF1,Cardiotrophin-1,41521,0.0477231179043233,0.00932663555069647,0.0294429122249582,0.0660033235836884,3.15115203061762e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,41465,0.016904276820554,0.00330392381263324,0.0104285861477928,0.0233799674933151,3.15866614290183e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,41740,0.0242518121683575,0.004744639031366,0.0149523196668802,0.0335513046698349,3.24248541120163e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNL1,Interferon lambda-1,41466,0.0256945468214755,0.00503219756955608,0.0158314395851456,0.0355576540578054,3.33700069571233e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES1,Liver carboxylesterase 1,41786,-0.0480703868855514,0.00942052180176366,-0.0665346096170082,-0.0296061641540947,3.39442180593887e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCTN3,Tectonic-3,39625,-0.0171930200680575,0.00337170762244085,-0.0238015670080416,-0.0105844731280734,3.46750787239515e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGH,Gamma-glutamyl hydrolase,41562,0.0191569358715662,0.00375922900901218,0.0117888470139023,0.02652502472923,3.51834417469984e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,41740,0.0467706676477683,0.00918755695717357,0.0287630560117081,0.0647782792838285,3.61765352638183e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,41465,0.0368334899221797,0.00724076855760558,0.0226415835492728,0.0510253962950866,3.68975441135722e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,39318,0.0205132328651652,0.00403271972976677,0.0126091021948223,0.0284173635355081,3.70513610060484e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,39600,0.0544277911467846,0.0107100795081276,0.0334360353108546,0.0754195469827146,3.79770804469458e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,39633,-0.0152998875752794,0.00301294329365523,-0.0212052564308436,-0.00939451871971511,3.87546448360627e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH1,Cadherin-1,41333,0.0226637638583851,0.00446628872569814,0.0139098379560167,0.0314176897607534,3.94186155737815e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMOT,Angiomotin,39408,0.0216207409955816,0.00426396783031129,0.0132633640481715,0.0299781179429917,4.03202262492852e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX8,Syntaxin-8,41740,0.0268656781185718,0.0053001272458603,0.0164774287166856,0.037253927520458,4.05617070504427e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,41739,0.0186796947167569,0.00368916926649371,0.0114489229544292,0.0259104664790846,4.1744816286171e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK4,Dickkopf-related protein 4,41612,0.0256876992934786,0.00507733248809174,0.0157361276168188,0.0356392709701384,4.26556079815516e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD244,Natural killer cell receptor 2B4,41911,0.0154150620927305,0.00304966201728636,0.00943772453884918,0.0213923996466117,4.3683935440457e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,41689,0.0523630752776735,0.010364288883794,0.0320490690654373,0.0726770814899098,4.42498988292248e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRY2,Protein sprouty homolog 2,41534,0.0519232456988764,0.0102827869135407,0.0317689833483367,0.0720775080494162,4.48925947495973e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,41765,0.045058850367525,0.00893575317543734,0.0275447741436678,0.0625729265913822,4.65514127096849e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RILPL2,RILP-like protein 2,39625,0.0552547858766596,0.0109635518071054,0.0337662243347331,0.0767433474185861,4.732592679664e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,39625,0.040450832902801,0.00805191356675097,0.0246690823119691,0.0562325834936329,5.14651123390319e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC4A1,Band 3 anion transport protein,39633,-0.0264346910398415,0.00526978435537708,-0.0367634683763806,-0.0161059137033025,5.35028592714841e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",41617,0.0539857251602812,0.0107641928799348,0.0328879071156091,0.0750835432049533,5.36464840632528e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRG,Histidine-rich glycoprotein,39596,0.0172365267265571,0.00343763353565114,0.0104987649966809,0.0239742884564334,5.41222619481559e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,41521,0.0529075872773727,0.0105528913650838,0.0322239202018085,0.073591254352937,5.4139333000617e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",39250,0.0306106786545741,0.00612005262338076,0.0186153755127478,0.0426059817964004,5.77327825581179e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G1B,Phospholipase A2,41915,0.0244708116304974,0.00489636983393291,0.0148739267559889,0.0340676965050059,5.87411587370442e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WNT9A,Protein Wnt-9a,41534,0.0161131929526027,0.00322645722213856,0.00978933679721112,0.0224370491079943,5.98871157199978e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FETUB,Fetuin-B,41819,0.0177707056353638,0.0035591694801671,0.0107947334542363,0.0247466778164913,6.02262946625973e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA4,Protein disulfide-isomerase A4,39633,0.033955122941737,0.00680011562651377,0.02062689631377,0.047283349569704,6.0259114351494e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3B,Protein FAM3B,41689,0.0193972146298694,0.00388540743832219,0.0117818160507579,0.0270126132089808,6.0424599758372e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINH1,Serpin H1,39427,0.071381017223535,0.0143312104453459,0.0432918447506571,0.0994701896964129,6.42964132849397e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,41689,0.0260115891625645,0.00522331546516405,0.015773890850843,0.0362492874742861,6.44278730264942e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,39334,-0.0693148640087836,0.0139195637732245,-0.0965972090043036,-0.0420325190132636,6.4682820340825e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROC,Vitamin K-dependent protein C,41819,0.0141260324299186,0.00283718276731645,0.00856515420597833,0.0196869106538588,6.47549367397682e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DRAXIN,Draxin,41636,0.0233513002828609,0.00469469432655337,0.0141496994028163,0.0325529011629055,6.6428693338264e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,39598,0.0601670834101457,0.0120969629722898,0.0364570359844578,0.0838771308358337,6.66675195621364e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEC31A,Protein transport protein Sec31A,39308,0.0427567024899795,0.00859881629585317,0.0259030225501073,0.0596103824298517,6.71564929817615e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,41905,0.0698338305389493,0.0140462105402998,0.0423032578799617,0.0973644031979369,6.71880463236702e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6L2,Seizure 6-like protein 2,41689,0.0132506042153668,0.00266633969175995,0.00802457841951729,0.0184766300112163,6.79442904869903e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,39250,0.0308389165564634,0.00621232778392567,0.0186627540999691,0.0430150790129577,7.00720423813275e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FIS1,Mitochondrial fission 1 protein,41747,0.0422310417123562,0.00851346666773828,0.0255446470435892,0.0589174363811232,7.11910993802974e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL12,Stromal cell-derived factor 1,41534,0.02168677366361,0.00437357425213042,0.0131145681294344,0.0302589791977856,7.19063655912167e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR2,Complement factor H-related protein 2,39578,0.0312519332025836,0.0063170899756602,0.0188704368502896,0.0436334295548776,7.64032665462341e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPL,N-acetylneuraminate lyase,39625,0.0254445278225383,0.00514696351985156,0.0153564793236293,0.0355325763214474,7.78220635727363e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDRKH,Tudor and KH domain-containing protein,41466,0.0465969157869348,0.00943039575530241,0.0281133401065421,0.0650804914673275,7.86437146676214e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR2,TGF-beta receptor type-2,41802,0.0187767139209606,0.00380298443118975,0.0113228644358287,0.0262305634060925,8.01538648012774e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KEL,Kell blood group glycoprotein,41466,-0.0197856129363472,0.00400921536024742,-0.0276436750424321,-0.0119275508302622,8.11402042239098e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,41925,0.0124848631789632,0.00253277448598708,0.00752062518642855,0.0174491011714979,8.35079533140678e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRIP2,Cysteine-rich protein 2,41636,0.0197988284355359,0.00401671495908836,0.0119260671157227,0.0276715897553491,8.36211054725129e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG2,Desmoglein-2,41758,0.0146778675014275,0.00298590253229934,0.00882549853812076,0.0205302364647342,8.95221592469139e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD5,T-cell surface glycoprotein CD5,41855,0.0193637558343979,0.00394667366258142,0.0116282754557383,0.0270992362130575,9.38899144244753e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP29,Synaptosomal-associated protein 29,41802,0.0497298723514388,0.0101418571183895,0.0298518323993955,0.0696079123034822,9.52988738095597e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRDL2,Chordin-like protein 2,41765,-0.0248793824835468,0.0050750265773305,-0.0348264345751146,-0.014932330391979,9.58427125149882e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM1,Intercellular adhesion molecule 1,41748,0.0157851542011177,0.00322239768175286,0.00946925474488207,0.0221010536573533,9.76836367452574e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,39408,0.0651499251430303,0.0133283299091547,0.039026398521087,0.0912734517649735,1.0328858141489e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,41740,0.0656058763208746,0.0134362370592677,0.0392708516847099,0.0919409009570393,1.05843408525022e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF23,Fibroblast growth factor 23,41866,0.0272251990420034,0.00558730486542301,0.0162740815057743,0.0381763165782325,1.11361786514677e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,39598,0.0485200188397429,0.00996767166534617,0.0289833823756644,0.0680566553038214,1.14451537718265e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMVK,Phosphomevalonate kinase,41459,0.0582681916100452,0.0119770534328038,0.0347931668817498,0.0817432163383405,1.15821836351624e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,41577,-0.0322301581530648,0.00662758096412289,-0.0452202168427457,-0.019240099463384,1.16954875881629e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,39600,0.0456166482690768,0.00938252739765847,0.0272268945696662,0.0640064019684874,1.17889113317329e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,39334,0.047638092144361,0.00980090236480947,0.0284283235093344,0.0668478607793876,1.18698522215214e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRAS,Ras-related protein R-Ras,39328,0.0712974430973736,0.014671681973078,0.0425409464301407,0.100053939764606,1.19332108817987e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MET,Hepatocyte growth factor receptor,41777,0.0103139520901306,0.00212326134356289,0.00615235985674734,0.0144755443235139,1.20183806984528e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300C,CMRF35-like molecule 6,41865,0.0189426930104164,0.00390007214090437,0.0112985516142439,0.026586834406589,1.20531361564949e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,41925,0.0122256974780918,0.00252824750712599,0.00727033236412489,0.0171810625920588,1.34199839388635e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLB1,Beta-galactosidase,41636,-0.0230574134261168,0.00476901282843272,-0.032404678569845,-0.0137101482823887,1.34773633752024e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAP,Prolyl endopeptidase FAP,41925,-0.0147001187677338,0.00304277446695119,-0.0206639567229581,-0.00873628081250941,1.37253439450815e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD84,SLAM family member 5,41740,0.0170536480726588,0.00353051101123267,0.0101338464906427,0.0239734496546748,1.37822192576779e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,39408,0.0191583633813585,0.00396788194845307,0.0113813147623905,0.0269354120003265,1.3954882879101e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLMP,CXADR-like membrane protein,41877,0.0118220447357782,0.00245305373253067,0.00701405942001804,0.0166300300515383,1.45644270959095e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA13,Carbonic anhydrase 13,41593,0.0562370946603277,0.0116725913289459,0.0333588156555938,0.0791153736650616,1.46733695044956e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRSF1,G-rich sequence factor 1,39169,0.0444695380427915,0.00923403667582452,0.0263708261581754,0.0625682499274076,1.48624733032924e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,41848,0.0102177098600831,0.00212535090061823,0.00605202209487133,0.0143833976252948,1.54477401090017e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,41689,0.0445240896683732,0.00927992647498318,0.0263354337774062,0.0627127455593402,1.62113076507221e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCK2,Cytoplasmic protein NCK2,41805,0.0567613778844257,0.0118369828049801,0.0335608915866646,0.0799618641821868,1.64239309369693e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PZP,Pregnancy zone protein,39650,0.0175906558804553,0.00366898892170098,0.0103994375939214,0.0247818741669892,1.65278323177789e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,41925,0.0209908159984888,0.00438097628026662,0.0124041024891663,0.0295775295078114,1.67444066024661e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,41805,0.0637228580599839,0.0133130294419898,0.037629320353684,0.0898163957662838,1.71551413457883e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTG,Protogenin,41877,-0.0130010707549187,0.00271727614282721,-0.01832693199486,-0.00767520951497731,1.7317467947072e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,41636,0.0556773554884514,0.0116419068386795,0.0328592180846397,0.0784954928922632,1.75027662987407e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,41765,0.0305856432862945,0.00640531676297312,0.0180312224308672,0.0431400641417218,1.81606654933359e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAT2,Linker for activation of T-cells family member 2,41689,0.0666613839618008,0.0139716005138298,0.0392770469546944,0.0940457209689073,1.85103760071183e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL1,Fc receptor-like protein 1,41765,0.0242176903974169,0.00507791429254912,0.0142649783840206,0.0341704024108132,1.86923044065248e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAN,Neurocan core protein,41865,0.019719992775965,0.00414013923630252,0.011605319872812,0.0278346656791179,1.92637344222915e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,39308,-0.0191287432602275,0.00401659169803554,-0.0270012629883772,-0.0112562235320779,1.9378340390254e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,41802,0.0144641914953396,0.00303771041849041,0.00851027907509844,0.0204181039155808,1.94158346039418e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEL1L,Protein sel-1 homolog 1,39308,0.0166577540619283,0.00349846628010464,0.00980076015292318,0.0235147479709334,1.94731536767071e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMMT,MICOS complex subunit MIC60,39589,0.0235855895333497,0.00495646568503615,0.0138709167906788,0.0333002622760205,1.97473167801303e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF1,Trefoil factor 1,41706,0.0423986862216718,0.0089116069692382,0.024931936561965,0.0598654358813787,1.97907351840648e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,41802,0.0500881369814535,0.0105299565415224,0.0294494221600695,0.0707268518028375,1.98838163442425e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB6,Integrin beta-6,41534,-0.0161500650742474,0.00339875005308856,-0.0228116151783009,-0.00948851497019378,2.03816994243054e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USO1,General vesicular transport factor p115,41689,0.0468049868525201,0.00985594589011231,0.0274873329079,0.0661226407971403,2.06686314703331e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEPACAM2,HEPACAM family member 2,39598,-0.0230549414254307,0.00485730377471594,-0.0325752568238739,-0.0135346260269874,2.09629420371521e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK4,Serine/threonine-protein kinase 4,41765,0.0459997895506516,0.00969616207366934,0.0269953118862597,0.0650042672150435,2.11610649382798e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKLR,Pyruvate kinase PKLR,41764,-0.0325965186859744,0.00689183738623762,-0.0461045199630001,-0.0190885174089486,2.27154448804442e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",41740,0.0502249795852704,0.0106220170393317,0.0294058261881803,0.0710441329823604,2.28664650248943e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA5,Integrin alpha-5,41758,0.0130148098384697,0.0027536590238494,0.00761763815172492,0.0184119815252146,2.30937152602885e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD48,CD48 antigen,41786,0.0161110583214984,0.0034089290592992,0.00942955736527198,0.0227925592777248,2.31198486781647e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,41805,0.0669107830294697,0.0141602684941563,0.0391566567809235,0.094664909278016,2.32204410517266e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,41521,0.0270929656514313,0.00573435355594945,0.0158536326817704,0.0383322986210922,2.32909855508121e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,41805,0.0655821593885025,0.0138956015007905,0.0383467804469532,0.0928175383300518,2.38693988262267e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCB,Tubulin-folding cofactor B,41636,0.052076319283851,0.011049503466768,0.0304192924889857,0.0737333460787163,2.46619519480335e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,39589,0.0496289605460069,0.0105307656007565,0.0289886599685242,0.0702692611234896,2.47384935987957e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOH,Beta-2-glycoprotein 1,41758,0.0191056905288123,0.00405546649336697,0.0111569762018131,0.0270544048558116,2.48908973559029e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STXBP1,Syntaxin-binding protein 1,39600,0.0407934650296896,0.0086605461082107,0.0238187946575966,0.0577681354017826,2.50422710621398e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALB1,Calbindin,41689,0.0235528045935029,0.00500240036845065,0.0137480998713396,0.0333575093156662,2.5235343086288e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNMT,Histamine N-methyltransferase,41584,0.0249475906348105,0.00530357348795228,0.0145525865984241,0.035342594671197,2.57842341843867e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAM,Basal cell adhesion molecule,41758,0.0127689616931884,0.00271846752752224,0.00744076533924479,0.018097158047132,2.66526906419765e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,41764,-0.0133328424915381,0.00284122717144316,-0.0189016477475667,-0.00776403723550954,2.72424506483666e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBQ1,Hemoglobin subunit theta-1,41877,-0.0317750975327518,0.00678763962317456,-0.045078871194174,-0.0184713238713297,2.87856543511436e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMA,Granzyme A,41911,0.0175585633549319,0.00375546017791377,0.0101978614062209,0.0249192653036429,2.96152684007073e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCC,Tubulin-specific chaperone C,41636,0.041618070021862,0.00890152401899492,0.0241710829446319,0.059065057099092,2.96341679541539e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,41765,0.0256301958636396,0.0054821352722335,0.0148852107300619,0.0363751809972173,2.96551685129251e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1F,Protein phosphatase 1F,39625,0.0276777131557047,0.00592902770263398,0.0160568188585421,0.0392986074528673,3.07477547355111e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,41686,0.0153579652519972,0.00329027200332394,0.0089090321254823,0.0218068983785121,3.07630375990467e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C9,Complement component C9,39655,0.0300072437574637,0.0064292372126018,0.0174059388207642,0.0426085486941632,3.08755375109773e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,41534,0.0179347427739968,0.00384538295542852,0.0103977921813569,0.0254716933666367,3.13275055917802e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,39600,0.018593629383151,0.00398688092499436,0.0107793427701621,0.0264079159961399,3.14226882322078e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RLN2,Prorelaxin H2,39381,0.0266999474147974,0.00572681945377715,0.0154753812853942,0.0379245135442006,3.16502829101256e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,39600,0.0519038807274922,0.0111350871928709,0.0300791098294653,0.0737286516255191,3.17925643182264e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,41521,0.039740436907736,0.00853839044144877,0.0230051916424964,0.0564756821729756,3.28276744916489e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLB,Beta-klotho,41466,0.0382628697200526,0.00823598252704289,0.0221203439670485,0.0544053954730566,3.4209120622235e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,A1BG,Alpha-1B-glycoprotein,39650,0.00849697453543344,0.00182887232931736,0.00491238476997142,0.0120815643008955,3.42312482844654e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR5,Cadherin-related family member 5,41765,0.0199273073253035,0.00428976730701209,0.0115193634035598,0.0283352512470472,3.42851505260042e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,39408,0.0651549352311805,0.0140481294258059,0.0376206015566009,0.0926892689057601,3.55960416991079e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CETN3,Centrin-3,39600,0.0404729759333512,0.00873609798246442,0.0233502238877209,0.0575957279789814,3.64817448828761e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP20,Centrosomal protein 20,41465,0.0385469542740953,0.00832390170826124,0.0222321069259032,0.0548618016222873,3.67688339671137e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KYNU,Kynureninase,41911,0.0233172431690669,0.00503847711612801,0.013441828021456,0.0331926583166778,3.72995513217726e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,39598,0.0394179709339139,0.00853368132716518,0.0226919555326702,0.0561439863351577,3.89773370223425e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,41925,0.00823041542035928,0.00178422949433773,0.00473332561145734,0.0117275052292612,4.00848973425175e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,L1CAM,Neural cell adhesion molecule L1,41802,-0.015142344334511,0.00328627258950114,-0.0215834386099333,-0.00870125005908881,4.10846630856644e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC1,Sialoadhesin,41805,0.0211919737737413,0.00460303618677936,0.0121700228476537,0.0302139246998288,4.18495309846053e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEP,Leptin,41765,0.0353135783176369,0.0076728514343512,0.0202747895063085,0.0503523671289653,4.21540587351966e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRAP2,GRB2-related adapter protein 2,41765,0.065803525258438,0.01430846198235,0.0377589397730319,0.093848110743844,4.28636218236233e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,39600,0.0386650591746086,0.00841176991593833,0.0221779901393695,0.0551521282098477,4.34343136015984e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA3,Protein disulfide-isomerase A3,39408,0.0125542696315534,0.00273405631261212,0.00719551925883364,0.0179130200042731,4.44377830576303e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,39600,0.0243825671493161,0.005311336458007,0.0139723476916223,0.0347927866070098,4.46732303877497e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALCAM,CD166 antigen,41925,0.00996605388629975,0.00217135062664276,0.00571020665807993,0.0142219011145196,4.4773503135749e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,41636,0.0480820904127506,0.0104992046557721,0.0275036492874373,0.0686605315380638,4.70193810010623e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOC,Brother of CDO,41521,-0.0117952139727226,0.00257630622359888,-0.0168447741709764,-0.00674565377446883,4.73046940287945e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,39600,0.0109229386354151,0.00238780098416781,0.00624284870644618,0.015603028564384,4.82632422138297e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA11,Annexin A11,41708,0.033471760147616,0.00733229596916571,0.0191004600480512,0.0478430602471808,5.04093435912067e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH17,Protocadherin-17,41765,0.0189678925127224,0.00415618611340817,0.0108217677304424,0.0271140172950024,5.06967805931796e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLSCR3,Phospholipid scramblase 3,39580,0.0292066828668865,0.0063993335554573,0.0166639890981902,0.0417493766355828,5.07282497433591e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUMB,Protein numb homolog,39334,0.0425147013413827,0.00932631930151266,0.0242351155104179,0.0607942871723475,5.20719140246643e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,41925,0.0164334766485922,0.00360838439910312,0.00936104322635007,0.0235059100708343,5.30394826752771e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MGLL,Monoglyceride lipase,41786,0.0439744731336749,0.00966170892057984,0.0250375236493384,0.0629114226180114,5.37619339969543e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,41689,0.0438535878527801,0.00963719256998616,0.0249646904156072,0.062742485289953,5.40123010731223e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1S,Complement C1s subcomponent,39650,0.0106261808039176,0.00233511888549015,0.00604934778835688,0.0152030138194783,5.40649493166407e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA12,Carbonic anhydrase 12,41689,0.0164786562087449,0.0036232262457157,0.0093771327671421,0.0235801796503477,5.46284580937535e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",41755,0.0268106061731474,0.00589630864288263,0.0152538412330975,0.0383673711131974,5.48977244577729e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD274,Programmed cell death 1 ligand 1,41636,0.0170191305368295,0.00374422830316974,0.00968044306261683,0.0243578180110422,5.53162102575433e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,41877,0.0203885222313178,0.00448712442568387,0.0115937583569774,0.0291832861056582,5.57407246911158e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARA5,Scavenger receptor class A member 5,41865,0.0153686904107656,0.00338630111824488,0.00873154021900568,0.0220058406025256,5.71566952695939e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",41911,0.0331681056770827,0.00731078059681272,0.0188389757073298,0.0474972356468357,5.75929758902036e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300LF,CMRF35-like molecule 1,41877,0.0301245878343801,0.00664179450029772,0.0171066706137966,0.0431425050549636,5.79404060555851e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3D,Protein FAM3D,39600,0.0439460815056845,0.0096918874551454,0.0249499820935995,0.0629421809177695,5.84011555437972e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,41689,0.0158858560255227,0.00350591611257607,0.00901426044487366,0.0227574516061718,5.91808142036604e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,41614,0.0450344313848935,0.00994778032746212,0.0255367819430678,0.0645320808267193,6.03339370408372e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,41758,-0.0261334265537972,0.00577317470065307,-0.0374488489670773,-0.0148180041405172,6.04376188598075e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,41534,0.0326257814807213,0.00722039495456639,0.0184738073697712,0.0467777555916714,6.2813720657823e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,41899,0.0194166213454701,0.0042979774603738,0.0109925855231374,0.0278406571678027,6.30777034172394e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",41758,0.0384435564987809,0.00851124542823552,0.0217615154594393,0.0551255975381225,6.33285547481804e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNN,Tenascin-N,39633,0.0215718846564088,0.0047782330020808,0.0122065479723304,0.0309372213404871,6.40889951839024e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VGF,Neurosecretory protein VGF,39600,0.0150938706778327,0.00334822055016838,0.00853135839950267,0.0216563829561627,6.61092791103638e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,41758,0.0160468976019277,0.00356005676228111,0.00906918634785678,0.0230246088559987,6.61671221771002e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACYBP,Calcyclin-binding protein,39385,0.0520100930805503,0.0115450216819705,0.0293818505838882,0.0746383355772124,6.70770657554061e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,39625,0.049255535321861,0.0109354665484679,0.0278220208868639,0.0706890497568581,6.73079524544646e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTD,Deoxycytidylate deaminase,39408,0.0479488482086392,0.0106583688065938,0.0270584453477153,0.0688392510695631,6.90823753204816e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,41865,0.0349631837407908,0.00777695867598262,0.0197203447358649,0.0502060227457167,6.99159740272173e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDC1,Syndecan-1,41765,0.0202017940021291,0.00449824714333541,0.0113852296011917,0.0290183584030666,7.14800834303952e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX9,Sorting nexin-9,41765,0.0339075136998394,0.00755165445828181,0.0191062709616071,0.0487087564380718,7.18023140800455e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARFIP1,Arfaptin-1,39600,0.0346140808168881,0.00771030402051037,0.0195018849366878,0.0497262766970884,7.21750183301328e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN9,Septin-9,41689,0.0142286451554264,0.00317401220825119,0.00800758122725411,0.0204497090835988,7.42756946071092e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH3,Cadherin-3,41865,0.018305956353507,0.00408536090261466,0.0102986489843822,0.0263132637226317,7.49627009388716e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,41802,0.0355969721781188,0.00796630016378311,0.0199830238571039,0.0512109204991337,7.94457849864314e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",41689,0.0171158441441924,0.00383040406101162,0.00960825218460965,0.0246234361037752,7.9461605812384e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,41802,-0.0208598731636733,0.00467022353295301,-0.0300135112882612,-0.0117062350390854,8.01443694732263e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,41758,0.0246318949594385,0.00551833356643379,0.0138159611692283,0.0354478287496487,8.12459112784274e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADA2,Adenosine deaminase 2,41720,0.0216539612693882,0.00485150335886178,0.0121450146860191,0.0311629078527573,8.1360272057307e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD1,Programmed cell death protein 1,41847,0.0207699498160359,0.00465852860188887,0.0116392337563337,0.0299006658757381,8.32219314039689e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3C,Protein FAM3C,41750,0.0150170631364919,0.00336886529341955,0.00841408716138963,0.0216200391115943,8.35670943112356e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,41251,-0.0187752588601055,0.00421329499981362,-0.0270333170597402,-0.0105172006604708,8.4144378564085e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLTA,Clathrin light chain A,41521,0.023093620454794,0.00518684689346985,0.0129274005435931,0.0332598403659949,8.56504765952869e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL3,C-X-C motif chemokine 3,41750,0.0470570456737749,0.0105700454885447,0.0263397565162273,0.0677743348313226,8.58047777412149e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,39600,0.0438642813413357,0.00985319710587276,0.0245520150138251,0.0631765476688463,8.59994266364316e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWF,von Willebrand factor,41925,0.0364578392174956,0.00819242988094582,0.0204006766508418,0.0525150017841494,8.64919088239408e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBIN,Erbin,41689,0.0503926257603106,0.0113391843874966,0.0281678243608172,0.072617427159804,8.89800579158935e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,41788,0.0587022507706992,0.013227510498109,0.0327763301944055,0.084628171346993,9.15814283829113e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,39408,0.0332504728946001,0.00749197547250034,0.0185662009684994,0.0479347448207008,9.16363865339473e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK3,Dickkopf-related protein 3,41925,0.0144354099142753,0.00325367066676636,0.00805821540741322,0.0208126044211374,9.21007948076244e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMOX2,Heme oxygenase 2,41466,0.0233306113539756,0.00527158660575429,0.0129983016066972,0.033662921101254,9.69081653764032e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD5L,CD5 antigen-like,39596,0.0234947649229355,0.0053168510773627,0.0130737368113046,0.0339157930345664,1.00142987091201e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",39408,0.0439098479883891,0.00993801101874396,0.024431346391651,0.0633883495851273,1.00414704344183e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,41696,0.0131769731239042,0.00298572100172682,0.00732495996051962,0.0190289862872888,1.02606464878979e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOD,Apolipoprotein D,39153,-0.0205972209770996,0.00466815626438638,-0.0297468072552969,-0.0114476346989023,1.03301696858754e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL15,Interleukin-15,41740,-0.0161343892360459,0.00365860791069454,-0.0233052607410072,-0.0089635177310846,1.04201468359863e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS1BP3,HCLS1-binding protein 3,39308,0.0447592108985276,0.0101554594709208,0.0248545103355228,0.0646639114615323,1.0563558059106e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,41465,-0.0250049798623086,0.00567588791972608,-0.0361297201849717,-0.0138802395396455,1.0640593658565e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIAE,Sialate O-acetylesterase,41769,0.0226986618690001,0.00515283435725282,0.0125991065287845,0.0327982172092156,1.06578355639225e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP6,Platelet glycoprotein VI,41736,0.0428043218962849,0.00975766805547134,0.0236792925075611,0.0619293512850087,1.15960159054827e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,39583,0.0341526183289033,0.00779090510554356,0.0188824443220379,0.0494227923357687,1.17791032499602e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS8,Prostasin,41703,0.020217122788298,0.00461952812546999,0.0111628476623768,0.0292713979142192,1.21562757373745e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,41689,0.00946955843927617,0.00216457074392672,0.00522699978117981,0.0137121170973725,1.22485642845646e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO2,Gamma-enolase,41865,0.031569836448789,0.00722028333287841,0.0174180811163474,0.0457215917812307,1.23834437685836e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,41840,0.0351568065917495,0.00806620828736009,0.0193470383485237,0.0509665748349753,1.31926521866205e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,39625,0.0442262165792,0.010148978760449,0.0243342182087201,0.06411821494968,1.32625553192707e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",39625,0.0367136355034198,0.00842562362792107,0.0201994131926945,0.0532278578141451,1.3282051529644e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL1A1,Collagen alpha-1(I) chain,41925,-0.011322442243111,0.00259889403166423,-0.0164162745451729,-0.00622860994104907,1.33062813854321e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP43,Centrosomal protein 43,41422,0.0340052732159127,0.00780659989653863,0.018704337418697,0.0493062090131284,1.3351135855855e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSC,Dipeptidyl peptidase 1,41745,-0.0213826123756172,0.00490967995735112,-0.0310055850920254,-0.011759639659209,1.33955359811476e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPING1,Plasma protease C1 inhibitor,39630,0.00893445587320141,0.00205217277639476,0.00491219723146769,0.0129567145149351,1.35092483705784e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM20A,Pseudokinase FAM20A,39625,0.0135805308967158,0.00312073432008295,0.00746389162935326,0.0196971701640784,1.36296268852942e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,39314,0.0412084720860721,0.00947529601389305,0.0226368918988417,0.0597800522733025,1.37996975652039e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",39308,0.0236407515001949,0.00543588867854409,0.0129864096902485,0.0342950933101413,1.38016569068475e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCG3,Secretogranin-3,41764,0.0160326152201325,0.00368704999721246,0.00880599722559607,0.0232592332146689,1.38191130114091e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFA,Vascular endothelial growth factor A,41869,0.0272463768242055,0.00626612705265647,0.0149647678009988,0.0395279858474122,1.38282372250059e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,39625,0.0128920779200029,0.00296728153497509,0.00707620611145172,0.0187079497285541,1.40686347010807e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,41521,0.0152112068641254,0.00350168804999217,0.00834789828614077,0.0220745154421101,1.41001864462447e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKD2,Polycystin-2,39250,0.0282814504259438,0.00651935135934947,0.0155035217616188,0.0410593790902688,1.45058690090682e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBD,Thrombomodulin,41765,0.0142268378998527,0.00328535921794322,0.00778753383268395,0.0206661419670214,1.49956611243334e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP5,Retinol-binding protein 5,41689,0.0270004192683391,0.00623618420539597,0.014777498225763,0.0392233403109152,1.50465229129021e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18R1,Interleukin-18 receptor 1,41911,0.0158129622076957,0.00365500417593021,0.00864915402287245,0.0229767703925189,1.52680053682834e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F11R,Junctional adhesion molecule A,41758,0.0266927906919815,0.00617624940606618,0.0145873418560918,0.0387982395278712,1.55866637297446e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,41466,0.0293937473642116,0.00680451847640565,0.0160568911504566,0.0427306035779667,1.57384848029078e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,41855,0.0308514917972258,0.00715411187338585,0.0168294325253895,0.044873551069062,1.62649381016344e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,39308,0.0185588470525238,0.00430513257270703,0.010120787210018,0.0269969068950296,1.64071336511183e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C5,Complement C5,39650,0.0071534980266237,0.00166413174699367,0.00389179980251611,0.0104151962507313,1.73325031901246e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",39598,0.0198355646325392,0.00462036332432545,0.0107796525168613,0.0288914767482171,1.77726051747059e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,39259,0.0472347171762936,0.011003120903281,0.0256686002058628,0.0688008341467243,1.77956169482751e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",41465,0.037391148093736,0.00873603606019787,0.0202685174157481,0.0545137787717238,1.88157870284797e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,39595,0.00943446416514551,0.00220724023221807,0.00510827330999809,0.0137606550202929,1.93332763322276e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,39598,0.0179542307552724,0.00420174113665116,0.00971881812743616,0.0261896433831087,1.94444512094697e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLA2,Src-like-adapter 2,39600,0.0506626735614183,0.0118694287242048,0.0273985932619768,0.0739267538608597,1.98589990343862e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,41836,0.0201806824604071,0.00473858373232586,0.0108930583450484,0.0294683065757658,2.06945642801071e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCS1,Neuronal calcium sensor 1,41877,0.0132811608022732,0.00312180179005948,0.00716242929375659,0.0193998923107897,2.11117348666438e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MINK1,Misshapen-like kinase 1,39598,0.0439770512527669,0.0103366834360188,0.0237171517181701,0.0642369507873637,2.1128509711009e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACHE,Acetylcholinesterase,39408,-0.0162051770983669,0.00381600198387753,-0.0236845409867669,-0.00872581320996696,2.18818271360813e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GC,Vitamin D-binding protein,39650,0.0121200807890264,0.00285964846362703,0.00651516980031739,0.0177249917777354,2.27036350918402e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD93,Complement component C1q receptor,41287,0.0147542645917481,0.00348318234347392,0.00792722719853925,0.021581301984957,2.29287426911642e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",39600,0.0686127468630151,0.0162017687195565,0.0368572801726843,0.100368213553346,2.30521101754927e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP2,Guanylate-binding protein 2,41534,0.0284759778903325,0.0067281150633685,0.0152888723661302,0.0416630834145347,2.32820660808662e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MITD1,MIT domain-containing protein 1,41636,0.0451494254854114,0.0106739780494281,0.0242284285085324,0.0660704224622904,2.35434442138295e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,41786,0.0244673084266273,0.0057845809757982,0.0131295297140628,0.0358050871391918,2.35534645956975e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XCL1,Lymphotactin,41877,0.0255919820202904,0.00606414519308979,0.0137062574418344,0.0374777065987464,2.45694330608313e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CERT,Ceramide transfer protein,41466,0.0287061840968946,0.00680256228757418,0.0153731620132492,0.04203920618054,2.46078568037612e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",41758,0.0216664646366924,0.00513716322720882,0.0115976247113632,0.0317353045620217,2.48576009105216e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX2,Peroxiredoxin-2,39489,-0.0282336700958522,0.00669917756269642,-0.0413640581187371,-0.0151032820729672,2.52353881991186e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,41829,0.0154305866143711,0.00366184950268022,0.00825336158911786,0.0226078116396243,2.5268805999153e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDC,Nuclear migration protein nudC,41911,0.0296086653458247,0.00702654372103343,0.0158366396525992,0.0433806910390502,2.52730569417872e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,39408,0.0410291458650791,0.00973633246432926,0.0219459342349937,0.0601123574951644,2.5289782132842e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD164,Sialomucin core protein 24,41758,0.0122986853253997,0.002919734852796,0.00657600501391955,0.0180213656368799,2.54510719517619e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,41465,0.0303856928236308,0.00722296989503307,0.0162286718293659,0.0445427138178956,2.60751177939515e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAL,Integrin alpha-L,39334,0.0203768805165717,0.00484413484067576,0.0108823762288472,0.0298713848042962,2.61456777657759e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,39589,0.0289276237429536,0.00687806967258001,0.0154466071846968,0.0424086403012105,2.62250679578579e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUSB,Beta-glucuronidase,41829,-0.0283923238266328,0.00675394796785124,-0.0416300618436213,-0.0151545858096444,2.64182634872296e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,39598,0.0251048251853997,0.00597336305288251,0.01339703360175,0.0368126167690494,2.6572180571309e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,41689,0.0113541884569079,0.00270260338479915,0.00605708582270152,0.0166512910911142,2.67258661406099e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSV,Cathepsin L2,41815,-0.0185937380572925,0.00443167155049591,-0.0272798142962645,-0.00990766181832051,2.73868458283769e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,41740,0.0557151484768749,0.0132867038303323,0.0296732089694236,0.0817570879843262,2.76726228843677e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMFG,Glia maturation factor gamma,39625,0.0334538529261315,0.00799480448251537,0.0177840361404014,0.0491236697118616,2.88074571671192e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNC5D,Netrin receptor UNC5D,39334,0.012165249359448,0.00290833696779525,0.00646490890256932,0.0178655898163267,2.9011738072291e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,39271,0.0238434166369216,0.00570055830650385,0.0126703223561741,0.0350165109176691,2.90440383391855e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPL,Lipoprotein lipase,41765,-0.022192597266546,0.00531240776247933,-0.0326049164810055,-0.0117802780520865,2.96627838829353e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGR1,Prostaglandin reductase 1,39625,0.0386928635970766,0.00927059142554371,0.0205225044030109,0.0568632227911423,3.01965054328372e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R9B,Neurabin-2,41911,0.0437537861086244,0.0104956365412051,0.0231823384878625,0.0643252337293863,3.08199421775003e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,41802,0.0386392385480118,0.00928200028029023,0.0204465179986429,0.0568319590973806,3.16344187152113e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",41805,0.0503688792772696,0.0121045765864289,0.026643909167869,0.0740938493866701,3.18663686978433e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FADD,FAS-associated death domain protein,41765,0.0352357657390798,0.00846946879395181,0.0186356069029343,0.0518359245752253,3.19808629292864e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTUD7B,OTU domain-containing protein 7B,39600,0.0292674282548242,0.0070347159826133,0.0154793849289021,0.0430554715807462,3.20066638266333e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP3B1,AP-3 complex subunit beta-1,39600,0.0355763754660808,0.00856463868883311,0.018789683635968,0.0523630672961937,3.29372410815168e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NID2,Nidogen-2,41758,0.0335254665572104,0.00807674639096731,0.0176950436309145,0.0493558894835064,3.33309790419313e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA3F,Semaphorin-3F,41765,0.0122532238524949,0.00295690790188875,0.00645768436479296,0.0180487633401969,3.43536623177893e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,41689,0.0260926402267435,0.00629896536949566,0.013746668102532,0.038438612350955,3.45895287347872e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,41689,0.0207848897223468,0.00502307599610117,0.0109396607699885,0.0306301186747051,3.52720869477051e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD63,CD63 antigen,41614,0.0230752556987244,0.005578022347097,0.0121423318984143,0.0340081794990345,3.54370508737468e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,39308,0.0224674813676348,0.00543482883914273,0.0118152168429151,0.0331197458923546,3.59249833852605e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,41925,0.0115076502517841,0.00278394772498508,0.00605111271081336,0.0169641877927549,3.59352952055633e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IST1,IST1 homolog,39522,0.0452573595561777,0.0109489093843687,0.0237974971628149,0.0667172219495404,3.5994272438368e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA3,Annexin A3,41840,0.0317898724007589,0.00769590557288052,0.016705897477913,0.0468738473236047,3.63800626374809e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,39408,0.029396790016151,0.00712640132548082,0.0154290434182085,0.0433645366140934,3.73423775222422e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIAPIN1,Anamorsin,41802,0.028011850304598,0.0067997214114956,0.0146843963380666,0.0413393042711293,3.81913522823813e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP4,Guanylate-binding protein 4,41466,0.0223911678208526,0.00543841799448407,0.0117318685516638,0.0330504670900413,3.85862746669173e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB1A1,Uteroglobin,41785,0.0243969192737093,0.00593421511158105,0.0127658576550104,0.0360279808924081,3.95942339573178e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,39308,-0.0184154419997678,0.0044793823790483,-0.0271950314627025,-0.00963585253683318,3.9662028520827e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCN2,Ficolin-2,41737,0.0183946082005162,0.00447634023145581,0.00962098134686286,0.0271682350541696,3.99275498311531e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,41689,0.0386997654341706,0.00942292495713588,0.0202308325181842,0.0571686983501569,4.03302541161138e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,39600,0.0520698373567741,0.0126989554951705,0.02717988458624,0.0769597901273082,4.15538487438872e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,39600,0.0292366612930359,0.00713343257533276,0.0152551334453837,0.0432181891406881,4.1874889864837e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,39250,0.0276910251135282,0.00676129236549705,0.014438892077154,0.0409431581499024,4.24332498585192e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,39633,0.0122556978485002,0.0029939431748249,0.00638756922584335,0.018123826471157,4.27942791706232e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM,Paralemmin-1,39533,0.0138976055100655,0.00340157051920612,0.0072305272924215,0.0205646837277095,4.42685122914099e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGMN,Legumain,41805,0.0164316694670532,0.00402488891927794,0.00854288718526841,0.024320451748838,4.48133369186029e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMA4,Laminin subunit alpha-4,41805,0.0154650800221648,0.00379374924284528,0.00802933150618807,0.0229008285381416,4.59936554693294e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD40LG,CD40 ligand,41911,0.0357708691544453,0.00877805898973769,0.0185658735345594,0.0529758647743312,4.62750249017093e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,41636,0.0357118929405661,0.00877526305516574,0.0185123773524412,0.0529114085286909,4.73696390391249e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MARCO,Macrophage receptor MARCO,41765,0.0116592226319258,0.00286509048814188,0.00604364527516771,0.0172747999886839,4.74077868765773e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA4,Annexin A4,41709,0.0326877556701742,0.00803383833868699,0.0169414325263477,0.0484340788140007,4.75409656485469e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPSE,Heparanase,39535,0.0430583152551358,0.0105821520463799,0.0223172972442312,0.0637993332660403,4.75559981969025e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM17,Splicing factor 45,39600,0.0347655475541411,0.00855682932017802,0.0179941620865922,0.05153693302169,4.88032739589634e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,39600,0.0127009270199981,0.00312780386218719,0.0065704314501112,0.018831422589885,4.92747561454165e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,41836,0.0122361474597248,0.00301877033118863,0.00631935761059504,0.0181529373088545,5.0777029076046e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,39625,0.0125769067927225,0.00311068186482355,0.00647997033766839,0.0186738432477767,5.3099987793288e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,39589,0.0215898382906546,0.00534133712236809,0.0111208175308132,0.0320588590504961,5.33519954228798e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18,Interleukin-18,41693,0.0198071089409135,0.00490108870500838,0.0102009750790971,0.02941324280273,5.34437765665826e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,41465,0.0141767655219344,0.0035079331962493,0.00730121645728575,0.021052314586583,5.34548603780238e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",39408,0.0470905099051772,0.0116540170549241,0.0242486364775259,0.0699323833328285,5.36584362900982e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,41689,0.034731457768509,0.00859874549278698,0.0178779166026465,0.0515849989343715,5.39557629817157e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNPEP,Aspartyl aminopeptidase,39598,0.0254734789306367,0.00631162505091548,0.0131026938308424,0.037844264030431,5.47473332007746e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NIT2,Omega-amidase NIT2,39574,0.0326758754915253,0.00809837238905765,0.0168030656089723,0.0485486853740783,5.50031266947479e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,39625,0.0400692572039039,0.00993738752797744,0.0205919776490682,0.0595465367587397,5.56357417808445e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIF1,Allograft inflammatory factor 1,41465,0.0233540677320517,0.00579521543249291,0.0119954454843656,0.0347126899797378,5.61246517330269e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,41740,0.0464397652499112,0.011548720084863,0.0238042738835798,0.0690752566162426,5.82248929553594e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,41689,0.051955583736717,0.0129321498071382,0.026608570114726,0.0773025973587079,5.91346591712804e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD58,Lymphocyte function-associated antigen 3,41722,-0.007735142001862,0.00192581266810504,-0.0115097348313479,-0.00396054917237612,5.93828831002265e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP3,"Fatty acid-binding protein, heart",39625,0.0241924800446085,0.00602349956344846,0.0123864209002495,0.0359985391889675,5.94985910027038e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL19,C-C motif chemokine 19,41865,0.0500770204783898,0.0124692303972744,0.0256373288997319,0.0745167120570476,5.95083830366901e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,41715,0.0182488907698203,0.00454822505837516,0.00933436965540499,0.0271634118842356,6.04612124233481e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA1,GDNF family receptor alpha-1,41862,0.0126843025693267,0.00316145405607541,0.00648785261941892,0.0188807525192345,6.04925151749732e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,41740,0.0323781565632991,0.00807762272574863,0.0165460160208318,0.0482102971057665,6.14750379086388e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,41689,0.0236591268395762,0.00590372770824235,0.0120878205314212,0.0352304331477312,6.17074467978531e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,39308,0.0336893022829487,0.0084173684386168,0.0171912601432598,0.0501873444226377,6.31376005988303e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,41740,0.0261069653498583,0.00652859890856255,0.0133109114890757,0.0389030192106409,6.39960635430395e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGMB,RGM domain family member B,41865,0.0124271148732567,0.00310861011185947,0.00633423905401213,0.0185199906925012,6.43225676267219e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,39427,0.0330273383014337,0.00827255456319993,0.0168131313575618,0.0492415452453055,6.58400712980518e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAXX,Protein PAXX,39408,0.0205370608739757,0.00515842002448182,0.0104265576259913,0.03064756412196,6.89967636844865e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF3,Granulocyte colony-stimulating factor,41534,0.0210901391482805,0.00530526788367648,0.0106918140962746,0.0314884642002864,7.06666535282855e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,39408,0.0384786801229376,0.00968380884680726,0.0194984147831953,0.0574589454626798,7.12822251184168e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRPK2,SRSF protein kinase 2,41740,0.0375162058031761,0.00946719509009747,0.0189605034265851,0.0560719081797672,7.44804669103878e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLNS1A,Methylosome subunit pICln,39328,-0.0147637377610902,0.00372793865392236,-0.0220704975227781,-0.00745697799940241,7.53409348880297e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LBR,Delta(14)-sterol reductase LBR,41865,0.0298648856288443,0.00754522873077939,0.0150762373165167,0.0446535339411719,7.59373272144071e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,41707,0.0088014067314415,0.00222404095240834,0.00444228646472115,0.0131605269981619,7.61713710317522e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CENPF,Centromere protein F,39427,-0.0236357161002556,0.0059877523097709,-0.0353717106274066,-0.0118997215731047,7.95228707130965e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TWF2,Twinfilin-2,39633,0.0373129322971135,0.00945349742128521,0.0187840773513945,0.0558417872428325,7.96283030099335e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",39308,0.011163468056117,0.00283258706446798,0.00561159740975977,0.0167153387024742,8.16292840763548e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,39634,0.0112467358960931,0.00285448968868909,0.00565193610626249,0.0168415356859237,8.19781346735821e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPG,Macrophage-capping protein,41637,0.0256385418400293,0.00651957845409808,0.0128601680699971,0.0384169156100616,8.44859766487105e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2,Microtubule-associated protein 2,39598,0.0205192119488567,0.00521935223977164,0.0102892815589043,0.0307491423388092,8.49805294390319e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",39600,0.0341957898075084,0.00869840503954817,0.017146915929994,0.0512446636850228,8.50157808785437e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,41758,-0.0231628595468229,0.00589286272936239,-0.0347128704963732,-0.0116128485972727,8.51454814232108e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",41447,0.0203302157087994,0.00517708397980145,0.0101831311083886,0.0304773003092103,8.64747771781434e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASAH1,Acid ceramidase,39545,0.0205330059033406,0.00524315277257119,0.010256426469101,0.0308095853375801,9.05181386183766e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APRT,Adenine phosphoribosyltransferase,41622,0.0202867290820396,0.0051829954408849,0.0101280580179052,0.030445400146174,9.1206408229474e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39107,0.0472365228708359,0.0120675392496579,0.0235841459415063,0.0708888998001655,9.12219281105565e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,41744,-0.0172225098438131,0.00441121950506219,-0.025868500073735,-0.00857651961389124,9.49896738863366e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,41765,0.0356575307653372,0.00913573394532847,0.0177514922324934,0.053563569298181,9.54481560556992e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,41636,0.0403542902787447,0.0103409499016036,0.0200860284716016,0.0606225520858878,9.57313708658383e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,39598,0.104303492749603,0.0267724266871674,0.0518295364427547,0.156777449056451,9.84022969395419e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,41805,0.0380228675336979,0.00977960595932988,0.0188548398534113,0.0571908952139845,0.00010157862400085
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L1,Bcl-2-like protein 1,39598,0.0430759781542188,0.011078821280475,0.0213614884444877,0.0647904678639498,0.000101610432316286
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,39427,0.015317604842881,0.00394021747131061,0.0075947785991122,0.0230404310866498,0.000101885543182195
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,41836,0.015434697518981,0.00397674472346085,0.00764027786099776,0.0232291171769643,0.000104429719792097
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRL,Prolactin,41865,0.0317122425724571,0.00817319019827373,0.0156927897838406,0.0477316953610736,0.000104947527115003
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,41465,0.0360987293144238,0.0093141793399136,0.0178429378081931,0.0543545208206544,0.000106857507670321
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NHLRC3,NHL repeat-containing protein 3,39160,0.0138692325595652,0.00358996324719879,0.00683290459505552,0.0209055605240748,0.000112517805850739
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN1,CCN family member 1,41667,0.0301184616920045,0.00779762257793321,0.0148351214392554,0.0454018019447536,0.000112765534255592
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL4,C-C motif chemokine 4,41769,0.0265984737752089,0.00688997948620329,0.0130941139822505,0.0401028335681674,0.000113715615264312
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,39589,0.0359725727179941,0.00932584198401977,0.0176939224293153,0.0542512230066728,0.00011530092453517
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,41863,0.012016349628501,0.00312899883783805,0.00588351190633844,0.0181491873506636,0.000123446707679243
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,39655,0.0112914847300858,0.00294087777027761,0.00552736430034171,0.0170556051598299,0.000123975403690418
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCA,Tubulin-specific chaperone A,39408,0.0358291066862443,0.00935071534882146,0.0175017046025542,0.0541565087699343,0.000127982983743215
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUS,RNA-binding protein FUS,41454,0.0168559741952176,0.00440173323001871,0.0082285770643809,0.0254833713260543,0.000129068736913693
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,41925,0.0172220854193125,0.00451370751800315,0.00837521868402633,0.0260689521545987,0.000136517226430269
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,41805,0.0125869535178882,0.00330089979012256,0.00611718992924796,0.0190567171065284,0.000137809296123632
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,39576,0.0153890969722334,0.00404120861550724,0.00746832808583922,0.0233098658586276,0.000140833620390513
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOK2,Docking protein 2,41765,0.0519104444667639,0.0136356333367955,0.0251846031266447,0.0786362858068831,0.000141317774948175
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,39600,0.0422461006710905,0.0111044741359895,0.020481331364551,0.06401086997763,0.000142905547188076
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YES1,Tyrosine-protein kinase Yes,41689,0.0480342501800387,0.0126403034226958,0.0232592554715549,0.0728092448885224,0.000145300585661694
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,39328,0.0228323467078792,0.00601073238338825,0.0110513112364382,0.0346133821793201,0.000146321064762512
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGCC,Regulator of cell cycle RGCC,39600,0.0323160385825389,0.00851485031431832,0.015626931966475,0.0490051451986028,0.000148282417602398
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,41465,-0.0126992356641651,0.00334728693656755,-0.0192599180598375,-0.00613855326849273,0.000148985161599996
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDS,Iduronate 2-sulfatase,41911,-0.00387147949644816,0.00102113153632987,-0.00587289730765471,-0.00187006168524162,0.000150484805885603
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,41783,0.0295028738913031,0.00778352916590974,0.01424715672612,0.0447585910564861,0.000151060355580069
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAT2,Signal transducer and activator of transcription 2,39334,0.0332369458853637,0.00876854678256384,0.0160505941915385,0.0504232975791888,0.000151183117909396
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMD,Osteomodulin,41805,-0.0172202445251624,0.00454427045426851,-0.0261270146155287,-0.00831347443479616,0.000151657442435816
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNC,Tenascin,41836,0.0202437944603507,0.00534220433607182,0.0097730739616499,0.0307145149590514,0.000151675661926324
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH2,Cadherin-2,41765,0.0148123502169536,0.00390902857079313,0.00715065421819906,0.0224740462157081,0.000151766019796237
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK24,Serine/threonine-protein kinase 24,41466,0.0260774105002652,0.00688827083942598,0.0125763996549902,0.0395784213455401,0.000153929368463037
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP2,Methionine aminopeptidase 2,41862,0.0233460757601645,0.00617230551829034,0.0112483569443154,0.0354437945760136,0.000156011079062296
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,39600,0.0167625874702202,0.0044315870051379,0.00807667694014994,0.0254484980002905,0.000156068134229192
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGXT,Serine--pyruvate aminotransferase,41765,0.0321078831913412,0.00849737138121958,0.0154530352841508,0.0487627310985315,0.000158428982174678
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRADD,Death domain-containing protein CRADD,41617,0.0311853158805085,0.00825677025219963,0.0150020461861972,0.0473685855748197,0.000159474381121889
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA7A,Semaphorin-7A,41888,0.0119445471128503,0.00316644351736194,0.00573831781882085,0.0181507764068797,0.000162498374716981
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,41466,0.0465064717431024,0.0123361790794593,0.0223275607473622,0.0706853827388425,0.000164026736133611
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELENOP,Selenoprotein P,39650,0.00940545477689314,0.00249520664843916,0.00451484974595239,0.0142960598078339,0.000164486215517855
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,41716,0.0373366713603151,0.00991526776540968,0.0179027465401122,0.0567705961805181,0.000166892817687977
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,41689,0.0285222287638056,0.00757809430097922,0.0136691639338864,0.0433752935937249,0.000168099790630995
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",41521,0.038164975049744,0.0101536979434603,0.0182637270805618,0.0580662230189263,0.000171532248394077
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAO1,Hydroxyacid oxidase 1,41877,0.0513646220545775,0.0136724768693994,0.0245665673905547,0.0781626767186003,0.000172842937789169
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,39655,0.0111306214961827,0.00296794885622867,0.00531344173797451,0.0169478012543909,0.000177543022066992
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QA,Complement C1q subcomponent subunit A,41846,0.00928856540871945,0.00248298962923668,0.00442190573541556,0.0141552250820233,0.000184150901288466
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDF2,Growth/differentiation factor 2,41765,-0.0146555692027719,0.00391957035851223,-0.0223379271054559,-0.00697321130008791,0.000185480851615729
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,41465,0.0315000170489214,0.00843028170606343,0.0149766649050371,0.0480233691928057,0.000187382629875323
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LACTB2,Endoribonuclease LACTB2,41765,0.0273262916294463,0.00732010567445512,0.0129788845075143,0.0416736987513784,0.000189974652874392
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYTL1,Cytokine-like protein 1,39633,0.0105515053866904,0.00282710419973723,0.00501038115520549,0.0160926296181754,0.00019071789399462
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEG1,Protein HEG homolog 1,39408,0.0114136279234892,0.00306649650374563,0.00540329477614781,0.0174239610708307,0.000198621166156139
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,41465,0.0153605570733861,0.00412800327399511,0.00726967065635567,0.0234514434904165,0.00019923121209961
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,41740,0.0465423201137149,0.0125399943011541,0.021963931283453,0.0711207089439769,0.000206876699762285
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD5,Programmed cell death protein 5,41865,0.023538349289081,0.00634545738386368,0.0111012528167082,0.0359754457614538,0.000208532664656497
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,39600,0.0407351645285958,0.0109931213649455,0.0191886466533027,0.0622816824038888,0.000211996858275997
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO3,Beta-enolase,39308,-0.0258079126964906,0.00696491103911245,-0.039459138333151,-0.0121566870598302,0.00021210457341683
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,39589,0.0231537206593299,0.00625378122035645,0.0108963094674312,0.0354111318512285,0.000214652106134394
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,41761,0.0161547535004141,0.00436780937893925,0.00759384711769317,0.024715659883135,0.000217679024987918
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSMB,Beta-microseminoprotein,41728,0.0285008937972121,0.0077125097611874,0.0133843746652848,0.0436174129291394,0.000220423758983343
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,41765,-0.0102853522072947,0.00278429182792418,-0.0157425641900261,-0.0048281402245633,0.000221591639192286
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRN1,Secernin-1,41740,0.022650410402536,0.00614011257541851,0.0106157897547157,0.0346850310503563,0.000226112853008211
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CILP,Cartilage intermediate layer protein 1,39633,-0.0224775520243907,0.0061112126590846,-0.0344555288361965,-0.0104995752125849,0.000236109855712378
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,39308,0.0128578222701238,0.00349831715167334,0.0060011206528441,0.0197145238874036,0.000238608382258077
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,41466,-0.0201956461663462,0.00549538953784459,-0.0309666096605216,-0.00942468267217081,0.000238800466227469
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAMR1,Inactive serine protease PAMR1,41758,0.0107504108240964,0.00292731327182779,0.00501287681131397,0.0164879448368789,0.000241188236142076
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCN1,Ficolin-1,39643,0.0227217652838086,0.00619100972861169,0.0105873862157297,0.0348561443518876,0.00024357612548151
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,39334,0.0370987249602524,0.0101141341326657,0.0172750220602276,0.0569224278602772,0.000245629705308182
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAA10,N-alpha-acetyltransferase 10,39250,0.0206793487492408,0.00564270042784664,0.00961965591066143,0.0317390415878202,0.000248737927843372
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP2B,DNA topoisomerase 2-beta,39334,0.0328389972833254,0.00896276866631763,0.0152719706973428,0.050406023869308,0.000249566469869117
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",41708,0.0258793831838364,0.00706527023235695,0.0120314535284168,0.039727312839256,0.00025035738547581
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,41740,-0.029673293596478,0.00811169675835193,-0.0455722192428478,-0.0137743679501082,0.000255098072136829
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN2,CCN family member 2,41766,0.0228938280708618,0.00625887919163261,0.0106264248552619,0.0351612312864617,0.000255365828936668
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",39598,0.0400984801485092,0.0110010588715486,0.0185364047602741,0.0616605555367444,0.000268660355906482
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCP1,Plastin-2,39633,0.0193184731460157,0.00530583503159377,0.00891903648409188,0.0297179098079395,0.000272838312036742
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTA2,"Actin, aortic smooth muscle",41521,0.017556516259064,0.00482218010503879,0.00810504325318795,0.02700798926494,0.000272870681890724
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELOB,Elongin-B,39250,0.0159268730492814,0.00437725411181603,0.00734745499012197,0.0245062911084408,0.000275470278498389
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLC,Galectin-10,41740,0.0269566111960113,0.00744240929327703,0.0123694889811884,0.0415437334108343,0.000293404076803003
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDI2,Protein DDI1 homolog 2,39408,-0.0300883744851795,0.00830927746706793,-0.0463745583206327,-0.0138021906497264,0.000294743536547437
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPPB,Natriuretic peptides B,41521,0.0561387103715683,0.0155085059185599,0.0257420387711908,0.0865353819719457,0.000295882438883795
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6AP2,Renin receptor,41465,0.0157425906387457,0.00435061736203999,0.00721538060914732,0.0242698006683441,0.000297482606475139
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",39598,0.0430228261152858,0.011890464447382,0.019717515798417,0.0663281364321545,0.000297916958487731
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNGR1,Interferon gamma receptor 1,41805,0.00866747591326078,0.00239685999781558,0.00396963031754225,0.0133653215089793,0.000300097018490632
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB2B,Ras-related protein Rab-2B,39589,0.024915616398405,0.00689101460919067,0.0114092277643913,0.0384220050324188,0.00030091567164427
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,41466,0.03438883207048,0.00951734494747584,0.0157348359734273,0.0530428281675326,0.000303500581066468
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPA1,Inositol monophosphatase 1,41636,0.0244560890987252,0.00676855520211971,0.0111897209025706,0.0377224572948798,0.000303588548420515
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,41465,0.0272846203154093,0.00755932061066629,0.0124683519185034,0.0421008887123152,0.000308070158532104
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,41636,0.0315030726024664,0.00874170141373256,0.0143693378315506,0.0486368073733822,0.000314804312718827
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,39600,0.0560777806825944,0.0155639383335409,0.0255724615488542,0.0865830998163347,0.000315882532108526
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,39408,0.017175169754787,0.00476873021316451,0.00782845853698453,0.0265218809725894,0.000317654639542799
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,39625,-0.0237450125506182,0.00660322120374558,-0.0366873261099596,-0.0108026989912769,0.000324592410660218
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",41802,0.0242536989941837,0.0067474770742541,0.0110286439286457,0.0374787540597218,0.000326219219308178
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",41786,0.0337426151398503,0.00939689344211247,0.0153247039933098,0.0521605262863907,0.00033082870332723
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP1,Interstitial collagenase,41317,0.0359320195130899,0.0100069202694412,0.0163184557849851,0.0555455832411947,0.000331011896752531
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUOM,Fucose mutarotase,39408,0.025746860978243,0.00717116473405801,0.0116913780994893,0.0398023438569967,0.000331721050702891
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,41689,0.0149234122723151,0.00416150542491274,0.00676686163948611,0.023079962905144,0.000336933358697462
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,41740,0.0193915011200096,0.00540772055564148,0.00879236883095229,0.0299906334090669,0.000337146862534285
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABHD14B,Protein ABHD14B,41597,0.0221729837143692,0.00618757705059647,0.0100453326952001,0.0343006347335383,0.000340302938489348
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP10,Caspase-10,41466,0.0282802230176976,0.00790809624062491,0.0127803543860728,0.0437800916493224,0.00035002382271041
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUB1,NEDD8 ultimate buster 1,41740,0.0333893286967327,0.00934752149668141,0.0150681865632371,0.0517104708302283,0.000355534725911097
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRKL,Crk-like protein,41764,0.0417022235186571,0.0116782279926434,0.0188128966530761,0.0645915503842381,0.000356973733087094
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARF6,ADP-ribosylation factor 6,39600,0.0431183640788427,0.0120861265219735,0.0194295560957745,0.0668071720619108,0.000361809423144166
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED8,Protein TMED8,39600,0.0409470948339589,0.0114799388146891,0.0184464147571681,0.0634477749107496,0.000362848381303467
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPP1,Osteopontin,41903,0.0173580001635757,0.00487003231364237,0.00781273682883666,0.0269032634983147,0.000366179897058864
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK11,Serine/threonine-protein kinase STK11,41521,0.0288078787590729,0.00809016108682069,0.0129511630289044,0.0446645944892415,0.000370979731275947
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOMO1,Nodal modulator 1,41758,0.0091658790848232,0.00257901269493501,0.00411101420275057,0.0142207439668958,0.000380710495144356
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD99,CD99 antigen,41758,0.00782432914202267,0.00220765172029457,0.00349733177024531,0.0121513265138,0.000395192425749311
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAA80,N-alpha-acetyltransferase 80,39328,0.0485567698493005,0.0137209712881278,0.02166366612457,0.075449873574031,0.000403539642856552
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,39334,0.00804787822912005,0.0022745205084352,0.00358981803258706,0.012505938425653,0.000404452703880388
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,39308,0.0183579041328169,0.00519017389249678,0.00818516330352323,0.0285306449621106,0.000406334823374432
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR1,TGF-beta receptor type-1,39334,0.00859788516333193,0.00243132995055877,0.00383247846023674,0.0133632918664271,0.000407501672474554
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL17,C-C motif chemokine 17,41728,0.0358656330356593,0.0101458442411323,0.01597977832304,0.0557514877482786,0.000409167524814651
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KITLG,Kit ligand,41765,0.0149726506854599,0.00423559858044651,0.00667087746778469,0.023274423903135,0.000409244313722511
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFRP1,Secreted frizzled-related protein 1,41590,0.0168207194954103,0.00476156531244945,0.00748805148300942,0.0261533875078112,0.000412917851364011
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDC4,Syndecan-4,41765,0.0185084854415052,0.00524107342761626,0.0082359815233773,0.028780989359633,0.000414732119375644
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARK7,Parkinson disease protein 7,41758,0.0198051983282714,0.00560832927563244,0.00881287294803186,0.030797523708511,0.000414795878212994
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL16,Pro-interleukin-16,41911,0.0165249502253186,0.00468761093582268,0.00733723279110619,0.0257126676595311,0.000424521956537848
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSHB,Thyrotropin subunit beta,41765,0.0266304888384111,0.00756234167900318,0.0118082991475649,0.0414526785292573,0.000430628442479844
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARG1,Arginase-1,41637,-0.0196752451597823,0.00559208717221254,-0.0306357360173188,-0.00871475430224568,0.000435622624803101
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,41765,0.0123869514378018,0.00352141057037485,0.00548498671986709,0.0192889161557365,0.000436918055346206
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,39600,0.050031171085766,0.0142245346334975,0.0221510832041109,0.0779112589674212,0.000437809613705103
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,41689,0.0533739127136967,0.0151758348610393,0.0236292763860597,0.0831185490413337,0.000437877628809926
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100G,Protein S100-G,39600,0.0190692102939722,0.0054242715937632,0.00843763797019627,0.029700782617748,0.000440637250939839
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RSPO1,R-spondin-1,41636,0.0132191724216374,0.00376212737043234,0.00584540277558998,0.0205929420676847,0.000443327023351108
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,41802,0.00875884413219747,0.00249340919283524,0.00387176211424041,0.0136459261501545,0.000444895959659877
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCHE,Cholinesterase,39474,0.0104786886318427,0.00298553572556013,0.00462703860974482,0.0163303386539405,0.000450227290284941
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFAP,Glial fibrillary acidic protein,41443,0.0177373813616471,0.00505464590446509,0.0078302753888955,0.0276444873343987,0.00045112358665533
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,41704,0.0103325598330704,0.00295174344961032,0.00454714267183414,0.0161179769943066,0.000465940722500973
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,39408,0.0204021831942859,0.00583044616851882,0.00897450870398898,0.0318298576845828,0.000468449005101904
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,39600,0.0331058101480821,0.00947168311072177,0.0145413112510674,0.0516703090450968,0.000475500366203454
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SULT2A1,Bile salt sulfotransferase,41740,0.0227975743863894,0.00652332679490424,0.0100118538683771,0.0355832949044017,0.000476020806130803
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOF,Apolipoprotein F,39655,0.00995785578599117,0.00285766171401044,0.00435683882653072,0.0155588727454516,0.00049475216273602
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,41911,0.0107519180415282,0.00309038483504383,0.0046947637648423,0.0168090723182141,0.000504612477323818
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSB,Cathepsin B,41773,-0.0194668984792711,0.00559909095362319,-0.0304411167483725,-0.00849268021016963,0.000509079303383098
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,41689,0.0206241276631862,0.00593391307217141,0.00899365804173021,0.0322545972846421,0.000511293287430545
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,39625,-0.0110937560085104,0.00319203167337932,-0.0173501380883338,-0.00483737392868692,0.000511953539309305
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPQ,Carboxypeptidase Q,39627,-0.0144035088403986,0.00415190660660739,-0.0225412457893491,-0.00626577189144809,0.000524139313512102
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,41617,0.0428343104148719,0.0123580622594205,0.0186125083864077,0.0670561124433361,0.000529765192347282
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XRCC4,DNA repair protein XRCC4,41466,0.0141594534412884,0.00409022820740747,0.00614260615476979,0.0221763007278071,0.000538366847266304
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MENT,Protein MENT,39408,-0.00914949746383565,0.00264366183435722,-0.0143310746591758,-0.0039679202684955,0.0005404163603209
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,41888,0.0127566030363741,0.00368742413575352,0.00552925173029716,0.019983954342451,0.000542899357692486
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",41636,0.0221766865352749,0.0064123362459699,0.00960850749317393,0.0347448655773759,0.00054504677745043
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MIF,Macrophage migration inhibitory factor,41728,0.0255560539912537,0.00740836896211451,0.0110356508255092,0.0400764571569981,0.000563140981667561
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,41689,0.0107061545238306,0.00311741721424495,0.00459601678391054,0.0168162922637508,0.000595921557416274
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTC,Probetacellulin,41465,0.0279464957308372,0.00814302897007718,0.0119861589494859,0.0439068325121885,0.000601135462777746
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5E,5'-nucleotidase,41802,0.0203963224171066,0.00595546750889057,0.00872360609968106,0.0320690387345321,0.000617109120678349
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL14,C-C motif chemokine 14,41774,0.0153151742779743,0.00447513662833638,0.00654390648643497,0.0240864420695136,0.000622868837290243
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LXN,Latexin,41585,-0.0259255905420997,0.00757564869615144,-0.0407738619865565,-0.0110773190976429,0.000623019245464785
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCA,Calcitonin,41617,0.0262569354569776,0.0076739567115262,0.0112159803023862,0.0412978906115689,0.000624534038482124
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,39308,0.0232647849568134,0.00680176577168156,0.00993332404431749,0.0365962458693092,0.000627616570241521
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,41458,0.0301551572937047,0.00881808260759397,0.0128717153828205,0.0474385992045889,0.000628859556786009
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR158,Probable G-protein coupled receptor 158,39600,0.0131706308832338,0.00385591505328201,0.00561303737880106,0.0207282243876665,0.000638493650071843
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RALB,Ras-related protein Ral-B,39334,0.0112448772965864,0.00329245180700911,0.00479167175484856,0.0176980828383243,0.00063935847120883
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA10,Annexin A10,41466,0.0308092935505356,0.00903947221378973,0.0130919280115077,0.0485266590895634,0.000655677501417733
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,39334,0.0114241455727026,0.00335327499223207,0.00485172658792778,0.0179965645574775,0.000659554158262337
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,39250,0.0262916442401381,0.0077282613339966,0.0111442520255048,0.0414390364547715,0.000671375488628268
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APCS,Serum amyloid P-component,39542,0.0122189962697956,0.00359334748694149,0.00517603519539027,0.0192619573442009,0.000675156292708118
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",39625,0.0274376900422107,0.0080690976752723,0.011622258598677,0.0432531214857444,0.000675403644055286
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX7,Syntaxin-7,39334,0.0185035902944282,0.00544239236321948,0.00783650126251798,0.0291706793263383,0.000676559298205952
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,39308,0.0178416048714974,0.00526685257381322,0.0075185738268235,0.0281646359161713,0.000707797468179751
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YWHAQ,14-3-3 protein theta,39408,0.0279818871811585,0.008261840318691,0.0117886801565241,0.0441750942057929,0.000709435192367826
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCS,Copper chaperone for superoxide dismutase,41636,-0.0173397675978827,0.00512204113169224,-0.0273789682159995,-0.00730056697976589,0.000713040755806028
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBNL,Drebrin-like protein,41805,0.0347150955716734,0.0102672381503308,0.0145913087970251,0.0548388823463217,0.000723917834782754
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMPD3,AMP deaminase 3,39598,-0.0257660276419287,0.00762668974096058,-0.0407143395342115,-0.010817715749646,0.000731613322920293
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,39476,0.020978472171648,0.00623102134596017,0.00876567033356605,0.0331912740097299,0.000763151193179879
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APPL2,DCC-interacting protein 13-beta,39408,0.0422670970373201,0.0125690313953911,0.0176317955023535,0.0669023985722867,0.000774250292585671
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,41689,-0.0198592535017841,0.00590604132344895,-0.0314350944957441,-0.00828341250782419,0.000774524353506318
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,39250,0.0150451576852993,0.00447605950425221,0.006272081056965,0.0238182343136337,0.000778632921147241
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,41740,-0.0365235207354841,0.0108761446769398,-0.0578407643022861,-0.0152062771686821,0.000786942396448563
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOLA1,BolA-like protein 1,39259,0.0203712270941901,0.00606689425182637,0.00848011436061038,0.0322623398277697,0.000788494225305586
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,39308,0.0338221723081433,0.0100893984345817,0.0140469513763632,0.0535973932399233,0.000804356114236098
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNM3,Dynamin-3,39600,0.0206280032448608,0.00615465381931866,0.00856488175899619,0.0326911247307254,0.000806136035776855
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D23,TBC1 domain family member 23,41689,0.0333863148395794,0.00997806697631175,0.0138293035660084,0.0529433261131505,0.000822258750279308
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,41736,-0.0297502056985403,0.00889516342470361,-0.0471847260109594,-0.0123156853861212,0.00082650619243368
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,41740,0.0244374421212535,0.00730716579561807,0.0101153971618421,0.0387594870806649,0.000827176472057481
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL4,Myosin light chain 4,39308,-0.0191261471689624,0.00572016329593696,-0.0303376672289988,-0.00791462710892591,0.000829716458986718
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,41911,0.0247484666821056,0.00741442601952576,0.0102161916838352,0.0392807416803761,0.000846515422260481
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,39250,0.0254336190010269,0.00762399207768076,0.0104905945287726,0.0403766434732811,0.000852845922161309
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,39625,0.0148900994236669,0.00446570718268626,0.00613731334560183,0.023642885501732,0.000857899997212867
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",39600,0.017349154310319,0.00520613164499177,0.00714513628613515,0.0275531723345029,0.000863699893274445
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,41414,0.0214480306332119,0.0064400653611832,0.0088255025252928,0.0340705587411309,0.000869644462711266
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CMIP,C-Maf-inducing protein,39589,0.0310244421921895,0.00933239665622216,0.012732944745994,0.0493159396383849,0.000889049734921601
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF1C,Kinesin-like protein KIF1C,39250,0.0129460335368122,0.00389459693312163,0.00531262354789381,0.0205794435257306,0.00089003444438934
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA2,GDNF family receptor alpha-2,41689,0.00769475124831847,0.00231635889014963,0.00315468782362519,0.0122348146730117,0.000896462470189299
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSF,Cathepsin F,41802,-0.014822469571812,0.00446396325846968,-0.0235718375584126,-0.00607310158521147,0.000901086755852617
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMM2,Phosphomannomutase 2,39250,0.0221677127144415,0.00668164316747045,0.00907169210619943,0.0352637333226836,0.000910648254335771
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RWDD1,RWD domain-containing protein 1,41865,0.0228751713753714,0.00690030572382769,0.00935057215666915,0.0363997705940737,0.000918575782631966
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CX3CL1,Fractalkine,41636,0.0122459169345398,0.00369740535040555,0.00499900244774496,0.0194928314213347,0.000928735749351393
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F11,Coagulation factor XI,39493,0.0115746610183779,0.00349510656582695,0.00472425214935711,0.0184250698873988,0.000930406250049081
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSN,Gelsolin,39608,-0.00697687367437875,0.00211184916326265,-0.0111160980343735,-0.00283764931438396,0.000957292538881801
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKD1,Polycystin-1,39625,-0.00991966946395999,0.00300654687235601,-0.0158125013337778,-0.00402683759414221,0.000972141131088838
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,39427,0.0272797067136867,0.00827356912037705,0.0110635112377477,0.0434959021896257,0.000979645230013575
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",41728,0.0400462286571345,0.0121490371331996,0.0162341158760632,0.0638583414382057,0.000982457782224495
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRGN,Neurogranin,39655,0.0339200708673201,0.0102948866471274,0.0137420930389504,0.0540980486956898,0.000987853168254767
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESYT2,Extended synaptotagmin-2,39598,0.030532944725649,0.00926709584318311,0.0123694368730101,0.0486964525782879,0.000988139560606481
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JUN,Transcription factor AP-1,41534,0.0176492860502029,0.00535968571922179,0.00714430204052817,0.0281542700598776,0.000994009462042201
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO1,Roundabout homolog 1,41764,0.008746928103796,0.00265841008129237,0.00353644434446296,0.013957411863129,0.0010034885252511
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,39633,-0.0103444465144991,0.00314567963464513,-0.0165099785984036,-0.00417891443059468,0.00101051867073589
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,39598,0.011302578289522,0.0034370618177857,0.004565937126662,0.018039219452382,0.00101059896975938
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM106A,Transmembrane protein 106A,39589,0.026176678329118,0.00796524003519627,0.0105648078601333,0.0417885487981027,0.00101807958959056
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA5,Annexin A5,41415,0.0110267558228792,0.00335985891339376,0.00444143235262744,0.017612079293131,0.00103382153484521
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNCA,Alpha-synuclein,39408,0.0430692562650997,0.0131248878999661,0.0173444759811662,0.0687940365490333,0.00103585662593235
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON3,Serum paraoxonase/lactonase 3,41805,-0.0105224114246117,0.00320741310629767,-0.0168089411129551,-0.00423588173626824,0.00103835292032279
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNCG,Gamma-synuclein,41636,0.0242124043229204,0.00738168727985175,0.00974429725441102,0.0386805113914299,0.0010405597505736
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,41465,0.0162158317071831,0.00494998306289343,0.00651386490391192,0.0259177985104542,0.00105590822319159
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK1,Dickkopf-related protein 1,41865,0.0213557818026626,0.00652559294551269,0.0085656196294577,0.0341459439758674,0.00106828329924744
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAP3,Cytosol aminopeptidase,41534,0.0173895490483906,0.00531580715730397,0.00697056702007482,0.0278085310767064,0.00107338237235233
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,41877,0.0121430345685653,0.00371274151135598,0.0048660612063076,0.0194200079308231,0.00107578573411899
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,41847,0.011024569248439,0.0033734294294357,0.00441264756674501,0.017636490930133,0.00108563303321996
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MLN,Promotilin,41740,0.0322754437025782,0.00988513710809174,0.0129005749707184,0.051650312434438,0.00109725763988871
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,39600,0.0197028465623788,0.00603426373491004,0.00787568964195512,0.0315300034828025,0.00109736171964679
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMMD1,COMM domain-containing protein 1,39308,0.022148414570536,0.00678609549239416,0.00884766740544349,0.0354491617356286,0.00110276056583769
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMI,N-myc-interactor,39546,0.0264922128651369,0.00811882877643093,0.0105793084633323,0.0424051172669416,0.00110554686873684
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",39625,0.0190178110389765,0.00583421564587809,0.00758274837305544,0.0304528737048976,0.00111867065422537
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,39625,0.00922298401383962,0.00283001473973742,0.00367615512395427,0.014769812903725,0.00112149167717068
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,39589,0.0188935030501444,0.0057984967815216,0.00752844935836208,0.0302585567419267,0.00112404467708073
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,41799,0.0176043590188718,0.00540432701282013,0.0070118780737443,0.0281968399639992,0.0011269953029356
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP7,Caspase-7,39598,0.0306051099913516,0.0094067496528122,0.0121678806718397,0.0490423393108635,0.00114326112417048
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F3,Tissue factor,41791,0.00938445616905895,0.00288830123269441,0.0037233857529779,0.01504552658514,0.00116049802671656
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLVRB,Flavin reductase,41758,-0.0228585143958922,0.00704054619803502,-0.0366579849440409,-0.0090590438477436,0.00117045194220544
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPI,Glucose-6-phosphate isomerase,39655,0.0172734669367809,0.00532610750809436,0.00683429622091592,0.0277126376526458,0.00118558863047545
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,41740,0.0357017490816837,0.011014493503558,0.01411334181471,0.0572901563486574,0.00119264412936423
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGRN,Neugrin,39598,0.00808316373671,0.00249800146900367,0.0031870808574628,0.0129792466159572,0.00121638913328926
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A13,Protein S100-A13,39334,0.0128025903460019,0.00395646748145035,0.00504791408235921,0.0205572666096446,0.00121642790805718
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA1,Alpha-1-antitrypsin,39470,0.00293199514731016,0.00090644084698122,0.00115537108722697,0.00470861920739335,0.00122167162069283
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCBP2,Poly(rC)-binding protein 2,39600,0.0262343164988814,0.00812845141234675,0.0103025517306818,0.042166081267081,0.00125256899663384
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AREG,Amphiregulin,41689,0.0140057065679071,0.00434060602356325,0.00549811876172308,0.022513294374091,0.00125547488695765
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,39600,-0.0156383076522636,0.00486050789381755,-0.025164903124146,-0.00611171218038115,0.00129722541811698
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX4,Syntaxin-4,41689,0.0210454670022208,0.00654322634279996,0.00822074337033291,0.0338701906341087,0.00130136793571838
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,41404,-0.0299624575140231,0.00932077690635878,-0.0482311802504864,-0.0116937347775599,0.00130955786752668
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRELP,Prolargin,41744,0.00835149017023617,0.00259826707522376,0.00325888670279759,0.0134440936376747,0.00131099733073271
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTH,Parathyroid hormone,39328,0.0297057180773951,0.00924299916681343,0.0115894397104408,0.0478219964443494,0.00131350188401093
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SARG,Specifically androgen-regulated gene protein,39583,0.0392481106694796,0.0122219623826835,0.01529306439942,0.0632031569395391,0.0013252693402953
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C8B,Complement component C8 beta chain,39650,0.0107481686363973,0.00334786898309056,0.00418634542953984,0.0173099918432548,0.00132905970253468
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,39625,0.0274698963473426,0.00856922042236143,0.0106742243195141,0.044265568375171,0.0013514330584912
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC13,Mucin-13,41466,0.0186939039327998,0.00583222590555494,0.00726274115791208,0.0301250667076874,0.0013526162665299
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYAP1,Synapse-associated protein 1,39408,0.0209672290106742,0.00654174311062429,0.00814541251385057,0.0337890455074978,0.00135387223351501
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL8,C-C motif chemokine 8,41855,0.0214779839777152,0.00670190635491895,0.00834224752207405,0.0346137204333563,0.00135496497133426
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TALDO1,Transaldolase,39615,0.0157186055585635,0.0049069825737657,0.00610091971398271,0.0253362914031443,0.00136242388615081
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP25,Synaptosomal-associated protein 25,39259,0.0171731402222266,0.00536285399921495,0.00666194638376527,0.0276843340606879,0.00136764312255585
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTX3,Pentraxin-related protein PTX3,41740,0.0176328974671926,0.00551176793143655,0.00682983232157693,0.0284359626128082,0.00138167107442099
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EHD3,EH domain-containing protein 3,39308,0.0419176713573858,0.0131160666285248,0.0162101807654772,0.0676251619492944,0.0013979872320161
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR4,Complement factor H-related protein 4,39616,0.0259025372517407,0.00811013695860125,0.0100066688128822,0.0417984056905991,0.00140785574795806
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",39385,0.0306286162122117,0.00959620128865376,0.0118200616864503,0.049437170737973,0.00141822242013951
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,41706,-0.06769859897276,0.0212487818137631,-0.109346211327736,-0.0260509866177844,0.00144593185746369
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTF4,Neurotrophin-4,41465,0.0133110479477616,0.00418553428254124,0.00510740075398081,0.0215146951415425,0.00147496773238962
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA1,Apolipoprotein A-I,39650,-0.00959655616026377,0.00301927111989594,-0.0155143275552598,-0.00367878476526772,0.00148480663865147
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPON1,Spondin-1,41764,0.0114768197730495,0.00361114801405019,0.00439896966551113,0.0185546698805879,0.00148553749365431
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COCH,Cochlin,39625,0.0161305769098238,0.00509177729783075,0.0061506934060755,0.0261104604135721,0.00153928447932686
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIMAP7,GTPase IMAP family member 7,39408,-0.0113797582578802,0.00359417225271739,-0.0184243358732063,-0.00433518064255411,0.00154889902987114
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM2,Paralemmin-2,39598,0.0135898086963818,0.00429236788313653,0.0051767676454342,0.0220028497473294,0.00154951310438304
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",39600,0.0246882654371857,0.00779898830599329,0.0094022483574389,0.0399742825169326,0.00155200087178001
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,39600,0.0318049590729366,0.0100549904177367,0.0120971778541727,0.0515127402917005,0.00156522246772397
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD80,T-lymphocyte activation antigen CD80,39625,0.0120259961686021,0.00380403889808103,0.00457007992836331,0.0194819124088409,0.0015745106769472
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,41805,0.0100449022003318,0.00317816889638193,0.00381569116342325,0.0162741132372404,0.00157803312900374
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAT,Catalase,39498,-0.01832202378025,0.00579677020430893,-0.0296836933806955,-0.00696035417980447,0.00157805304072135
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,39625,0.0249320532030761,0.00788812891556059,0.00947132052857733,0.0403927858775748,0.00157813386269537
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELE,E-selectin,41925,-0.0176172342623261,0.00558057938480799,-0.0285551698565497,-0.00667929866810241,0.00159820908452134
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,41802,-0.0085384207210663,0.00270697247215078,-0.0138440867664818,-0.00323275467565077,0.00161281665699665
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,41740,0.0355641680666923,0.0112891661261016,0.0134374024595332,0.0576909336738515,0.00163473252376503
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,41465,0.02692474117441,0.00856394238890636,0.0101394140921535,0.0437100682566664,0.00167053972530041
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATG16L1,Autophagy-related protein 16-1,39600,0.0301015189795576,0.00958464787056649,0.0113156091532473,0.0488874288058679,0.00169050377175282
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRP,Gastrin-releasing peptide,39308,0.0185805675400681,0.00591803348871468,0.00698122190218736,0.0301799131779489,0.00169608291846733
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,41865,0.0331490602798372,0.0105807249810553,0.0124108393169688,0.0538872812427056,0.00173425739029909
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASC3,Protein CASC3,39328,0.0150859166738506,0.00482034916191068,0.00563803231650569,0.0245338010311955,0.00175495076359317
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,41888,0.00679742986496953,0.00217264356045613,0.00253904848647552,0.0110558112434635,0.00175994215660267
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP23,Synaptosomal-associated protein 23,41765,0.0300575035668062,0.00962521066159079,0.0111920906700882,0.0489229164635241,0.00179534329145854
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,39600,0.0272028094639322,0.00871539433201827,0.0101206365731764,0.044284982354688,0.0018055954321865
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,41465,0.0220417942204408,0.00706218399838924,0.00819991358359794,0.0358836748572837,0.00180574673796227
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THPO,Thrombopoietin,41521,0.0134621780909857,0.0043140809459129,0.00500657943699639,0.0219177767449749,0.00180929358140127
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,39573,0.015693529025645,0.00503255629318965,0.00582971869099327,0.0255573393602967,0.00182305645718435
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPEP2,Dipeptidase 2,41689,0.0103821270423066,0.00333326527807753,0.00384892709727463,0.0169153269873385,0.00184528634138676
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,39408,0.0199045770532738,0.00640722693713315,0.0073464122564928,0.0324627418500548,0.0018975398820697
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",39600,0.0164235016391575,0.00529319272797272,0.00604884389233101,0.0267981593859841,0.0019221146655794
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLMH,Bleomycin hydrolase,41925,0.0106272197112821,0.00342874610489805,0.00390687734568194,0.0173475620768823,0.00194285619986797
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JCHAIN,Immunoglobulin J chain,41534,0.0209687829122805,0.0067676222245867,0.00770424335209053,0.0342333224724704,0.00194987430869303
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",39250,0.0216230135595457,0.00699270825776679,0.00791730537432282,0.0353287217447686,0.00199177002859479
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF2,Fibroblast growth factor 2,41740,0.0237455770944245,0.00768568347113383,0.00868163749100214,0.0388095166978468,0.00200854449573825
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,41925,0.00938250093270386,0.00303865108648908,0.00342674480318525,0.0153382570622225,0.00202113428135115
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSTL3,Follistatin-related protein 3,41706,0.0112031670619754,0.0036291465833168,0.00409003975867443,0.0183162943652763,0.00202611156933578
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMN,Protein amnionless,41534,0.0161382568731783,0.00523453316568734,0.00587857186843116,0.0263979418779255,0.00205331303502467
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASHC3,WASH complex subunit 3,39598,0.0260249194307674,0.00844218297508632,0.00947824079959821,0.0425715980619366,0.00205622954087649
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACE,Angiotensin-converting enzyme,39655,0.00919940877108128,0.00299109496749837,0.00333686263478447,0.0150619549073781,0.00210592994823319
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFC,Platelet-derived growth factor C,41465,0.00946728605228109,0.00308014063498346,0.00343021040771351,0.0155043616968487,0.00211897143445863
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,41744,0.0183996805035386,0.00598784685503614,0.00666350066766771,0.0301358603394094,0.00212467766102027
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFC1,Cryptic protein,41465,0.0162534315056037,0.00528986090574443,0.00588530413034458,0.0266215588808627,0.0021267249254802
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEP1B,Meprin A subunit beta,41765,-0.0390200738702938,0.0127032954356263,-0.0639185329241212,-0.0141216148164663,0.00213313661319867
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,39427,0.0241681931179826,0.00788351154091037,0.00871651049779824,0.0396198757381669,0.00217722618125666
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLIC5,Chloride intracellular channel protein 5,39328,0.0107019835625974,0.00349098733131798,0.0038596483932142,0.0175443187319807,0.00217771047035557
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,39600,0.0171635815368437,0.0056059194012942,0.00617597951030707,0.0281511835633803,0.00220623097994244
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRD1,Natural killer cells antigen CD94,41911,0.0160033706365081,0.00522813928901358,0.00575621763004148,0.0262505236429747,0.00221033444052896
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,41521,0.0142972274435759,0.00467346202755815,0.00513724186956196,0.0234572130175899,0.00222356061187568
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG3,Desmoglein-3,41814,-0.011889265921254,0.00389192325080177,-0.0195174354928255,-0.00426109634968255,0.00225616997771231
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTNB,Dystrobrevin beta,39572,0.0153628270240361,0.00504954394767965,0.00546572088658399,0.0252599331614882,0.00235239942904376
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,41740,0.0287223761088129,0.00944387520432309,0.0102123807083396,0.0472323715092861,0.00235963683322315
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP1,Caspase-1,41466,0.0231916595663625,0.00763444520558559,0.00822814696341474,0.0381551721693103,0.00238816521099173
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APP,Amyloid-beta precursor protein,41733,0.0222597064654048,0.00732907753013926,0.00789471450633185,0.0366246984244777,0.00239273693440489
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,41802,-0.00830892223912209,0.00273582571064003,-0.0136711406319765,-0.00294670384626764,0.00239348083015561
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP7,Retinoid-binding protein 7,39600,0.0210010747963406,0.0069214541368871,0.00743502468804185,0.0345671249046393,0.00241737682516366
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP3,Caspase-3,41925,0.029558004853199,0.00975298664241069,0.0104421510340741,0.048673858672324,0.00244486563443571
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,41466,0.0229084116826455,0.0075629597683334,0.00808501053671205,0.037731812828579,0.00245829111272461
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,41706,0.00649837707513411,0.00214542209954627,0.00229334976002342,0.0107034043902448,0.00245882758831426
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,39625,0.0210199580515328,0.00694236452118669,0.00741292359000692,0.0346269925130587,0.0024692611331954
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FYB1,FYN-binding protein 1,41736,0.031009443992417,0.0102493571528447,0.0109207039728414,0.0510981840119926,0.00248701432861758
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCND2,G1/S-specific cyclin-D2,39427,-0.0125185454112676,0.00413795818378958,-0.0206289434514952,-0.00440814737104008,0.00248973343059395
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",39600,0.0272996618769092,0.00902767850588924,0.00960541200536625,0.0449939117484521,0.00250035152430218
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",39625,0.0297639268158496,0.00984399572452893,0.0104696951957729,0.0490581584359263,0.00250392685600695
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THTPA,Thiamine-triphosphatase,39567,0.0294436548456843,0.00976995959753916,0.0102945340345076,0.0485927756568611,0.00258678711597461
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,41798,0.0192810164834057,0.00640459686089985,0.00672800663604205,0.0318340263307694,0.00261314048257777
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABO,Histo-blood group ABO system transferase,39655,0.0483927388696909,0.0160806880191216,0.0168745903522126,0.0799108873871692,0.00262380277978559
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,39408,0.0199444679685593,0.00662768904489808,0.00695419744055904,0.0329347384965595,0.0026248495039109
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL5,C-X-C motif chemokine 5,41723,0.0375383675055713,0.0124818898220133,0.0130738634544253,0.0620028715567172,0.00263968832475123
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOST,Sclerostin,41750,0.0128951128963197,0.00429063317594323,0.00448547187147098,0.0213047539211684,0.00265723016352422
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,39250,0.0109360153087805,0.00364005569044199,0.00380150615551423,0.0180705244620468,0.0026676458442979
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",39297,0.0263933186570662,0.00878904007649207,0.00916680010714179,0.0436198372069907,0.00267967313308997
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",41689,0.0283069837121408,0.00942969558621401,0.00982478036316132,0.0467891870611202,0.00268808269674938
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,41689,0.0130571477617041,0.00435402787212054,0.00452325313234788,0.0215910423910604,0.00271495466718386
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAMDC4,Apical endosomal glycoprotein,39589,-0.0187921777383874,0.00627332382266693,-0.0310878924308146,-0.0064964630459602,0.00274543701330852
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,39408,0.0277418768690914,0.00926377650684319,0.00958487491567874,0.045898878822504,0.00275371631150206
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPB1,Heat shock protein beta-1,41576,0.0231973573376918,0.00775158547458726,0.00800424980750077,0.0383904648678828,0.00277136850829385
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPART,Spartin,39408,0.025918735266015,0.00866131373133837,0.00894256035259181,0.0428949101794382,0.00277353497815031
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,39406,0.0220269830163805,0.00736441671364775,0.00759272625763089,0.0364612397751301,0.00278691014206999
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,39598,0.0122250351225348,0.00409413404686911,0.00420053239067132,0.0202495378543982,0.00283286234374475
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSLN,Mesothelin,41667,0.0192186690122533,0.0064408976173964,0.00659450968215636,0.0318428283423502,0.00285172942705323
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,41465,0.0222017871235859,0.00745668357508299,0.00758668731642319,0.0368168869307485,0.00291213213740775
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLU,Clusterin,39650,0.00973144340478282,0.00326875396150538,0.00332468564023227,0.0161382011693334,0.00291609531358632
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF2,Trefoil factor 2,41786,0.0192459418509912,0.00646651080344482,0.00657158067623933,0.031920303025743,0.00292328072852776
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY96,Lymphocyte antigen 96,41636,0.0120411020415137,0.00404632029977875,0.00411031425394736,0.0199718898290801,0.00292746900729148
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTN3,Myeloblastin,41429,0.0158348559013057,0.00532380524443834,0.00540019762220653,0.0262695141804048,0.00294157159224728
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17C,Interleukin-17C,41534,0.0232845995995428,0.00782988177328879,0.00793803132389674,0.0386311678751888,0.00294667411601326
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,39600,0.039160699667386,0.0132019845568035,0.0132848099360511,0.0650365893987208,0.00302079960797178
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMT,Catechol O-methyltransferase,41367,0.0273554372035681,0.00922777043893158,0.00926900714326218,0.045441867263874,0.00303766220162053
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,41805,0.0281348679522621,0.00949170460843655,0.00953112691972649,0.0467386089847978,0.00304058948713999
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D17,TBC1 domain family member 17,41466,-0.0141155757331291,0.00476445679384445,-0.0234539110490642,-0.00477724041719395,0.00305528234581285
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",39625,0.0097815374788729,0.00330270502571754,0.00330823562846652,0.0162548393292793,0.00306623418075055
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFRC,Transferrin receptor protein 1,41818,0.0122957133773584,0.00415235344060879,0.00415710063376515,0.0204343261209516,0.00307044057866441
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,41865,0.0166760228051122,0.00563249855914636,0.00563632562918537,0.0277157199810391,0.00307504519635013
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",41740,0.0134998047431116,0.00456663048966636,0.00454920898336551,0.0224504005028576,0.00312023611951039
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS2,Trypsin-2,41836,0.0186638620959859,0.00632043519125468,0.00627580912112668,0.031051915070845,0.00315316773013037
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EEF1D,Elongation factor 1-delta,39625,0.0299005237182018,0.0101254269062582,0.0100546869819356,0.0497463604544679,0.00315351954522642
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,39589,0.0176861030756597,0.00599148313138283,0.00594279613814932,0.02942941001317,0.00316519412993434
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPL,Periplakin,39334,0.0106046297938449,0.00360002904489101,0.00354857286585847,0.0176606867218312,0.00322909688468005
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN2,Ataxin-2,39259,0.0346246839372148,0.011760518036808,0.0115740685850711,0.0576752992893586,0.00324546017331763
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFC,Vascular endothelial growth factor C,41802,0.0180475458546113,0.00613329339595753,0.00602629079853453,0.0300688009106881,0.00326083289668867
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXLNA,Alpha-taxilin,41636,0.0286584477174568,0.00974428207247493,0.00955965485540593,0.0477572405795077,0.00327673821510092
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MST1,Hepatocyte growth factor-like protein,39520,0.0221845767511686,0.00754851938337377,0.00738947875975601,0.0369796747425812,0.00330035903878052
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",39633,0.0205795987934656,0.00700437712182624,0.00685101963468612,0.034308177952245,0.00330908103559347
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,39598,-0.0224633465319549,0.00764676984037371,-0.0374510154190874,-0.00747567764482241,0.00331422495541238
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,41751,0.0184977545157947,0.00629928019061293,0.0061511653421934,0.0308443436893961,0.00332527887840101
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,41925,-0.00796563658645695,0.00271276699115709,-0.0132826598891248,-0.00264861328378905,0.0033266592777319
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBLN2,Fibulin-2,39633,0.0104215092007397,0.00355376517744772,0.00345612945294214,0.0173868889485372,0.00336907696805091
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUGT1,Protein SGT1 homolog,41465,0.0259422840017615,0.0088486433199348,0.00859894309468929,0.0432856249088337,0.00337617838246289
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,41925,0.0103450343183821,0.003538011208062,0.00341053235058055,0.0172795362861836,0.00346181291178558
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFB1,BPI fold-containing family B member 1,41720,-0.0209352501252216,0.00716625397087386,-0.0349811079081344,-0.00688939234230883,0.00349094259359823
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,39250,0.0224626105110523,0.00769257987541722,0.00738515395523455,0.03754006706687,0.00350724672673666
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,39589,0.0279398752574318,0.00957524327448765,0.00917239843943598,0.0467073520754276,0.00353079204655176
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,39589,0.0155655625415509,0.0053520862343456,0.00507547352223355,0.0260556515608683,0.00364107577794877
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNMBP,Dynamin-binding protein,41636,0.0195440219998512,0.00672128546619844,0.00637030248610224,0.0327177415136001,0.00364617825283723
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,41899,0.0166535248250319,0.00573827993181112,0.00540649615868208,0.0279005534913817,0.00371183200044472
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10,Interleukin-10,41534,0.0247457818121844,0.00853322181770376,0.00802066704948502,0.0414708965748838,0.00373869298859654
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,41521,0.0305944485094023,0.0105561457247159,0.00990440288895909,0.0512844941298456,0.00375871076400396
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,41466,0.0230955281562062,0.00797925994354001,0.0074561786668678,0.0387348776455446,0.00380467944268012
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSME2,Proteasome activator complex subunit 2,41577,0.0112628303748637,0.0038955360890026,0.0036275796404186,0.0188980811093088,0.00384392969699313
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP2,Caspase-2,41740,0.0219363614527134,0.0075893713434538,0.00706119361954397,0.0368115292858829,0.00385374996645452
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QDPR,Dihydropteridine reductase,41702,0.0135235344609551,0.00468343821151005,0.0043439955663954,0.0227030733555148,0.0038892378153408
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGS10,Regulator of G-protein signaling 10,39600,0.0191448140818484,0.00663107561087735,0.00614790588452875,0.032141722279168,0.00389524008408148
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,41740,0.018208962473694,0.00631069827536931,0.00583999385397015,0.0305779310934178,0.00391538145305031
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPO,Myeloperoxidase,41758,0.0143486528276921,0.00497431328247865,0.00459899879403395,0.0240983068613503,0.00392610340517884
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA1,Carbonic anhydrase 1,41522,-0.0179052991123055,0.00620905925950509,-0.0300750552609354,-0.00573554296367549,0.00393634592539501
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSTL1,Follistatin-related protein 1,39308,-0.00740957877720513,0.00256937211587198,-0.0124455481243142,-0.00237360943009605,0.00393679745560438
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,41740,0.0136627878479623,0.00474462242213459,0.0043633279005785,0.0229622477953461,0.00398777012763797
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,39427,0.0279490748409783,0.00972114228638317,0.00889563595966729,0.0470025137222893,0.00404710774293871
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL7,Interleukin-7,41740,0.0206025101404773,0.00716984373962167,0.00654961641081883,0.0346554038701358,0.00406608170184966
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELP,P-selectin,41836,0.0177650196343622,0.00618312153098463,0.00564610143363235,0.0298839378350921,0.00407050808641918
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENSA,Alpha-endosulfine,39589,0.0168973412781522,0.00588490575138457,0.00536292600543844,0.0284317565508659,0.00409566206986462
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,41534,0.0174582492492539,0.0060880266175599,0.00552571707883654,0.0293907814196713,0.00414218392556882
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",39308,0.0218555244918524,0.00764135345427838,0.00687847172146681,0.0368325772622381,0.00424240852392804
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,39334,0.0135398235183228,0.00473617864483553,0.00425691337444517,0.0228227336622005,0.00426055665923897
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",41465,0.0158861913940986,0.00556164368083322,0.00498536977966545,0.0267870130085317,0.0042918267442882
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAGED1,Melanoma-associated antigen D1,41465,0.0153000606585275,0.00535782990940783,0.00479871403608814,0.0258014072809668,0.00430182357759239
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD69,Early activation antigen CD69,41703,0.0277303135999462,0.00971455009477434,0.00868979541418853,0.0467708317857039,0.00431704468628282
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMIGO2,Amphoterin-induced protein 2,41689,0.00739178821695244,0.00259076969928653,0.00231387960635085,0.012469696827554,0.00433595575082736
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL17,C-X-C motif chemokine 17,41911,0.013452771549522,0.00472206717443543,0.0041975198876286,0.0227080232114155,0.00439357769303291
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PVALB,Parvalbumin alpha,41824,0.0350993606952108,0.0123685446993013,0.0108570130845803,0.0593417083058413,0.00454958783998376
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,39408,0.0132039112096484,0.00465421480227452,0.00408165019719029,0.0223261722221064,0.00456272948595338
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,41740,0.0152452561302451,0.00537946354693161,0.00470150757825915,0.025789004682231,0.00460432520038026
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCB,Calcitonin gene-related peptide 2,39598,0.0127276109809742,0.00449252173014895,0.00392226838988228,0.0215329535720662,0.00461877295511251
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,41465,0.0121496280544439,0.00429764098519237,0.00372625172346689,0.020573004385421,0.00470521047484347
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,39334,0.0138715020503398,0.00491284581864705,0.00424232424579158,0.023500679854888,0.00475874248942526
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,41765,0.0087035407138735,0.00308267400376738,0.00266149966648943,0.0147455817612576,0.00475924748945962
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,39598,0.00956943772569687,0.00339723910436989,0.00291084908113189,0.0162280263702619,0.00485869364215043
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,39408,0.0117043689819589,0.00415990893607195,0.00355094746725793,0.01985779049666,0.00490768047130076
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,41465,0.0231051561722595,0.00822305672438337,0.00698796499246811,0.0392223473520509,0.00496469112018351
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADM,Pro-adrenomedullin,41877,0.00814698338070281,0.00289980180343941,0.00246337184596157,0.013830594915444,0.00496915865786439
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTR,Transthyretin,39534,0.00770715001547482,0.00274609397411005,0.00232480582621912,0.0130894942047305,0.00501580496641517
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,39308,-0.0176451043630008,0.00628885426663379,-0.0299712587256031,-0.00531895000039858,0.00502864414346433
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCG2,Secretogranin-2,41809,0.0102452743965499,0.00365294746255518,0.00308549736994171,0.017405051423158,0.00504432988294913
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,41728,0.0198559431902515,0.00708086740938662,0.00597744306785371,0.0337344433126493,0.00505206660511224
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL16,C-X-C motif chemokine 16,41911,0.007206192127469,0.00257886193533628,0.00215162273420989,0.0122607615207281,0.00520817008250031
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,41466,0.0155545081711604,0.00557141566765957,0.00463453346254763,0.0264744828797731,0.00524863552840653
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,39334,0.0281380246309439,0.010083726446517,0.00837392079577049,0.0479021284661173,0.00527294890944616
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,39308,0.0227721608620641,0.00816859605941194,0.00676171258561671,0.0387826091385115,0.00531658939332495
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,39250,0.0203056306632177,0.00728804675936767,0.00602105901485703,0.0345902023115783,0.00534316426801236
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPB2,Carboxypeptidase B2,39630,0.00694273552925233,0.00249355308979528,0.00205537147325359,0.0118300995852511,0.00537390597271109
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,41711,-0.00802058131622586,0.00288265646631123,-0.0136705879901959,-0.00237057464225584,0.00540426819330954
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RP2,Protein XRP2,41689,0.0131530732543704,0.00472902231648237,0.00388418951406499,0.0224219569946759,0.00542105121595033
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICA1,Islet cell autoantigen 1,41534,0.0246161824824935,0.00886734322804519,0.00723618975552494,0.0419961752094621,0.00551029455723263
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,39427,0.0114762088995642,0.00413393795248542,0.00337369051269278,0.0195787272864356,0.00551104308091846
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG6,Large proline-rich protein BAG6,41521,0.0113890557117596,0.00410329720020726,0.00334659319935339,0.0194315182241659,0.00551815002859619
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNB3,Plexin-B3,41720,0.0147827724958415,0.00532864045497396,0.00433863720409257,0.0252269077875905,0.00554140147897857
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEXN,Nexilin,39655,0.0215443078422396,0.00777484589554837,0.00630560988696474,0.0367830057975144,0.00559731620237766
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,41466,0.0242651793333423,0.00876380280457528,0.00708812583637473,0.0414422328303098,0.00563444456360334
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ING1,Inhibitor of growth protein 1,41447,0.0146179809679817,0.00528502267968755,0.00425933651579406,0.0249766254201693,0.00568425031303253
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,41689,0.0065625895370736,0.00237298773418842,0.0019115335780643,0.0112136454960829,0.00569084748520487
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,39578,0.0240533643104724,0.00870050047568448,0.00700038337813081,0.041106345242814,0.00570885217129856
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,39589,0.0243998830828977,0.0088336994031033,0.0070858322528152,0.0417139339129801,0.00575198887522015
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,39334,0.0155968317509951,0.00565177953484323,0.00451934386270232,0.0266743196392878,0.00579646144739911
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA6,Integrin alpha-6,41740,0.0156124632255324,0.00566014337246836,0.00451858221549441,0.0267063442355704,0.00581803559900549
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA2,Annexin A2,39165,0.0216826450823285,0.00786868803753274,0.00626001652876437,0.0371052736358927,0.00586920841101498
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,41740,-0.018688582243927,0.00678251788213382,-0.0319823172929093,-0.00539484719494475,0.00587003011841183
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRR3,Small proline-rich protein 3,39598,0.0192382883193505,0.00698439077023174,0.00554888240969623,0.0329276942290047,0.00588840741065041
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,39250,-0.0185569115477763,0.00673876933155786,-0.0317648994376297,-0.00534892365792291,0.00590159831407257
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,39308,-0.00750978008055481,0.00273783258908736,-0.012875931955166,-0.00214362820594358,0.00609883529053287
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,39600,0.0149502938229028,0.00545086626101617,0.00426659595131113,0.0256339916944945,0.00610280248719022
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,39625,-0.0121496895853898,0.00443387373862311,-0.0208400821130911,-0.00345929705768848,0.00615010950612905
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,41708,0.026226492541345,0.00958355587108413,0.00744272303402007,0.0450102620486698,0.00621587175894684
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM3,Intercellular adhesion molecule 3,41925,0.00821789192376308,0.00300313033802656,0.00233175646123102,0.0141040273862951,0.00621898311137484
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOC,Myocilin,41758,-0.0135419732491328,0.00495443681150311,-0.0232526693996789,-0.00383127709858674,0.00627865458331999
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SF3B4,Splicing factor 3B subunit 4,41689,0.0219277082951024,0.00802742486181846,0.00619395556593823,0.0376614610242666,0.00631122110217065
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,41689,-0.00998255406560654,0.00365620378672377,-0.0171487134875851,-0.00281639464362796,0.0063360277252678
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,39297,0.0172552199160142,0.0063205230259895,0.00486699478507476,0.0296434450469536,0.00634321334955752
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,39589,0.0219229717094917,0.00803286944484892,0.00617854759758784,0.0376673958213956,0.00635972714443366
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,41534,0.0130577827993208,0.00479778789665555,0.00365411852187587,0.0224614470767656,0.00650486319019934
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,41866,0.00934447456352814,0.00344985177182773,0.00258276509074578,0.0161061840363105,0.00676422510046203
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MB,Myoglobin,41925,0.016806324405318,0.00620554138913154,0.00464346328262022,0.0289691855280159,0.00677199048524097
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN6,Dynactin subunit 6,41466,0.0216378116415997,0.00800738494067152,0.00594333715788351,0.0373322861253159,0.0068966023488625
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,39655,-0.00809284241199018,0.00299562119200828,-0.0139642599483264,-0.00222142487565395,0.00691208359066321
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,39598,0.0143436535865615,0.00531444859677436,0.00392733433688372,0.0247599728362392,0.00696561328693264
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC51B,Organic solute transporter subunit beta,39250,0.0217277645558438,0.00806719085095536,0.00591607048797128,0.0375394586237163,0.00708488431211537
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,41452,0.0175804416585514,0.00652888785338257,0.00478382146592159,0.0303770618511813,0.00709644671953167
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYT1,Synaptotagmin-1,39598,0.0118558451218591,0.00441860180016488,0.00319538559353594,0.0205163046501823,0.0073037729855545
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP8,Caspase-8,41840,0.0181729097083947,0.0067757246089724,0.00489248947480885,0.0314533299419806,0.0073260803735752
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMG4,Proteasome assembly chaperone 4,39334,-0.0166576998935026,0.00621169782828248,-0.0288326276369363,-0.00448277215006893,0.00733685820511112
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,41765,0.011007235465586,0.00411125814418269,0.00294916950298788,0.019065301428184,0.00743013246999561
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR1,Toll-like receptor 1,39334,0.00797166126601521,0.00297754288997793,0.00213567720165846,0.013807645330372,0.00743395298277883
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,39600,0.0261582086496169,0.0097778125663911,0.0069936960194903,0.0453227212797434,0.00747814192672317
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,41827,-0.00710367113875826,0.00265644002640845,-0.0123102935905188,-0.00189704868699771,0.00750150355813778
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD1,Sushi domain-containing protein 1,41521,0.0144164420401649,0.00539308361388847,0.00384599815694347,0.0249868859233863,0.00752403458165871
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,41617,-0.00679410613715781,0.00254621753503073,-0.011784692505818,-0.00180351976849758,0.00763275834281118
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,41636,-0.0214701162990124,0.00806262698026668,-0.0372728651803351,-0.00566736741768972,0.00775613860542178
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,39328,0.0181110342242672,0.00680467228945701,0.00477387653693146,0.0314481919116029,0.00778956756047395
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPB1,Carboxypeptidase B,41925,0.0182023055908677,0.00686172412607381,0.00475332630376301,0.0316512848779723,0.00799382016898789
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GTPBP2,GTP-binding protein 2,39328,0.0242863725343768,0.0091595506501404,0.00633365326010158,0.042239091808652,0.00802574612660869
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,39308,0.0302928945664521,0.0114270240600165,0.00789592740881978,0.0526898617240845,0.00803749840433939
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,41765,0.019712271437409,0.00745695996980273,0.00509662989659565,0.0343279129782224,0.00821575619058353
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HJV,Hemojuvelin,39600,-0.0123702116384448,0.00468123390358348,-0.0215454300894685,-0.00319499318742122,0.0082410358072421
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17A,Interleukin-17A,41498,0.0125406273900424,0.00474625374532042,0.00323797004921433,0.0218432847308704,0.00824649545940077
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",39308,0.0128294196901596,0.00485557936639832,0.00331248413201884,0.0223463552483003,0.00824887864257312
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,39625,0.0141711777134402,0.00537526242230829,0.00363566336571593,0.0247066920611644,0.00839158597222934
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBS2,Thrombospondin-2,41758,-0.011283995432652,0.00428227967580369,-0.0196772635972273,-0.00289072726807682,0.00842249658215689
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF3,Fibroblast growth factor 3,39334,0.00867317667046767,0.00329466993058557,0.00221562360651996,0.0151307297344154,0.00848835541524772
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCLY,Selenocysteine lyase,41840,0.0141382863161688,0.00538962059609493,0.00357462994782271,0.0247019426845149,0.008719687150434
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,39334,0.0257527135890193,0.00984092000082914,0.00646451038739423,0.0450409167906444,0.00888564444558307
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBXN1,UBX domain-containing protein 1,39408,0.0200400681785389,0.007675262272483,0.00499655412447218,0.0350835822326056,0.00904039964444639
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP10,Bone morphogenetic protein 10,39408,-0.00822050647225398,0.00314936762351695,-0.0143932670143472,-0.00204774593016076,0.00906118494741242
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VNN1,Pantetheinase,39655,-0.0212476503530855,0.00814100436522288,-0.0372040189089223,-0.00529128179724865,0.0090676369175882
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,39598,0.0241419719176173,0.00925320426653112,0.00600569155521629,0.0422782522800183,0.00909197525416238
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,41758,0.0161115087210806,0.00618310529554524,0.00399262234181194,0.0282303951003493,0.00917816911717698
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EHBP1,EH domain-binding protein 1,39625,0.0217032301792713,0.00832883263612189,0.00537871821247236,0.0380277421460701,0.00917845213633486
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,39625,0.00823079402410686,0.0031588019918128,0.00203954212015377,0.0144220459280599,0.00918181238812509
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,41465,0.0182467399087268,0.00700998590823114,0.00450716752859381,0.0319863122888599,0.00925277462479872
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB33A,Ras-related protein Rab-33A,39250,0.0193057043754883,0.0074169937188293,0.00476839668658291,0.0338430120643938,0.00925666193472385
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES3,Carboxylesterase 3,41689,-0.0204343350905842,0.00785563369549059,-0.0358313771337457,-0.0050372930474226,0.00929938018662968
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EP300,Histone acetyltransferase p300,39334,0.00893745470747534,0.00343605343755288,0.0022027899698717,0.015672119445079,0.00930578772563258
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,41466,0.0211852663616754,0.00814894893195765,0.00521332645503843,0.0371572062683124,0.0093397051333973
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCG,Pro-glucagon,41465,0.0355807686872147,0.0136888025055667,0.00875071577630393,0.0624108215981256,0.00935314024798896
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,41636,0.00867284371286571,0.00333856710294215,0.00212925219109909,0.0152164352346323,0.0093935652965898
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,41534,0.0104372815699362,0.00401845527151726,0.00256110923776233,0.01831345390211,0.00940561692684492
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,39241,-0.00896080409931324,0.00345057931054557,-0.0157239395479826,-0.00219766865064392,0.00941991533585234
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARG2,"Arginase-2, mitochondrial",39589,0.0120515877001561,0.0046409741927613,0.00295527828234399,0.0211478971179683,0.00942275974049049
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPTC,Opticin,41689,0.0130402151974176,0.00502933597315755,0.00318271669002875,0.0228977137048064,0.00952955738511993
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCOF1,Treacle protein,39625,0.00936198881403457,0.0036116825959379,0.00228309092599628,0.0164408867020729,0.0095506636630613
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATG4A,Cysteine protease ATG4A,41465,-0.0166891944367227,0.006444990028824,-0.0293213748932178,-0.0040570139802277,0.00962283402345747
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PREB,Prolactin regulatory element-binding protein,41534,0.00812128247965,0.00313681908391547,0.00197311707517567,0.0142694478841243,0.00963577086413585
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,39334,0.0231935606979606,0.00899795279032872,0.0055575732289163,0.0408295481670049,0.00996072236900358
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGF,Pro-epidermal growth factor,41703,0.0297171041665908,0.0115331788581329,0.00711207360465041,0.0523221347285312,0.00998678349229276
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK10,Kallikrein-10,41759,0.0116591062833127,0.00452942034543625,0.00278144240625764,0.0205367701603677,0.0100614367269684
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",39308,0.0107846670004326,0.00419002945242707,0.00257220927367554,0.0189971247271897,0.010069599696262
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP9,Caspase-9,39334,0.0183669596736596,0.00713591550100994,0.00438056529168006,0.032353354055639,0.0100699277644495
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,39600,0.0106902721345513,0.00415846081590439,0.00253968893537872,0.0188408553337239,0.0101615257099664
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPH1,Neurexophilin-1,41466,0.0109697892753915,0.00427395800666677,0.00259283158232461,0.0193467469684583,0.0102795853481996
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,41636,0.0122111019636973,0.00475954978788009,0.00288238437945235,0.0215398195479423,0.01031082509813
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,39600,0.00856066245858869,0.0033407365034622,0.00201281891180278,0.0151085060053746,0.0104051240752136
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPLAH,5-oxoprolinase,39308,0.0197027335320421,0.00771171893129733,0.00458776442669936,0.0348177026373849,0.0106352870414812
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSR,"Glutathione reductase, mitochondrial",39615,0.00651731795679445,0.0025533729992569,0.00151270687825094,0.011521929035338,0.0107106663111066
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PI16,Peptidase inhibitor 16,39655,-0.00684636157631939,0.00268378516917489,-0.0121065805079022,-0.0015861426447366,0.0107544898966339
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,39598,0.0181236839096784,0.00710595233187851,0.00419601733919652,0.0320513504801603,0.0107704896139629
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,39534,0.00824903193117467,0.00323537986968516,0.00190768738659176,0.0145903764757576,0.0107971575279554
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",39576,0.0312040184462194,0.0122461013144033,0.00720165986998903,0.0552063770224498,0.0108453381637061
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,39408,0.0235394129556725,0.0092417402026837,0.0054256021584124,0.0416532237529325,0.0108767191404234
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OBP2B,Odorant-binding protein 2b,41601,0.016124042897788,0.00633381198329897,0.00370977141052203,0.028538314385054,0.0109170439060486
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB7,Integrin beta-7,41877,-0.012981199229218,0.00510123081344218,-0.0229796116235647,-0.00298278683487131,0.0109477893374509
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPE,Carboxypeptidase E,41750,-0.0110084286372273,0.0043301385524476,-0.0194955002000246,-0.00252135707443002,0.0110245308635662
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD22,B-cell receptor CD22,41911,0.0120099160699004,0.00472916401400082,0.00274075460245881,0.021279077537342,0.0111110120034376
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK13,Kallikrein-13,41467,-0.0125989717361227,0.00496579281601086,-0.022331925655504,-0.00286601781674143,0.0111875450346535
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMB,Granzyme B,41740,0.0190819683254242,0.00752193999495683,0.00433896593530882,0.0338249707155396,0.0111972323934175
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DXO,Decapping and exoribonuclease protein,39598,0.012795240164065,0.00504390551694766,0.00290918535084758,0.0226812949772824,0.0112016716761238
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,41689,0.00959768219388769,0.003784242649126,0.00218056660160072,0.0170147977861747,0.0112170679827031
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,41447,0.0135633654598873,0.00536540872812013,0.0030471643527718,0.0240795665670027,0.0114856803635236
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL6,C-X-C motif chemokine 6,41911,0.0210942466278186,0.0083481885078807,0.00473179715237241,0.0374566961032647,0.0115220185155936
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JAM3,Junctional adhesion molecule C,39408,0.0142738455207683,0.00565264715334295,0.00319465710021606,0.0253530339413204,0.0115787038190531
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THOP1,Thimet oligopeptidase,41703,-0.00874517524248488,0.00347431507365624,-0.0155548327868511,-0.00193551769811866,0.0118445829596241
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,39600,0.0179618965489109,0.00716200403153171,0.0039243686471087,0.031999424450713,0.0121579145018774
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BSG,Basigin,41899,0.00579465895223544,0.00231388983233304,0.00125943488086267,0.0103298830236082,0.0122814996937366
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,41740,-0.00769500804342398,0.00307671423192916,-0.0137253679380051,-0.00166464814884283,0.0123947348457402
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C7,Complement component C7,39397,0.0092661467015446,0.00370483760436683,0.00200466499698561,0.0165276284061036,0.0123957280044611
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,41865,0.0155033587260276,0.00620651199604859,0.00333859521377238,0.0276681222382829,0.0125045172986828
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LUZP2,Leucine zipper protein 2,39589,0.012457897270394,0.00498963248497577,0.00267821759984153,0.0222375769409465,0.0125480240398347
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRR5,Proline-rich protein 5,39334,-0.0131635374537592,0.00527449634272953,-0.0235015502855091,-0.00282552462200937,0.0125859337720428
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_A,,39600,0.00910184930260477,0.00364733123867308,0.00195308007480554,0.016250618530404,0.0125931513942148
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPPC,C-type natriuretic peptide,41740,0.0145677603400122,0.00583804663704378,0.00312518893140642,0.0260103317486181,0.0125967374903062
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP4,Dipeptidyl peptidase 4,41581,-0.00770693156316973,0.00309132116966225,-0.0137659210557077,-0.00164794207063171,0.0126761523887969
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGKA,Diacylglycerol kinase alpha,39334,0.0153922764575889,0.00618602534626413,0.00326766677891119,0.0275168861362666,0.0128529840839364
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD6,Programmed cell death protein 6,41765,0.0194813507251774,0.00783036438565094,0.00413383652930151,0.0348288649210532,0.0128613966652602
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,39600,0.0135717895423351,0.00545562787144511,0.00287875891430267,0.0242648201703675,0.0128730754140582
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,39250,0.0173971020314075,0.00699420008135202,0.0036884698719576,0.0311057341908575,0.0128846509991938
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,41636,0.0154185845955837,0.0062031677318069,0.00326037584124214,0.0275767933499252,0.0129458139270529
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,41836,-0.0126954779755129,0.00511047866015276,-0.0227120161494123,-0.00267893980161346,0.012996366055249
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH7,Protocadherin-7,39600,0.00964950607156977,0.00388664027184587,0.00203169113875186,0.0172673210043877,0.0130525233133813
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK11,Kallikrein-11,41685,0.0088939450237182,0.00358279561872881,0.00187166561100973,0.0159162244364267,0.0130623788953809
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,39598,0.00841063134067132,0.00338863248010341,0.00176891167966863,0.015052351001674,0.0130790494957328
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",41466,0.0140098016762167,0.00565130562353614,0.00293324265408582,0.0250863606983475,0.0131864406235534
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53,Cellular tumor antigen p53,41465,0.0122291531384365,0.00493630143761443,0.00255400232071226,0.0219043039561608,0.0132473951139925
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,39334,0.0160909638334663,0.00651216431360895,0.00332712177879279,0.0288548058881399,0.0134924329584313
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",39589,0.0102737354799552,0.00415822936706405,0.00212360592050969,0.0184238650394008,0.0134999651320341
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTXR,Neuronal pentraxin receptor,41765,0.00938264596585223,0.00379948068736685,0.0019356638186132,0.0168296281130913,0.0135445012474731
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,41521,0.00859638300589742,0.0034830149515114,0.00176967370093508,0.0154230923108598,0.0135965933200497
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L15,Bcl-2-like protein 15,39334,0.0155765872706145,0.0063118970906506,0.00320526897293934,0.0279479055682897,0.0136095763778359
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,39600,0.0126479535644769,0.00512886681813656,0.00259537460092925,0.0227005325280246,0.0136770248472927
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,39250,0.0182325401236078,0.00739667291845252,0.00373506120344088,0.0327300190437748,0.0137183234346612
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,41740,0.0167861037004173,0.00681036063622163,0.00343779685342289,0.0301344105474117,0.0137220819837725
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,41805,0.0106443022948622,0.00433422769313929,0.00214921601630916,0.0191393885734152,0.0140671632611662
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,41465,0.0129233669351444,0.00526416351409203,0.00260560644752403,0.0232411274227648,0.0141027501803771
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSTN,Growth/differentiation factor 8,41521,-0.0146928483324405,0.00598699534917886,-0.0264273592168311,-0.00295833744804996,0.0141357992917048
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNRD2,Protein ZNRD2,39600,0.0190501653098573,0.00776267193538923,0.00383532831649441,0.0342650023032202,0.0141402099745263
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,39427,0.0107928893315209,0.00441194612237718,0.0021454749316616,0.0194403037313802,0.0144493774975827
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,39308,0.0230203591595458,0.00942033282242574,0.00455650682759137,0.0414842114915002,0.0145540014445627
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSNAX,Translin-associated protein X,39250,-0.0106824449735699,0.00437930508980255,-0.0192658829495829,-0.00209900699755688,0.0147319005369488
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A14,Protein S100-A14,39600,0.0139980282780666,0.00574262632006535,0.00274248069073854,0.0252535758653947,0.014802263008229
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB27B,Ras-related protein Rab-27B,39625,0.0223085731369228,0.00915395545781623,0.00436682043960297,0.0402503258342426,0.0148236693273418
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLNK,B-cell linker protein,39334,0.0113237356173312,0.00466993425878522,0.00217066447011218,0.0204768067645502,0.0153325023225341
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",41840,-0.0183168650335166,0.00755983265966113,-0.0331341370464524,-0.00349959302058077,0.0154096666936738
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC13A1,Solute carrier family 13 member 1,39589,0.0161558198181881,0.00666998106933563,0.00308265692229025,0.0292289827140859,0.0154442524841462
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFP,Alpha-fetoprotein,41598,0.0173980589382675,0.00720042438356974,0.00328522714647086,0.0315108907300642,0.0156947796693722
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,41465,0.0160654672353741,0.00664947583993005,0.00303249458911124,0.029098439881637,0.0157037341803379
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,41765,0.0105011373485265,0.00434911555279618,0.00197687086504604,0.0190254038320071,0.015768401355783
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPEP,Glutamyl aminopeptidase,39250,-0.0114423810734505,0.00474459060871046,-0.020741778666523,-0.00214298348037796,0.0158965075133388
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PI3,Elafin,41591,0.0150147835152543,0.00622619608037584,0.00281143919771765,0.0272181278327909,0.0158986516695197
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESPL1,Separin,39241,0.014305159063138,0.00593422238972387,0.00267408317927921,0.0259362349469968,0.0159422474373266
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD6,T-cell differentiation antigen CD6,41899,-0.0139276119932025,0.0057784996170041,-0.0252534712425306,-0.00260175274387449,0.0159552029294316
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,39334,0.0109011078661182,0.00452698709548546,0.00202821315896667,0.0197740025732697,0.0160557422858226
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPT2,Angiopoietin-2,41877,0.0099301863642485,0.00412928697559293,0.00183678389208635,0.0180235888364106,0.0161940933842425
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRAP1,Proline-rich acidic protein 1,39633,0.0103888288724107,0.00432392255701441,0.00191394066066247,0.0188637170841589,0.0162936200665778
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,41521,0.0147965750653731,0.00617219135902885,0.0026990800016765,0.0268940701290696,0.0165306457367782
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA2,Carbonic anhydrase 2,41724,-0.0175620040654913,0.00732694429602452,-0.0319228148856994,-0.00320119324528325,0.0165480183674293
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST6,Cystatin-M,41490,0.0132294280360751,0.00551962463169582,0.00241096375795125,0.0240478923141989,0.0165531690735931
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,41466,0.0176163173126117,0.00736423989180952,0.00318240712466501,0.0320502275005583,0.0167645629485014
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,39625,0.00908133625968909,0.00379917760241734,0.00163494815895111,0.0165277243604271,0.0168493433456806
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD207,C-type lectin domain family 4 member K,41455,0.0103474287024874,0.00432990872537145,0.00186080760075938,0.0188340498042155,0.0168738523738389
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,41925,0.0189939942030545,0.00795791835260879,0.00339647423194129,0.0345915141741677,0.0170093975555778
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,41636,0.0193174346238537,0.00809869464409709,0.00344399312142338,0.035190876126284,0.0170815849575528
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARF2,Scavenger receptor class F member 2,41865,0.00750968040169587,0.00314998552968041,0.00133570876352227,0.0136836520398695,0.0171378806740289
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARTN,Artemin,41534,0.0119445757500005,0.00501078986041362,0.00212342762358981,0.0217657238764112,0.01715059849031
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPOCK1,Testican-1,41636,0.00689145137637009,0.00289149813015465,0.00122411504126697,0.0125587877114732,0.0171701191199017
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",41466,0.00736036390115184,0.00308907387631079,0.00130577910358268,0.013414948698721,0.0172002099694701
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRZB,Secreted frizzled-related protein 3,41595,0.00647088054352213,0.00272289690105257,0.00113400261745909,0.0118077584695852,0.0174936231360543
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,41805,0.0273787426036678,0.0115253428950049,0.00478907052945819,0.0499684146778773,0.017538184022008
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYO9B,Unconventional myosin-IXb,41534,0.0173650629555957,0.00731267900786167,0.00303221210018684,0.0316979138110046,0.0175800357698578
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSZ,Cathepsin Z,41791,-0.00848224450712342,0.00357469626396741,-0.0154886491844995,-0.00147583982974729,0.0176653275331752
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBX2,Chromobox protein homolog 2,39250,-0.0104418092528568,0.00440204950114613,-0.0190698262751033,-0.00181379223061043,0.0177081520976943
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,39600,0.0131993174136848,0.00556693461391939,0.00228812557040283,0.0241105092569668,0.0177561642709337
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBKS,Ribokinase,41455,-0.0128801376345661,0.00543302241217834,-0.0235288615624356,-0.00223141370669655,0.0177684661949476
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,41465,0.0128456705280276,0.00542699355193724,0.00220876316623057,0.0234825778898246,0.0179478578104175
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPM,Carboxypeptidase M,41813,-0.00886703104055699,0.00375875281136054,-0.0162341865508236,-0.00149987553029034,0.018336976657413
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AOC3,Membrane primary amine oxidase,41836,0.00771101472037696,0.00327114938450979,0.00129956192673777,0.0141224675140162,0.0184238403679397
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,39408,0.00776876737498825,0.00329573538713668,0.00130912601620036,0.0142284087337761,0.0184301547941218
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD200,OX-2 membrane glycoprotein,41740,0.00710360331639397,0.00301693476617661,0.00119041117468782,0.0130167954581001,0.0185584621138337
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,39250,0.010314059242854,0.00438232438892312,0.00172470344056473,0.0189034150451433,0.0186127266289339
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL14,C-X-C motif chemokine 14,41534,0.0148341200623143,0.00631651101358406,0.00245375847568949,0.027214481648939,0.0188658227227056
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGLN1,Egl nine homolog 1,41740,0.0145696474178035,0.0062167910000857,0.00238473705763556,0.0267545577779715,0.0191136629355806
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNPY2,Protein canopy homolog 2,41521,0.0158059632567007,0.00674470715962949,0.00258633722382687,0.0290255892895745,0.0191207986323384
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFIC,Nuclear factor 1 C-type,39600,0.011848671367523,0.00506411335101013,0.00192300919954311,0.0217743335355028,0.0193153380795937
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,41636,0.015931908686288,0.00681025601119019,0.00258380690435521,0.0292800104682208,0.0193297906673825
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,41465,0.0220779847668208,0.00943869206733058,0.00357814831485284,0.0405778212187887,0.0193458089724207
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRAL,GDNF family receptor alpha-like,39250,-0.0163476647145687,0.00700897527389149,-0.030085256251396,-0.00261007317774134,0.019698712228651
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASQ2,Calsequestrin-2,39250,-0.0123461608896112,0.00529398441420596,-0.0227223703414549,-0.00196995143776755,0.0197133777784999
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CR2,Complement receptor type 2,41836,0.0120276447804095,0.00515857666661726,0.0019168345138397,0.0221384550469793,0.019737616368314
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD177,CD177 antigen,41744,0.033305569288406,0.0142909599037632,0.00529528787703011,0.061315850699782,0.0197929908344511
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELL,L-selectin,39650,0.00599759907642762,0.00257388682851595,0.000952780892536366,0.0110424172603189,0.0198149718054508
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,41689,-0.00947902671501025,0.00406865463015372,-0.0174535897901115,-0.00150446363990897,0.0198334741744859
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDF1,Endothelial differentiation-related factor 1,39600,0.0171728927211908,0.00737474165014951,0.00271839908689773,0.0316273863554838,0.0198977929284767
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEK,Angiopoietin-1 receptor,41802,0.00567384345973718,0.00245363152099407,0.000864725678588794,0.0104829612408856,0.020769474568395
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFP,Properdin,39650,0.00609070765999774,0.00263451764437021,0.000927053077032118,0.0112543622429634,0.0208021951694741
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,41534,0.0139665141108845,0.00604205700464551,0.00212408238177929,0.0258089458399897,0.0208181564017339
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLRX,Glutaredoxin-1,41679,-0.0141897185132901,0.00614930381802215,-0.0262423539966135,-0.0021370830299667,0.0210406861872358
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN5,Contactin-5,41787,-0.00945494261449956,0.00410236423334067,-0.0174955765118473,-0.00141430871715184,0.0211957803584523
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,39619,0.0121711765660828,0.00528487048367491,0.00181283041807995,0.0225295227140856,0.0212961014497536
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,39427,0.0174375613221459,0.00760146181657505,0.00253869616165884,0.032336426482633,0.021811007274407
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFA2,BPI fold-containing family A member 2,38964,-0.0281888370327882,0.0123206025751101,-0.0523372180800041,-0.00404045598557234,0.0221608813520533
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,39625,0.02734068052903,0.0119603632089766,0.00389836863943594,0.0507829924186241,0.0222766142880111
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFRP4,Secreted frizzled-related protein 4,39408,-0.010166640700314,0.00444992662173647,-0.0188884968789175,-0.00144478452171056,0.0223511210816754
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,41705,-0.00855960414235626,0.00374807179254591,-0.0159058248557462,-0.00121338342896628,0.0224030129760912
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,39589,0.00887952471458273,0.00389571220627509,0.00124392879028356,0.0165151206388819,0.0226678984166899
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,41465,0.014593073319891,0.00640891304353973,0.00203160375455308,0.0271545428852288,0.0228027713794526
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGA,Protein O-GlcNAcase,39600,0.0180422604307617,0.00794026308233293,0.00247934478938912,0.0336051760721342,0.0230906477736777
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPXM1,Probable carboxypeptidase X1,41802,0.0172836785011127,0.00761867513483849,0.00235107523682923,0.0322162817653961,0.0233091181455856
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASPN,Asporin,39625,-0.00700899798526018,0.00309404484915848,-0.0130733258896108,-0.000944670080909565,0.0235124394914991
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX5,Sorting nexin-5,39308,0.00749546313614512,0.00331316435058897,0.00100166100899074,0.0139892652632995,0.0236971238712999
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPP,Lipoma-preferred partner,39250,0.0166235792681747,0.00735931963152351,0.00219931279038862,0.0310478457459608,0.0239130224188982
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,39317,0.00672025844995674,0.00298229755519331,0.000874955241777855,0.0125655616581356,0.0242551427277285
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,39598,0.0120949108755401,0.00537534337352775,0.00155923786342568,0.0226305838876545,0.0244640440739339
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC2,Mucin-2,39633,0.023105760755469,0.0102821124982297,0.0029528202589388,0.0432587012519991,0.0246481876274196
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,39600,0.0132233886365235,0.00589273080135619,0.00167363626586542,0.0247731410071817,0.0248511084308217
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,39600,-0.00677477168134012,0.00302217619770386,-0.0126982370288397,-0.000851306333840546,0.0250014943295762
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD248,Endosialin,39633,-0.0100046677194694,0.0044753951559217,-0.0187764422250759,-0.00123289321386283,0.0254056118109163
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1R,Complement C1r subcomponent,39650,0.00463150590743189,0.00207290587886185,0.000568610384862662,0.00869440143000112,0.0254828688613139
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,41466,0.0130614030122656,0.00584701801069906,0.00160124771129543,0.0245215583132358,0.025509588518374
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STXBP3,Syntaxin-binding protein 3,41465,0.0107543378978508,0.00481805735868469,0.0013109454748288,0.0201977303208728,0.0256261596058317
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMPR2,GMP reductase 2,39408,0.0165092773897027,0.00740062285807763,0.00200405658787052,0.0310144981915348,0.0257151063838865
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBN1,Drebrin,39334,0.0126558850890206,0.00567616329633426,0.00153060502820541,0.0237811651498357,0.0257909690658002
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,39598,0.0172979110295065,0.00776456279882565,0.00207936794380819,0.0325164541152047,0.0259138482204083
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXO1,Forkhead box protein O1,41740,0.0213637385097692,0.00960660424226214,0.00253479419493543,0.040192682824603,0.0261748279023186
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAT,Tissue-type plasminogen activator,41888,0.0125653427652854,0.00565266835818861,0.00148611278323577,0.0236445727473351,0.0262389901582393
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,39655,0.0100930064916823,0.00454098901622013,0.0011926680198908,0.0189933449634737,0.0262598987606721
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLA,Alpha-galactosidase A,39385,0.00971747709149885,0.00437703238698774,0.00113849361300289,0.0182964605699948,0.026432263061634
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OXT,Oxytocin-neurophysin 1,41865,0.0356397668490368,0.0160545368054557,0.00417287471034375,0.0671066589877299,0.0264411255243852
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMOX1,Heme oxygenase 1,41633,0.0121101549897436,0.00545772230435632,0.00141301927320519,0.022807290706282,0.0265104996843411
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANPEP,Aminopeptidase N,41808,0.00670157010104809,0.00302408142335103,0.000774370511280075,0.0126287696908161,0.0267038240553621
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARD3,Partitioning defective 3 homolog,39427,0.0182662025873557,0.00824942445458976,0.00209733065635975,0.0344350745183516,0.0268330508176908
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,39589,0.0108048879786934,0.00488286074744231,0.00123448091370643,0.0203752950436803,0.026930589015362
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,39598,0.0173766730525753,0.00785506661657248,0.0019807424840932,0.0327726036210573,0.0269760057904503
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTYMK,Thymidylate kinase,39625,0.0164727612237011,0.00746180121406261,0.0018476308441384,0.0310978916032638,0.0272918541160985
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,41636,0.00893889691297276,0.00405272050583731,0.000995564721531632,0.0168822291044139,0.0274256592504827
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN8,Tetraspanin-8,39600,0.0232371221917466,0.0105560891479544,0.00254718746175602,0.0439270569217373,0.0277354642046665
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,41636,0.0128121353751494,0.00582165629302107,0.00140168904082813,0.0242225817094707,0.0277696722112022
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP112,Centrosomal protein of 112 kDa,39250,-0.0108713234888452,0.00494925960272356,-0.0205718723101834,-0.00117077466750705,0.0280736792361914
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPA2,Replication protein A 32 kDa subunit,39334,0.00758304491102849,0.00345907818281072,0.000803251672719483,0.0143628381493375,0.0283853439061576
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,39334,-0.0102040245033814,0.00466335593965242,-0.0193442021451002,-0.00106384686166271,0.0286816868598849
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UMOD,Uromodulin,41889,-0.0130552167881903,0.00596869656919321,-0.0247538620638089,-0.00135657151257157,0.0287393803366374
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,39600,0.0203067619810409,0.00928596724563238,0.00210626617960138,0.0385072577824803,0.0287764743541224
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCN1,Transcobalamin-1,39476,0.00868250615227982,0.00397063347666126,0.000900064538023754,0.0164649477665359,0.0287870993097238
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTTG1,Securin,39427,-0.0101179869449886,0.00462767866491265,-0.0191882371282174,-0.00104773676175982,0.0288072079516785
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPB6,Heat shock protein beta-6,41877,0.00982388596962987,0.00449803739187116,0.0010077326815624,0.0186400392576973,0.0289768695900049
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY2A,Pancreatic alpha-amylase,41293,0.0118040328005902,0.0054051361328779,0.00120996598014952,0.0223980996210309,0.0289911568513831
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA4,Apolipoprotein A-IV,39650,-0.0082425180932043,0.0037779983787506,-0.0156473949155555,-0.00083764127085312,0.0291515248216503
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIP1,Huntingtin-interacting protein 1,39250,0.00797445698935755,0.00365780755570122,0.000805154180183155,0.0151437597985319,0.0292704366912495
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FN1,Fibronectin,39650,0.00657696162807265,0.0030216477424329,0.000654532052904173,0.0124993912032411,0.0295304598049798
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,41466,0.0152437401984955,0.00702066933582784,0.00148322830027293,0.0290042520967181,0.0299292906706193
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,39598,-0.0114188774273237,0.00526132176630183,-0.0217310680892753,-0.00110668676537214,0.0300021337764025
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP2B1,AP-2 complex subunit beta,39328,0.0117885991616451,0.00543266298735746,0.00114057970642449,0.0224366186168657,0.0300326169676684
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",39427,0.0120194482765043,0.00555023008298334,0.00114099731385695,0.0228978992391517,0.0303653204819184
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPME1,Protein phosphatase methylesterase 1,41689,-0.0139299793267393,0.00643328991079299,-0.0265392275518935,-0.00132073110158499,0.030383002041387
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,41411,-0.013101225259396,0.00606137205662496,-0.024981514490381,-0.00122093602841111,0.0306806810142728
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A12,Protein S100-A12,41533,0.0175412554193149,0.00812152591625711,0.00162306462345095,0.0334594462151788,0.0308028133061428
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],41534,-0.0128917247419299,0.00596990911846392,-0.0245927466141192,-0.00119070286974065,0.0308335362776448
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AK1,Adenylate kinase isoenzyme 1,41765,-0.0146498157285054,0.00682077110941011,-0.0280185271029492,-0.00128110435406159,0.0317459369200337
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,41855,0.00722173306099824,0.00336703422150673,0.00062234598684504,0.0138211201351514,0.0319841578919424
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,39600,0.0181389372116006,0.00849461687099799,0.00148948814444448,0.0347883862787566,0.0327548689534771
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF12,Fibroblast growth factor 12,39334,0.0107807801512599,0.00505081879052328,0.000881175321834302,0.0206803849806856,0.0328275798630324
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNG,Interferon gamma,41534,0.0270053542252844,0.0126561647048419,0.00219927140379423,0.0518114370467745,0.0328803080796875
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPHN1,Oligophrenin-1,39598,0.0256853407859499,0.0120574336539067,0.00205277082429287,0.049317910747607,0.0331731583501933
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,39625,0.00766157932743331,0.00359677979630457,0.00061189092667636,0.0147112677281903,0.0331836306128626
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,41802,-0.0107896633187774,0.00506594521464758,-0.0207189159394867,-0.000860410698068168,0.0332030945165185
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX1B,Syntaxin-1B,39328,0.00950625948465312,0.00446375959178138,0.000757290684761614,0.0182552282845446,0.0332229617410168
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,40174,-0.00734397519089319,0.0034494192256367,-0.0141048368731411,-0.000583113508645264,0.0332714338894025
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN4,CCN family member 4,41877,0.00921559429345234,0.00433005213500043,0.00072869210885149,0.0177024964780532,0.0333316461729525
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHR,Growth hormone receptor,39408,-0.00664745740755378,0.00312815616378139,-0.0127786434885653,-0.000516271326542261,0.0336058868056734
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,41865,0.0122469163335103,0.00576433417323686,0.000948821353966057,0.0235450113130545,0.0336382703073049
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,39633,0.00961298654782342,0.00452751950535386,0.000739048317329849,0.018486924778317,0.0337563859589659
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,39427,0.0157764046747628,0.00743152670566983,0.00121061233164996,0.0303421970178757,0.0337846708205929
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAPPA,Pappalysin-1,41534,-0.0111327489637338,0.00524943914130199,-0.0214216496806857,-0.000843848246781903,0.0339618075905238
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,41521,0.0064476330164179,0.0030565169564478,0.000456859781780206,0.0124384062510556,0.0349231529767303
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP7,Dipeptidyl peptidase 2,41676,-0.0147084690452589,0.00697988038705188,-0.0283890346038806,-0.00102790348663721,0.035113464400491
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,39600,0.00705190654333341,0.00334644283048523,0.000492878595582354,0.0136109344910845,0.0351155151216076
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,41862,-0.00983598557091066,0.00467073942295514,-0.0189906348399027,-0.00068133630191859,0.0352341036252755
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39023,0.0121222582088448,0.00576414122773644,0.000824541402481413,0.0234199750152083,0.0354855977702362
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOK1,Docking protein 1,39598,0.0320741173093711,0.0152542589930692,0.00217576968295548,0.0619724649357867,0.0355204799930405
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,41925,0.0162935062214982,0.00776229099144161,0.00107941587827266,0.0315075965647238,0.0358304726344213
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRAP,BRCA1-associated protein,39485,0.0256986159403572,0.0122574170370615,0.0016740785477166,0.0497231533329979,0.0360540781106644
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,41287,-0.0144475583322218,0.0069066493103192,-0.0279845909804474,-0.000910525683996145,0.0364732695054737
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLG4,Disks large homolog 4,39598,0.0167572302168955,0.00801151891338609,0.00105465314665879,0.0324598072871323,0.0364934232775509
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX6,Syntaxin-6,41465,0.0151869829855585,0.00727019401947319,0.000937402707391068,0.029436563263726,0.0367329271117573
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,41466,0.0088623700482216,0.00424908613535071,0.000534161222934221,0.017190578873509,0.0370243705258331
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,41765,-0.004041217179504,0.00194402096056637,-0.00785149826221409,-0.000230936096793902,0.03765569694036
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORT1,Sortilin,41750,0.00874803551285239,0.00422677486673565,0.00046355677405052,0.0170325142516543,0.0385025990712059
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAMBP,STAM-binding protein,41617,0.0144048038793511,0.00697196009508248,0.000739762092989463,0.0280698456657128,0.0388382732976143
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB8,Serpin B8,41911,0.0134068821844299,0.0064892007881022,0.000688048639749613,0.0261257157291102,0.0388449691381398
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,39334,0.00746353347959624,0.00361452209854684,0.000379070166444423,0.014547996792748,0.0389588629386089
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAM1,Neural cell adhesion molecule 1,41836,0.00749560803560029,0.00363067729984851,0.000379480527897223,0.0146117355433034,0.0389878195648235
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPBP,Platelet basic protein,39580,0.0196165833523659,0.00950823603849012,0.000980440716925234,0.0382527259878065,0.039125169195832
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,39589,0.0108119265530428,0.00525731739549578,0.000507584457871031,0.0211162686482145,0.0397532645240381
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAL,Galanin peptides,41805,-0.0151787885916747,0.00738850640821179,-0.0296602611517698,-0.00069731603157961,0.039958711488551
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,39408,-0.0174679253087869,0.00850305097617883,-0.0341339052220974,-0.000801945395476407,0.0399694340580877
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,39633,0.0315738937799967,0.0153840985253329,0.00142106067034423,0.0617267268896492,0.0401570595018007
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,39589,0.00795852606630689,0.00389990070043888,0.000314720693446687,0.0156023314391671,0.0413045361490229
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM132A,Transmembrane protein 132A,39308,-0.0142029084281405,0.00696107096920314,-0.0278466075277787,-0.000559209328502395,0.0413415703154952
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTPN,Myotrophin,41521,0.00736685399055917,0.0036110113314146,0.00028927178098655,0.0144444362001318,0.0413598366238272
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA9,Carbonic anhydrase 9,41877,0.0105602242968038,0.00518084348613232,0.000405771063984456,0.0207146775296231,0.0415375718279409
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,41447,0.0121215771640115,0.00596207782415526,0.000435904628667204,0.0238072496993558,0.0420616366671306
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,41466,0.0335255476451726,0.0164897912672814,0.0012055567613011,0.065845538529044,0.0420619692066623
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMS,Spermine synthase,39259,0.0145539502032835,0.00716037343949862,0.000519618261866191,0.0285882821447008,0.0421208641300722
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY2B,Alpha-amylase 2B,40938,0.0112205832209498,0.00553857023967129,0.000364985551194101,0.0220761808907056,0.0427966255826784
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",39600,0.00939554235963237,0.00463861138823699,0.00030386403868788,0.0184872206805769,0.0428393711904963
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WIF1,Wnt inhibitory factor 1,41877,-0.00752194226511149,0.00372121463728222,-0.0148155229541846,-0.000228361576038333,0.0432617628445037
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,39308,0.0166483030907903,0.00825406928853875,0.000470327285254316,0.0328262788963262,0.043722377317424
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,39328,0.0144503451136479,0.00717501863873596,0.000387308581725431,0.0285133816455704,0.0440365336736194
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL5,Fc receptor-like protein 5,41758,0.0132125926573023,0.00656150044749029,0.000352051780221341,0.0260731335343833,0.0440661753508474
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,39250,0.00734684302656513,0.00366193067409707,0.000169458905334876,0.0145242271477954,0.044852063773748
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QL2,Complement C1q-like protein 2,39334,0.00959244093879487,0.00478813923418843,0.000207688039785551,0.0189771938378042,0.0451620878385287
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSPN,Persephin,41740,0.0191805483156777,0.00958242797985897,0.000398989475154127,0.0379621071562013,0.0453442417710166
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD226,CD226 antigen,39334,0.009482773174591,0.00474368973969509,0.000185141284788625,0.0187804050643934,0.045630388065009
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,39625,0.00659484025640322,0.00330246816958352,0.000122002644019535,0.0130676778687869,0.0458559287461224
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,41617,-0.0159234871773585,0.00797893447288237,-0.0315621987442079,-0.000284775610509026,0.0459883764296019
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP1,DNA topoisomerase 1,39600,-0.0266854896793433,0.0133754254392149,-0.0529013235402044,-0.000469655818482146,0.0460551461293342
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,41543,0.032153086334628,0.0161325642931554,0.000533260320043465,0.0637729123492125,0.0462763944740023
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NADK,NAD kinase,41765,0.0120490025878347,0.00606272821732296,0.000166055281881652,0.0239319498937877,0.0468999324856096
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREML1,Trem-like transcript 1 protein,39655,0.0117086502344367,0.00590656897407906,0.000131775045241799,0.0232855254236317,0.0474692838418381
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBS,Cystathionine beta-synthase,39308,0.0113717106016061,0.00573840850515697,0.000124429931498424,0.0226189912717137,0.0475401831380232
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL1,Growth-regulated alpha protein,41738,0.0203771372712097,0.0102928106333176,0.000203228429907158,0.0405510461125123,0.0477530587040654
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDN1,Endothelin-1,39308,0.00645315981847083,0.00326247189255948,5.87149090542438e-05,0.0128476047278874,0.047954631737267
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,39589,0.0156341202358454,0.00790939259198165,0.000131710755561338,0.0311365297161294,0.048105890714917
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,39589,0.0116639675666471,0.00590529950953781,8.95805279529597e-05,0.0232383546053412,0.0482739003037835
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM3,Myomesin-3,39408,-0.0212831800819354,0.0107800149284187,-0.042412009341636,-0.000154350822234858,0.0483709872168132
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,41689,-0.0117200752332304,0.00593733780501011,-0.0233572573310502,-8.28931354106104e-05,0.0484071340772417
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM13A,Protein FAM13A,39600,0.0148965419378343,0.00755084271975704,9.68902071105254e-05,0.0296961936685581,0.0485397390444669
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXDC2,Plexin domain-containing protein 2,39598,-0.00598989556212884,0.00304133882996472,-0.0119509196688597,-2.88714553979795e-05,0.0489215637760933
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD2,T-cell surface antigen CD2,39250,0.00857669306478732,0.00435669446340793,3.75719165077778e-05,0.0171158142130669,0.0490221828745344
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,41431,-0.006340104457051,0.00322445701294782,-0.0126600402024287,-2.01687116732647e-05,0.0492906961715317
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2,Interleukin-2,41534,-0.00697292208779407,0.00354653658996756,-0.0139241338041305,-2.17103714576514e-05,0.0493059243025747
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEFTY2,Left-right determination factor 2,41862,0.0111908314994032,0.00569659386507065,2.55075238647529e-05,0.0223561554749417,0.0494955711879105
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SATB1,DNA-binding protein SATB1,39600,-0.00640967608600257,0.00326307966627075,-0.0128053122318932,-1.40399401119002e-05,0.0495201420545199
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN3,Contactin-3,41758,0.00615109534113865,0.00313576460200382,4.99672121117428e-06,0.0122971939610661,0.049830886953537
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,39308,0.0221962732930247,0.0113309561204345,-1.240070302699e-05,0.0444049472890763,0.0501497587005193
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CABP2,Calcium-binding protein 2,39328,0.0142151296506449,0.00727172506432626,-3.74514754345572e-05,0.0284677107767244,0.0506267444817981
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,41925,-0.00722473414280516,0.0036979218199394,-0.0144726609098864,2.31926242760683e-05,0.050754262727967
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",39600,0.0137776369123454,0.00705808461356639,-5.62089302447426e-05,0.0276114827549355,0.0509592393456678
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH23,Cadherin-23,39598,-0.00576752351291487,0.00295591981938136,-0.0115611263589023,2.60793330726095e-05,0.0510613187374222
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELN,Elastin,39625,0.00746657076373403,0.00384197359597838,-6.36974843835824e-05,0.0149968390118516,0.0519907709108353
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,41877,-0.00569631259247916,0.0029366058047681,-0.0114520599698246,5.94347848663166e-05,0.0524299275781378
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,39589,0.0232640508879035,0.0119934637223316,-0.000243138007866437,0.0467712397836735,0.0524383766517318
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39090,0.0107101293813299,0.00552274335127799,-0.000114447587174939,0.0215347063498348,0.0524943918703352
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,39633,0.00471038820654596,0.0024306641064575,-5.37134421107312e-05,0.00947448985520266,0.0526606935230219
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,39241,-0.00940709679713402,0.00485748673557383,-0.0189277707988587,0.000113577204590678,0.0528184835865785
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX2,Sorting nexin-2,39589,0.0183029044739943,0.00947622756554036,-0.000270501554464821,0.0368763105024534,0.0534525271806274
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,41836,0.00915082415968352,0.00474157937036295,-0.000142671406227864,0.0184443197255949,0.0536392621277902
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFB,Vascular endothelial growth factor B,39334,0.00633557278798206,0.00328979749564749,-0.000112430303487029,0.0127835758794511,0.0541526663853135
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA2,Carboxypeptidase A2,41821,0.0141495295057397,0.00735928930432976,-0.000274677530746576,0.0285737365422261,0.0545422012551661
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,41836,0.00913663161407572,0.00476091266865267,-0.000194757216483505,0.0184680204446349,0.0549941121127499
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCT,Secretin,39328,0.0102785918982831,0.00535853577068935,-0.000224138212267981,0.0207813220088343,0.0551157523255439
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,41799,0.0103220909677294,0.00538166288010761,-0.000225968277281498,0.0208701502127403,0.055131113121467
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,41744,0.0637630929954031,0.0332487668779487,-0.00140449008537641,0.128930676076183,0.0551633329119119
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTSS2,Protein MTSS 2,39589,0.0214249071599811,0.0111723634813029,-0.000472925263372618,0.0433227395833349,0.0551787500946706
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADA,Adenosine deaminase,41911,0.00755644117000596,0.00394139703453087,-0.00016869701767454,0.0152815793576865,0.0552340775504094
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAG,Myelin-associated glycoprotein,39328,0.0103662225220134,0.00541241456906192,-0.000242110033347927,0.0209745550773748,0.055484937872496
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMCN2,Hemicentin-2,39393,-0.0123462129331191,0.00645163294541427,-0.024991413506131,0.000298987639892907,0.0556904121133677
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNGR2,Interferon gamma receptor 2,41636,-0.0111546515032219,0.00583975265587276,-0.0226005667087325,0.000291263702288701,0.0561391743400902
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,39600,0.0140068221650779,0.00733570757527676,-0.000371164682464498,0.0283848090126204,0.0562361104350614
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SWAP70,Switch-associated protein 70,39600,0.00766941810371875,0.00403336990207837,-0.000235986904354849,0.0155748231117923,0.057263783651972
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,39598,0.00996622039535522,0.00524248558627918,-0.00030905135375197,0.0202414921444624,0.0573217487398949
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,41728,0.00722053916349165,0.00379981486446646,-0.000227097970862618,0.0146681762978459,0.0574242443970948
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,39334,0.00714150748366664,0.00376079447239869,-0.000229649682234794,0.0145126646495681,0.0575996974767936
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFASC,Neurofascin,41911,0.00613749431972026,0.00323612288213683,-0.000205306529267936,0.0124802951687084,0.0579079450181938
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UROS,Uroporphyrinogen-III synthase,39328,-0.0139763471711563,0.00736918447764797,-0.0284199487473464,0.000467254405033705,0.0579084498644312
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",39250,0.0106200591790473,0.00560062095178194,-0.000357157886445298,0.0215972762445399,0.0579568251533273
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCAM,Cell surface glycoprotein MUC18,41836,-0.00671095698655766,0.00354497237928179,-0.01365910284995,0.000237188876834648,0.058367498819473
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,39598,0.0133893147755516,0.00707527078779715,-0.000478215968530817,0.027256845519634,0.0584625822870477
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH2B3,SH2B adapter protein 3,41465,0.0206367402499114,0.0109120526331071,-0.000750882910978481,0.0420243634108013,0.0586217306387107
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN3,CCN family member 3,41914,0.00711533245821666,0.00376249540776056,-0.000259158540994043,0.0144898234574274,0.0586299395664975
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,41740,-0.00935052383945355,0.00495046426927613,-0.0190534338072348,0.000352386128327664,0.0589382815724492
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,39250,0.0157318132668199,0.00833504690122415,-0.000604878659579436,0.0320685051932192,0.0591297495595726
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRG1,Scrapie-responsive protein 1,39625,0.0057114251149599,0.00302962350103483,-0.000226636947068364,0.0116494871769882,0.0594300550503888
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,41765,0.0059052789639295,0.00313755329462366,-0.000244325493532876,0.0120548834213919,0.059840587799127
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KHK,Ketohexokinase,39308,0.0131524373320902,0.00699775342081056,-0.000563159372698472,0.0268680340368789,0.0602002707874717
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,39328,0.0130485228164645,0.00694315437033843,-0.000560059749398871,0.0266571053823278,0.0602256569327298
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNB2,Ephrin-B2,39328,0.0120514581812581,0.00642160973659402,-0.000534896902466143,0.0246378132649824,0.0605858482061864
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,39600,0.0138768180688127,0.00741005466003729,-0.000646889064860415,0.0284005252024857,0.0611361652564799
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,39600,0.00753055979949695,0.00402856444150565,-0.000365426505854131,0.015426546104848,0.061608870639453
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3BP1,SH3 domain-binding protein 1,39600,0.0102396599662713,0.00547948384547716,-0.000500128370863915,0.0209794483034065,0.0616873488409249
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,39427,0.0131172654672625,0.00703012780704196,-0.000661785034539725,0.0268963159690647,0.0620873545369127
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1R2,Interleukin-1 receptor type 2,41721,-0.00413577308725681,0.00221676389897204,-0.00848063032924201,0.000209084154728401,0.0621083835369164
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TADA3,Transcriptional adapter 3,39589,0.0084169801103754,0.00451206186795626,-0.00042666115081887,0.0172606213715697,0.0621464006515026
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN1,Calsyntenin-1,41466,-0.010457435564828,0.00561497183880513,-0.0214627803688861,0.000547909239230039,0.0625666962871836
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",39598,-0.0122809734551,0.00659632899706001,-0.0252097782893376,0.000647831379137591,0.0626594767478305
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F7,Coagulation factor VII,41813,0.00639049581225476,0.00343433888501355,-0.000340808402371802,0.0131218000268813,0.0627996402099949
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM171B,Protein FAM171B,39589,0.00547555143383893,0.0029480437431711,-0.000302614302776435,0.0112537171704543,0.0632879934184797
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",39241,0.0117211460894852,0.00631102414156814,-0.000648461227988317,0.0240907534069588,0.0633032822778879
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,39600,0.0135745908609457,0.0073095058093882,-0.00075204052545523,0.0279012222473465,0.0633215436362347
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN1,Tetraspanin-1,41521,0.0150254479088441,0.00809741447704688,-0.000845484466167794,0.030896380283856,0.0635353643387377
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNR,Tenascin-R,41636,0.00856812352182564,0.0046197908716534,-0.000486666586615024,0.0176229136302663,0.0636679100580572
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PODXL,Podocalyxin,41689,-0.0031023523536119,0.00167308929256625,-0.00638160736704176,0.00017690265981796,0.0637236116775003
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRB1,Chymotrypsinogen B,41758,0.0119399886290146,0.00644770562453318,-0.000697514395070462,0.0245774916530996,0.0640740962520844
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PQBP1,Polyglutamine-binding protein 1,41465,-0.0115671722778433,0.00624864431368368,-0.0238145151326633,0.000680170576976689,0.0641710095261657
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAMDC2,MAM domain-containing protein 2,39625,0.00728767459962332,0.00393950370256922,-0.000433752657412355,0.015009101856659,0.0643551918756799
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN8,Septin-8,39576,0.0066719896159175,0.00361002578933799,-0.000403660931184956,0.01374764016302,0.0646027032484144
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSO,Cathepsin O,41911,0.00625945953908643,0.00338857646588567,-0.000382150334049478,0.0129010694122223,0.0647368690570945
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNLR1,Interferon lambda receptor 1,41740,0.00744849200901041,0.00403909394532543,-0.000468132123827437,0.0153651161418483,0.0651911068597593
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,39600,-0.00896037141835064,0.00485891032986378,-0.0184838356648836,0.000563092828182364,0.0651937969944095
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,39600,0.00608832624399325,0.00330365468714456,-0.000386836942810094,0.0125634894307966,0.0653695728600501
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB10,Ras-related protein Rab-10,39625,0.0109337223283783,0.00594277498162558,-0.000714116635607798,0.0225815612923645,0.0658194080080144
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDCP1,CUB domain-containing protein 1,41636,0.0113633705863423,0.00617723213445288,-0.000744004397185341,0.0234707455698699,0.0658560278104241
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA5,Plasma serine protease inhibitor,39509,0.00615765852535559,0.00334965200255301,-0.000407659399648304,0.0127229764503595,0.0660456792974836
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MILR1,Allergin-1,41534,0.0103865173864027,0.00565320923391566,-0.000693772712071945,0.0214668074848774,0.0661917825467633
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC16A1,Monocarboxylate transporter 1,41466,0.0111988948689715,0.0060999961240986,-0.000757097534261798,0.0231548872722047,0.0663976456533372
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSC22D1,TSC22 domain family protein 1,39600,0.0135180511510732,0.007363373500898,-0.00091416091068686,0.0279502632128333,0.0664067823495754
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGN,Secretagogin,41534,0.00899973425056622,0.00491524051026073,-0.00063413714954481,0.0186336056506773,0.0671256955148066
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA1,Ephrin type-A receptor 1,41783,0.0065141039704325,0.003565064281085,-0.000473422020494096,0.0135016299613591,0.0676915191901447
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHCY,Adenosylhomocysteinase,41765,0.0136206874054369,0.00746701862573983,-0.00101466910101315,0.028256043911887,0.0681576142801642
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMPER,BMP-binding endothelial regulator protein,39408,0.00469170819286578,0.0025738817959405,-0.000353100127177607,0.00973651651290917,0.0683591557362033
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSAB1,Tryptase alpha/beta-1,41896,0.010535752001095,0.00578142202303482,-0.000795835164053261,0.0218673391662432,0.0684249353170527
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH4,Cadherin-4,39259,0.00931182920498505,0.0051235094481579,-0.000730249313404433,0.0193539077233745,0.0691731076379281
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX6,Peroxiredoxin-6,41877,-0.0120804528583978,0.00665280198160756,-0.0251199447423486,0.000959039025553042,0.0694167981240399
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,39598,0.00835089815890602,0.00460191743727845,-0.000668860018159738,0.0173706563359718,0.0696039860040162
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,39308,0.0146967518733898,0.00810412706647707,-0.00118733717690522,0.0305808409236849,0.0697842905495268
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,39600,-0.0333928846645234,0.0184284611694434,-0.0695126685566325,0.00272689922758573,0.0700091508934586
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMOTL2,Angiomotin-like protein 2,39554,0.00979751597799607,0.00541223617842881,-0.00081046693172441,0.0204054988877165,0.0702839752091942
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,39427,0.0070109116102348,0.00387786116801062,-0.000589696279066017,0.0146115194995356,0.0706447296871331
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDHD2,Phospholipase DDHD2,39600,0.0133549894479069,0.00738993927045076,-0.00112929152217656,0.0278392704179904,0.0707607057275148
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,41465,-0.00759745792286201,0.00420711083130727,-0.0158433951522243,0.000648479306500232,0.0709633973054591
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STC2,Stanniocalcin-2,41736,0.00479086310242765,0.00265302989654963,-0.000409075494809629,0.00999080169966493,0.0709711884470644
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDA,Cytidine deaminase,39613,0.00953175503813959,0.00528177244389112,-0.000820518951887011,0.0198840290281662,0.0711566439709347
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,39598,0.00731060991864518,0.00405449748724436,-0.00063620515635376,0.0152574249936441,0.0714019820061058
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,39328,0.0159372395989778,0.00885102375110688,-0.00141076695319171,0.0332852461511473,0.0717924888913917
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,39600,0.0204937682945112,0.0114121861670434,-0.00187411659289374,0.0428616531819162,0.0725570497498582
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRND,Prion-like protein doppel,39598,0.00971629644584651,0.00542778190754876,-0.000922156092949059,0.0203547489846421,0.0734646235299736
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD55,Complement decay-accelerating factor,41350,0.00523598642988,0.00292561804225739,-0.000498224932944481,0.0109701977927045,0.0735254464019493
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBA,Lysosomal acid glucosylceramidase,39328,0.0110105879133986,0.0061636263413463,-0.00107011971564014,0.0230912955424374,0.0740657437084111
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP1,Guanylate-binding protein 1,39580,0.0128429434333552,0.007194127116188,-0.00125754571437331,0.0269434325810837,0.074256754010652
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,39328,-0.0107688283044089,0.00603392738399098,-0.0225953259770312,0.00105766936821342,0.0743361385447521
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL19,Interleukin-19,41386,0.0145561027414935,0.00815892778235579,-0.0014353957119239,0.0305476011949108,0.0744359097742007
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUP50,Nuclear pore complex protein Nup50,39250,-0.00632007766527735,0.00354286308258691,-0.0132640893071477,0.000623933976592998,0.0744700214427051
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,39241,0.0150065083713227,0.0084261012018758,-0.00150864998435392,0.0315216667269992,0.0749482957725872
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS22,Brain-specific serine protease 4,39334,0.00687756273109022,0.00386375627916667,-0.000695399576076456,0.0144505250382569,0.0751009993888907
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,39598,0.0171834776827593,0.00965568671836676,-0.00174166828523958,0.0361086236507581,0.0751653618840364
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHAD,Chondroadherin,39408,-0.00926247530303307,0.00521030326498075,-0.0194746697023953,0.000949719096329205,0.0754774916536522
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",39589,0.0103045085895047,0.00580493933645711,-0.00107317250995126,0.0216821896889606,0.0759044785290608
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,41534,0.00723139578544351,0.00408092314203634,-0.000767213572947711,0.0152300051438347,0.076418096286415
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,41740,0.0179825095791511,0.0101483227497748,-0.0019082030104075,0.0378732221687097,0.0764229337844871
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP152,Centrosomal protein of 152 kDa,39241,-0.00826540655280018,0.00466859365233302,-0.0174158501113729,0.000885037005772533,0.0766845793790939
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,41465,0.0177883041598868,0.0100545925173693,-0.0019186971741571,0.0374953054939307,0.0768888530729366
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,39625,0.0129829686722205,0.00733990980974178,-0.00140325455487341,0.0273691918993144,0.0769518035768519
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,39600,0.0114019145879848,0.00645414573119342,-0.00124821104515427,0.0240520402211239,0.0773224310064432
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPARC,SPARC,41802,0.013653545765326,0.00774005511825529,-0.00151696226645439,0.0288240537971064,0.0777531773819378
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP350,Centrosome-associated protein 350,39241,-0.00715501697873903,0.00405724541930559,-0.015107218000578,0.000797184043099928,0.0778422050597793
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,39408,0.00645419867652695,0.00366010938844331,-0.000719615724821946,0.0136280130778758,0.0778630617548789
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYTL4,Synaptotagmin-like protein 4,39625,0.0142472531516854,0.00808859941711051,-0.00160640170585121,0.030100908009222,0.0781985621096873
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR3,Folate receptor gamma,41753,0.037417346919066,0.0212728110002178,-0.00427736264136084,0.0791120564794927,0.0786129563193376
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,39241,-0.00495847043325773,0.00281953126504044,-0.010484751712737,0.000567810846221545,0.0786716371156992
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEF,Thyrotroph embryonic factor,39250,0.00834757856905799,0.00474945895349039,-0.000961360979783178,0.0176565181178992,0.0788468470975706
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,41877,0.00650471302554663,0.00370107509266624,-0.000749394156079198,0.0137588202071725,0.0788522808843533
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAN,Brevican core protein,41636,0.00670157173933307,0.0038165661255261,-0.000778897866698083,0.0141820413453642,0.0791261350899542
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,41534,0.0135804895852153,0.00776220996449413,-0.00163344194519322,0.0287944211156238,0.0802171474438821
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRR4,Proline-rich protein 4,39327,0.0138100652097556,0.00789592687918207,-0.00166595147344129,0.0292860818929524,0.0803176682724269
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTF,Ciliary neurotrophic factor,39259,-0.00671345271742091,0.00384026244905569,-0.0142403671175701,0.000813461682728244,0.0804624324486104
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,39373,0.01054344011268,0.00604314438407075,-0.00130112288009862,0.0223880031054587,0.0810665957588019
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRIB,Protein scribble homolog,39308,0.0169807983857242,0.00973615842090691,-0.00210207211925331,0.0360636688907018,0.0811709840595456
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNA4,Plexin-A4,41740,0.0155560722880701,0.00892703301514114,-0.00194091242160656,0.0330530569977467,0.0814303395190376
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF5,Fibroblast growth factor 5,41534,0.00657416549192607,0.00377286557967434,-0.000820651044235629,0.0139689820280878,0.0814472046290733
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,41758,-0.00768105928786617,0.00440853480129043,-0.0163217874983954,0.000959668922663074,0.0814765860348114
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,39241,-0.0176475605225818,0.0101317060433657,-0.0375057043675786,0.00221058332241505,0.0815696647864601
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,39308,-0.00414578995476746,0.0023840374571618,-0.00881850337080458,0.000526923461269659,0.0820672779908614
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FMR1,Synaptic functional regulator FMR1,41465,0.00696863869592661,0.00400791315080664,-0.000886871079654395,0.0148241484715076,0.082107950875619
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL4,Early placenta insulin-like peptide,39589,0.00930409943466602,0.00535290187678155,-0.00118758824382582,0.0197957871131579,0.0822139428800422
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",39600,-0.00803138004656665,0.00462774564956135,-0.0171017615197069,0.0010390014265736,0.0826830598662966
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHPK,Sedoheptulokinase,39427,0.00772524599854019,0.004454006357775,-0.00100460646269881,0.0164550984597792,0.0828669430263841
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBH,Dopamine beta-hydroxylase,39643,-0.0219737716298632,0.0126906966450012,-0.0468475370540656,0.00289999379433925,0.083392934748629
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM25,Transmembrane protein 25,39600,-0.00903507969632635,0.00522083699155619,-0.0192679201997765,0.00119776080712378,0.0835546223920098
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEB,Nebulin,39250,0.00757558435378717,0.00438325032569291,-0.00101558628457094,0.0161667549921453,0.0839629142115132
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHRL,Appetite-regulating hormone,41765,0.0159067047515333,0.00921748213964982,-0.00215956024218039,0.0339729697452469,0.084422991760434
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBPL,FK506-binding protein-like,39600,0.0113819879646481,0.00659925589063656,-0.00155255358099956,0.0243165295102957,0.0846027751163989
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNG,Uracil-DNA glycosylase,39589,0.00671778917750361,0.00389587802620793,-0.000918131753863936,0.0143537101088711,0.0846759537456127
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,39334,-0.00847948592424879,0.00492479041555979,-0.018132075138746,0.0011731032902484,0.0851352349828425
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREH,Trehalase,39633,-0.0143486963587286,0.00833750228008512,-0.0306902008276954,0.00199280811023827,0.0852820168380753
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MME,Neprilysin,41689,0.0148320029262316,0.00861985860381087,-0.00206291993723773,0.0317269257897009,0.0853328652156245
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECE1,Endothelin-converting enzyme 1,41466,-0.00672640928369803,0.00391145180896625,-0.0143928548292719,0.000940036261875827,0.0855163567342534
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS2,"Nitric oxide synthase, inducible",39250,0.00773519517545785,0.00449855220957923,-0.00108196715531745,0.0165523575062331,0.0855550661136254
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA9,Serpin A9,41644,-0.0137305726941487,0.00798717168137483,-0.0293854291896434,0.00192428380134595,0.0856238597594478
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,39259,-0.0223062335512882,0.012998154764788,-0.0477826168902727,0.00317014978769637,0.08617138830331
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BIN2,Bridging integrator 2,41758,0.0169815514711351,0.0098964521483492,-0.00241549473962929,0.0363785976818996,0.0861996463525267
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAGEA3,Melanoma-associated antigen 3,39427,0.0162573169683106,0.00951823941983089,-0.00239843229455795,0.0349130662311792,0.087661810475694
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A11,Protein S100-A11,41650,0.00876008697992845,0.00513640837281025,-0.00130727343077965,0.0188274473906365,0.0881270960184045
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,41466,0.0121723505840781,0.00714063687466371,-0.00182329769026276,0.026167998858419,0.088282192247325
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTB,Lymphotoxin-beta,39589,-0.00647299802620263,0.00380306465649874,-0.0139270047529402,0.000981008700534887,0.0887746831340913
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST5,Cystatin-D,41470,0.0105586174814104,0.00621800176484879,-0.0016286659776932,0.022745900940514,0.0895182624436269
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACAN,Aggrecan core protein,41621,-0.00514856382313158,0.00303531054033986,-0.0110977724821977,0.00080064483593454,0.089867542846444
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPL14,60S ribosomal protein L14,39308,0.00736887894991615,0.00434435801478731,-0.00114606275906697,0.0158838206588993,0.0898779976441232
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",41689,0.00799129150683675,0.00471813099099342,-0.00125624523551035,0.0172388282491839,0.0903383187155862
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,41865,0.00524216495739022,0.00309718271929962,-0.000828313172437027,0.0113126430872175,0.0905628953436457
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",39598,0.0105027358995905,0.00621090397625818,-0.00167063589387553,0.0226761076930565,0.0908621453279099
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,39308,0.0119249583871111,0.00709440350210322,-0.0019800724770112,0.0258299892512334,0.0928121745078373
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYM,Ketimine reductase mu-crystallin,39259,0.0140175221506826,0.00837638866549797,-0.00240019963369344,0.0304352439350586,0.0942668036823357
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGA4,Pepsin A-4,39655,0.0139530702845137,0.00833822847150541,-0.00238985751963692,0.0302959980886643,0.0942797303809071
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,39259,0.00910224956227854,0.00544000332164194,-0.00156015694813966,0.0197646560726967,0.0943159719906126
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRDT,Bromodomain testis-specific protein,39250,0.00680071441885991,0.00406557638041523,-0.00116781528675394,0.0147692441244738,0.0944048502600387
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,39308,0.0106547708183736,0.00637590507479095,-0.00184200312821669,0.0231515447649638,0.0947312777083573
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,39589,-0.00644494925542502,0.00385753964695855,-0.0140057269634638,0.00111582845261374,0.0948013432554659
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13,Interleukin-13,41534,-0.00896625769095514,0.00537424220126972,-0.0194997724054438,0.00156725702353351,0.095265278180517
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,41663,0.00400847198127883,0.00240759528762856,-0.000710414782473143,0.0087273587450308,0.0959511708695451
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PF4,Platelet factor 4,39588,0.017897566626059,0.0108017156560666,-0.00327379605983163,0.0390689293119496,0.0975644262018479
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESM1,Endothelial cell-specific molecule 1,41744,0.00636604073713644,0.00384348981185838,-0.00116719929410599,0.0138992807683789,0.0976813391401654
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300LG,CMRF35-like molecule 9,41758,-0.00682149315875752,0.00412339647578212,-0.0149033502512905,0.00126036393377544,0.0980826251015844
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,41856,0.00581775505011357,0.0035177030943942,-0.00107694301489907,0.0127124531151262,0.0981815679015025
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,41721,0.00447407432074423,0.00270868604660826,-0.00083495033060796,0.00978309897209642,0.0986092929165388
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCR,Breakpoint cluster region protein,41740,0.0168933282361254,0.0102423537058171,-0.0031816850272762,0.0369683414995269,0.099097813193322
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC39A5,Zinc transporter ZIP5,41740,-0.00961666148332426,0.00584451078820596,-0.0210719026282079,0.00183857966155942,0.0999076203291753
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RLN1,Prorelaxin H1,39600,0.00807467845839129,0.004908675706948,-0.00154632592722679,0.0176956828440094,0.100002294397668
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,41587,0.00553907681093414,0.0033700106152328,-0.00106614399492214,0.0121442976167904,0.100275248511969
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F12,Coagulation factor XII,39650,0.00750641108404885,0.00456729202383114,-0.00144548128266019,0.0164583034507579,0.100304958626046
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB44,Ras-related protein Rab-44,39589,-0.00817421419626402,0.00498004478897982,-0.0179351019826645,0.00158667359013643,0.1007443310104
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK15,Kallikrein-15,39570,0.00958646630083635,0.00584600025118489,-0.00187169419148604,0.0210446267931587,0.101068489850246
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PADI4,Protein-arginine deiminase type-4,41447,-0.0132847584746232,0.00810381122259199,-0.0291682284709035,0.0025987115216571,0.101170638575918
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,39250,0.00889210642735928,0.00543255137634497,-0.00175569427027687,0.0195399071249954,0.101697720856002
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL2,Fc receptor-like protein 2,41844,0.00908425320507353,0.00555042684558623,-0.00179458341227548,0.0199630898224225,0.101721840642508
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,41751,-0.0104764374411206,0.006402574530477,-0.0230254835208555,0.0020726086386143,0.101803857624038
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,39598,-0.00617082441871641,0.00377220050776757,-0.0135643374139409,0.00122268857650804,0.101895702857118
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,39600,0.00934725995896005,0.00572302620947293,-0.00186987141160689,0.020564391329527,0.102440367630703
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL5A1,Collagen alpha-1(V) chain,39408,0.00745053784944012,0.00456503941044105,-0.00149693939502433,0.0163980150939046,0.102690459801071
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,41689,0.0144393193686208,0.00885166738780427,-0.00290994871147559,0.0317885874487172,0.102860756890718
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR101,Probable G-protein coupled receptor 101,39259,0.0105306503652827,0.00645704362639854,-0.00212515514245845,0.0231864558730238,0.10294560999034
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES2,Cocaine esterase,41689,0.0100590314978883,0.00617345153305726,-0.00204093350690394,0.0221589965026805,0.103252104671102
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,41734,0.00930775041064264,0.0057470367232116,-0.00195644156685211,0.0205719423881374,0.105347858738543
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,39427,0.0205991062083857,0.0127187696995872,-0.00432968240280518,0.0455278948195766,0.105350957148638
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC3B,Tetranectin,39399,-0.00377263654148186,0.00233162019131273,-0.00834261211645482,0.000797339033491096,0.105684863774285
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,41836,-0.00575022170008883,0.0035611619355931,-0.0127300990938513,0.00122965569367366,0.106398690628339
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFGE8,Lactadherin,41758,0.00807506192009593,0.00500214877852173,-0.00172914968580665,0.0178792735259985,0.106482311044976
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELAVL4,ELAV-like protein 4,39259,0.0146841918068012,0.00910575239628759,-0.00316308288992252,0.0325314665035248,0.106854943317216
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",39241,0.00927507581524269,0.00576802111366611,-0.00203024556754288,0.0205803971980283,0.107861130166845
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGFR,Opioid growth factor receptor,41689,0.0057237754635049,0.00356173768834948,-0.00125723040566008,0.0127047813326699,0.108074608997308
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,41465,-0.00954274310287301,0.00593906810836794,-0.0211833165952742,0.00209783038952816,0.1081283885958
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,39600,0.0128759810005734,0.00802826769188789,-0.00285942367552691,0.0286113856766736,0.108780117641914
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,39308,-0.00597684492392161,0.00372749208316474,-0.0132827294069245,0.00132903955908128,0.108864966375459
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTP1,Glutathione S-transferase P,41392,0.0124401732101552,0.00775869527522173,-0.00276686952927937,0.0276472159495898,0.10887443775667
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CORO1A,Coronin-1A,41511,0.0156853614160605,0.00981913868501198,-0.00356015040656301,0.0349308732386839,0.110194935575895
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,41877,0.00945719879588259,0.00594068922631571,-0.0021865520876962,0.0211009496794614,0.111422825640543
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGA,Glycoprotein hormones alpha chain,41758,0.0108863282993553,0.00684015682475766,-0.00252037907716974,0.0242930356758803,0.111513927608965
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLIT2,Slit homolog 2 protein,41466,0.00906399527793437,0.00569517608489923,-0.00209854984846812,0.0202265404043369,0.111516824545399
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLIN1,Perilipin-1,41466,0.00597580788250494,0.00375709225154554,-0.00138809293052432,0.0133397086955342,0.111737563411659
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,39589,0.00698627895675289,0.00439577734495925,-0.00162944463936725,0.015602002552873,0.112017851656426
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,41911,-0.00646726504427319,0.00406952784984414,-0.0144435396299677,0.00150900954142133,0.112040582911104
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHMP6,Charged multivesicular body protein 6,39625,0.010118130565943,0.00636679320824805,-0.00236078412222313,0.0225970452541092,0.112043112022172
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,39650,0.00322726288337056,0.0020380538096367,-0.000767322583517374,0.0072218483502585,0.113335641789045
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARSB,Arylsulfatase B,41689,0.00975022455893145,0.00616023803882184,-0.00232384199715935,0.0218242911150223,0.113498627390021
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,41465,0.00815475387103332,0.00516440868671033,-0.00196748715491892,0.0182769948969856,0.114353866927106
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENG,Endoglin,41925,-0.00301768455412433,0.0019122185409253,-0.00676563289433791,0.000730263786089254,0.114564877209097
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,41465,-0.00990341050023202,0.00628019917975066,-0.0222126008925433,0.00240577989207927,0.114837099205627
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POF1B,Protein POF1B,39334,0.00790940960460062,0.00502403457513264,-0.00193769816265935,0.0177565173718606,0.115444270775986
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,41465,0.00944952388122263,0.00600542231817259,-0.00232110386239564,0.0212201516248409,0.115627992102859
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL24,C-C motif chemokine 24,41786,0.0143576798966794,0.00912914796047456,-0.00353545010585074,0.0322508098992095,0.115805468743096
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,39334,0.00638261884244378,0.00406139551516342,-0.00157771636727652,0.0143429540521641,0.116088268472733
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,39250,-0.00868912311088479,0.00553030856018631,-0.01952852788885,0.00215028166708039,0.116170009010816
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,39589,0.00965106679950802,0.00614886992154761,-0.00240071824672529,0.0217028518457413,0.116544540483581
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPK3A,Uroplakin-3a,39259,-0.00845618028260887,0.00538902822223889,-0.0190186755981971,0.00210631503297935,0.116643251971115
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,41786,0.0132066086792439,0.00842678876081784,-0.00330989729195907,0.0297231146504469,0.117087916351234
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],41689,0.00980449907643398,0.00628223230876577,-0.00250867624874694,0.0221176744016149,0.118625524640443
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,41447,0.00704780082105446,0.00451888936430008,-0.0018092223329737,0.0159048239750826,0.118871692149441
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUOX2,Dual oxidase 2,41521,-0.0121492445894925,0.00780565046375411,-0.0274483194984506,0.00314983031946556,0.119621355272789
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,41802,-0.0189056444926476,0.0121766211313924,-0.0427718219101766,0.00496053292488141,0.120538327407725
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB2A2,Mammaglobin-A,39250,0.00535958844200258,0.00345383549553211,-0.00140992912924036,0.0121291060132455,0.120744892148915
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEMIP2,Cell surface hyaluronidase,39334,0.00557230372147116,0.00359342592341338,-0.00147081108841906,0.0126154185313614,0.121004534248862
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,41614,0.00577601907850013,0.00373366679687948,-0.00154196784338364,0.0130940060003839,0.121885201166281
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",39633,0.00741490076223111,0.00479952519484189,-0.00199216861965899,0.0168219701441212,0.122393373589467
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COPB2,Coatomer subunit beta',39250,0.00739329096872537,0.00479712506633709,-0.00200907416129532,0.0167956560987461,0.123299764313521
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGMA,Repulsive guidance molecule A,41865,-0.00547827753078189,0.00356231114792262,-0.0124604073807102,0.00150385231914644,0.124110702647788
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",41716,0.0116201630871604,0.00756059852134469,-0.00319861001467522,0.026438936188996,0.124332876433727
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS1,"Nitric oxide synthase, brain",41466,0.00998279233396821,0.00649709784225182,-0.00275151943684535,0.0227171041047818,0.124440331415023
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCAN,Versican core protein,41865,0.0051044390064635,0.00332440452023356,-0.00141139385319427,0.0116202718661213,0.124698502473754
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTF2,Transcription termination factor 2,39328,0.00850686394675309,0.00554602607417088,-0.00236334715862182,0.019377075052128,0.125091972005002
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RILP,Rab-interacting lysosomal protein,41840,0.00995407931169126,0.00649191664186701,-0.00277007730636809,0.0226782359297506,0.125224955369067
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPC1,Glypican-1,41877,0.00501828939064464,0.0032747948962177,-0.00140030860594205,0.0114368873872313,0.125448058376125
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,41466,0.0144685894873417,0.00944669708961701,-0.00404693680830765,0.032984115782991,0.125645021011045
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17D,Interleukin-17D,41534,0.00576185060840712,0.00376466535750569,-0.00161689349230403,0.0131405947091183,0.125915480145267
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,39408,0.0131328562891331,0.00858785158460293,-0.00369933281668865,0.0299650453949548,0.126235084683305
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTN4,Alpha-actinin-4,41534,0.00530978393957177,0.0034844614665916,-0.00151976053494777,0.0121393284140913,0.127571543062143
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOE,Apolipoprotein E,39650,-0.0116428299175641,0.0076419467606141,-0.0266210455683678,0.00333538573323951,0.127651677682687
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPS10,40S ribosomal protein S10,39250,0.00709252250159617,0.00466281587685518,-0.00204659661703999,0.0162316416202323,0.12826909913526
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,39241,0.013661072544162,0.00898121108447523,-0.0039421011814094,0.0312642462697335,0.128271375630755
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP1,Retinol-binding protein 1,39328,0.011855930720404,0.00780884793836606,-0.00344941123879345,0.0271612726796015,0.128976099572332
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH15,Cadherin-15,41846,-0.0116753823652517,0.00769425666387641,-0.0267561254264494,0.0034053606959461,0.129185741572119
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,39600,0.00677156339273039,0.0044686571127055,-0.0019870045481724,0.0155301313336332,0.129713441181644
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF830,Zinc finger protein 830,39589,-0.0130339711264431,0.00861316440266845,-0.0299157733556732,0.00384783110278709,0.130241975370915
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,39600,0.0158919974347272,0.0105057115860243,-0.00469919727388042,0.0364831921433347,0.130384425984276
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAPIN,SNARE-associated protein Snapin,39600,-0.00975063226890532,0.0064797103833737,-0.0224508646203178,0.00294960008250714,0.132405640458467
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN3,Ataxin-3,39598,-0.010186322824623,0.00677896575285389,-0.0234730957002166,0.00310045005097062,0.132961461688607
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PXN,Paxillin,41466,0.00850983143934051,0.00567899623499271,-0.00262100118124519,0.0196406640599262,0.134034528623994
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,41466,0.00488060207304473,0.00326059089177485,-0.00151015607483398,0.0112713602209234,0.134457892582018
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17RA,Interleukin-17 receptor A,41758,0.0073469493316805,0.00490952695115265,-0.00227572349257869,0.0169696221559397,0.134555759790241
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,41465,-0.00589965929532692,0.00394367557527509,-0.0136292634228661,0.00182994483221226,0.134683429403146
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSME1,Proteasome activator complex subunit 1,41622,0.00599775592777731,0.00401839307429233,-0.00187829449783567,0.0138738063533903,0.135572509293206
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,39336,-0.0045350920029447,0.00304188448925136,-0.0104971856018774,0.00142700159598796,0.136021755807147
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA1,Carboxypeptidase A1,41925,0.0106389959832245,0.0071465249978422,-0.00336819301254622,0.0246461849789952,0.136591369351389
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMOD1,Leiomodin-1,39600,0.0057521620908344,0.00386460381899266,-0.00182246139439121,0.01332678557606,0.136668253803343
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN2L,Ataxin-2-like protein,39600,0.00798394365792917,0.00537569567674149,-0.00255241986848414,0.0185203071843425,0.137521456905818
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,39554,0.00449779547827475,0.00303077525950134,-0.00144252403034788,0.0104381149868974,0.137826752363889
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,41908,0.00988067628773179,0.00665950067103969,-0.003171945027506,0.0229332976029696,0.137913199150191
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSHB,Follitropin subunit beta,39308,0.00674206748379449,0.00454684096309785,-0.00216974080387728,0.0156538757714663,0.138156301172082
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPCAM,Epithelial cell adhesion molecule,41745,0.0153738319028633,0.0103728014998465,-0.00495685903683575,0.0357045228425624,0.138329894110559
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,39334,0.0160226539421978,0.0108120991452266,-0.00516906038244638,0.0372143682668421,0.138391233449361
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMMD9,COMM domain-containing protein 9,39589,0.00657843256878561,0.00443933486589818,-0.00212266376837482,0.015279528905946,0.138408633338864
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,39328,0.00718591972578429,0.00484987205547969,-0.0023198295029559,0.0166916689545245,0.138456955833265
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP290,Centrosomal protein of 290 kDa,39427,-0.00871181953225443,0.00588094857721204,-0.02023847874359,0.00281483967908117,0.138538973777936
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL13,C-C motif chemokine 13,41891,-0.0111681261213016,0.00753938710669008,-0.0259453248504142,0.0036090726078109,0.138549223666333
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF9,Protein turtle homolog A,39625,-0.0140790889687193,0.00956346787760968,-0.0328234860088343,0.00466530807139567,0.141002434875868
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20,Interleukin-20,41534,0.00758378291651708,0.00515401537329068,-0.00251808721513265,0.0176856530481668,0.141198665715626
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX1,Peroxiredoxin-1,41375,-0.014951756363574,0.0101629107997929,-0.034871061531168,0.00496754880402009,0.141259486807087
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",39334,-0.00612430458904137,0.00416455556753697,-0.0142868335014138,0.00203822432333109,0.141434537362685
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,41780,0.00367623179485914,0.00250655351358484,-0.00123661309176716,0.00858907668148543,0.142495683278323
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS53,Serine protease 53,39598,-0.00622125108564151,0.00424385011143289,-0.01453919730405,0.00209669513276696,0.142691845165087
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TJAP1,Tight junction-associated protein 1,41802,0.0135136609363682,0.00922325249079702,-0.00456391394559394,0.0315912358183304,0.142897525358374
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX15,Sorting nexin-15,39408,0.00879053001035544,0.00600086029529969,-0.00297115616843196,0.0205522161891428,0.142983211995369
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TG,Thyroglobulin,39589,0.0170116259786929,0.0116408318525834,-0.00580440445237048,0.0398276564097564,0.143941024705705
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,39598,-0.00542241852029715,0.0037114640444302,-0.0126968880473803,0.00185205100678605,0.144046260432226
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPB41L5,Band 4.1-like protein 5,39328,0.010123746603051,0.00694842293007269,-0.00349516233989145,0.0237426555459935,0.145149843518241
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD4,Sushi domain-containing protein 4,39589,0.00621759804498982,0.00427111354648496,-0.0021537845061207,0.0145889805961003,0.145495197692364
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC12A2,Solute carrier family 12 member 2,39250,0.00427227972360915,0.00294192780764173,-0.00149389877936863,0.0100384582265869,0.14647431237229
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,39328,0.00585557924111437,0.0040352752888887,-0.00205356032510748,0.0137647188073362,0.146781857924222
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AXIN1,Axin-1,41740,0.0155390133665299,0.0107133303212589,-0.00545911406313756,0.0365371407961974,0.146960495129247
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF19,Fibroblast growth factor 19,41805,-0.0124481016637895,0.00861077662713608,-0.0293252238529762,0.00442902052539721,0.148301328499959
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,39308,-0.00827756601406001,0.00572751659510015,-0.0195034985404563,0.0029483665123363,0.148423182801606
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,39221,0.0138123555280261,0.00956255005456402,-0.00493024257891936,0.0325549536349716,0.148649867530176
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,41465,-0.015661813305779,0.0108480377709817,-0.0369239673369032,0.00560034072534523,0.148834730799927
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,41465,0.00790386696167247,0.00547510443995934,-0.00282733774064784,0.0186350716639928,0.148875556153135
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MATN2,Matrilin-2,41764,0.00472291031378638,0.00327560869143577,-0.00169728272142773,0.0111431033490005,0.149370729121967
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXDC1,Plexin domain-containing protein 1,41465,-0.00514791335075733,0.00357531407154664,-0.0121555289309887,0.00185970222947408,0.14993438094157
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,41765,0.00454363429114156,0.00315737882623592,-0.00164482820828084,0.010732096790564,0.150159387128117
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC27,Cell division cycle protein 27 homolog,41465,0.00971784952351098,0.00675503357429534,-0.00352201628210789,0.0229577153291298,0.150285769390857
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,39334,0.00934859004907223,0.00652336277444523,-0.00343720098884042,0.0221343810869849,0.151860187585966
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,41465,0.00734089923202792,0.00512627199434147,-0.00270659387688137,0.0173883923409372,0.152163776036518
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,41689,0.0094753068853638,0.00663121192408902,-0.00352186848585069,0.0224724822565783,0.153058220687295
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAB2,Stabilin-2,39633,0.0044373154119762,0.00310962638325576,-0.00165755229920509,0.0105321831231575,0.153619449830742
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,39308,0.00439633644719106,0.00308218597078596,-0.00164474805554942,0.0104374209499315,0.153790830420051
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,39250,0.0106837856764968,0.00749327101866805,-0.00400302552009258,0.0253705968730862,0.153960019105827
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,39598,0.00621614056391858,0.00436423230112103,-0.00233775474627863,0.0147700358741158,0.154377113904036
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FZD10,Frizzled-10,39328,-0.00942665362359346,0.00662239142660774,-0.0224065408197446,0.0035532335725577,0.154634366251767
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,39241,0.00738276083249247,0.00520116944938428,-0.00281153128830072,0.0175770529532857,0.155799349192314
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,39308,0.0419171898790389,0.0295929959405371,-0.0160850821644137,0.0999194619224915,0.156670996421457
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GH2,Growth hormone variant,41465,0.025342530210321,0.0179128919405136,-0.00976673799308575,0.0604517984137277,0.157161650330513
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,39308,0.00502428272956946,0.00355170671015061,-0.00193706242232573,0.0119856278814647,0.157211712284536
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA3,Carbonic anhydrase 3,41905,-0.00918102639224249,0.00649602979231688,-0.0219132447851836,0.00355119200069859,0.157582445786139
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYZL2,Lysozyme-like protein 2,39241,0.0057109228324018,0.00404130068211543,-0.00221002650454444,0.013631872169348,0.157643872811153
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM5,Tripartite motif-containing protein 5,41740,0.0136141373687804,0.00964399355218127,-0.00528808999349487,0.0325163647310557,0.158070798964248
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RALY,RNA-binding protein Raly,39589,0.00755684737352474,0.00535625335118564,-0.00294140919479912,0.0180551039418486,0.158318403652086
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHIT1,Chitotriosidase-1,41826,0.0243276212157044,0.0172497283509731,-0.0094818463522029,0.0581370887836117,0.158469000693205
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN1,Dynactin subunit 1,41877,0.00995505996814203,0.00708762934616579,-0.00393669355034292,0.023846813486627,0.160173062277506
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPAG1,Sperm-associated antigen 1,39600,0.00910164253139209,0.00648685479255692,-0.00361259286201948,0.0218158779248037,0.160618161612542
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKIV2L,Helicase SKI2W,39250,0.00611490766896004,0.00435850951145837,-0.00242777097349836,0.0146575863114184,0.160651544658309
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AAMDC,Mth938 domain-containing protein,39308,0.00824484373855733,0.00588199728447253,-0.00328387093900883,0.0197735584161235,0.161031389863765
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL26,C-C motif chemokine 26,41740,0.0139270664291609,0.00994293766699186,-0.00556109139814317,0.0334152242564649,0.161327607949051
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANK2,Ankyrin-2,39250,0.010743019438632,0.00768720019922352,-0.00432389295184612,0.0258099318291101,0.162286233594129
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,41521,0.00544555097257332,0.00389686062192199,-0.00219229584639378,0.0130833977915404,0.162311301600915
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMA1,Laminin subunit alpha-1,39250,0.00802703507999209,0.00575024160100047,-0.00324343845796882,0.019297508617953,0.162759419665202
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTA3,Glutathione S-transferase A3,41465,-0.0119188837130741,0.00856098746247453,-0.0286984191395242,0.004860651713376,0.163876113139613
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD5,Sushi domain-containing protein 5,39368,0.00533579738699801,0.00383305291819408,-0.00217698633266238,0.0128485811066584,0.163936316946236
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FEN1,Flap endonuclease 1,41465,-0.00992622552804767,0.00713410157937651,-0.0239090646236256,0.0040566135675303,0.164135165327788
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",39600,-0.00628475565623644,0.00451730444847014,-0.0151386723752379,0.00256916106276504,0.164174019420279
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,39600,0.00914469167532499,0.00658625390128363,-0.00376436597119091,0.0220537493218409,0.16502783070831
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,41689,0.00691645345810287,0.00498541862967021,-0.00285496705605074,0.0166878739722565,0.165362784628227
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FZD8,Frizzled-8,39259,0.00664672211418665,0.0047927763062217,-0.00274711944600788,0.0160405636743812,0.1655253982667
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,39408,-0.00405363239711029,0.00292388175992694,-0.0097844406465671,0.00167717585234651,0.165657284578474
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAM2,Neural cell adhesion molecule 2,41758,-0.00413079846222357,0.0029837087273892,-0.00997886756790639,0.00171727064345926,0.166243886205361
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,39600,0.00670284585764316,0.00484605925387188,-0.00279543027994573,0.0162011219952321,0.166645747536118
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,39600,0.00447053190992111,0.00323846038407244,-0.00187685044286086,0.0108179142627031,0.167476253660763
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMBN,Ameloblastin,41534,-0.00419915551375134,0.00304194610161941,-0.0101613698729254,0.0017630588454227,0.167482002800901
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53BP1,TP53-binding protein 1,39334,-0.0131735924973589,0.00955449383526965,-0.0319004004144874,0.00555321541976966,0.16798979320542
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,39259,-0.00481241682344547,0.00349282360790417,-0.0116583510949377,0.00203351744804671,0.168293576802532
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF174,Zinc finger protein 174,39334,-0.00567152675954886,0.00411835733772296,-0.0137435071414859,0.00240045362238814,0.168499776268022
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMH,Granzyme H,41521,0.0120163370076142,0.0087279745381549,-0.00509049308716937,0.0291231671023978,0.168609933206816
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AZU1,Azurocidin,41383,-0.0114575467853454,0.00834153241900464,-0.0278069503265945,0.00489185675590365,0.16960421553056
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CORO6,Coronin-6,39259,-0.00595415069067342,0.00434060783300009,-0.0144617420433536,0.00255344066200677,0.170175752349704
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXJ3,Forkhead box protein J3,39334,0.00692081872734031,0.00505237485813519,-0.00298183599460468,0.0168234734492853,0.170773319698218
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL6,Fc receptor-like protein 6,41740,0.0104422607206788,0.00762571489814517,-0.00450414047968574,0.0253886619210433,0.170913789137921
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHBG,Sex hormone-binding globulin,39655,0.00713024437386855,0.0052109481662034,-0.00308321403189012,0.0173437027796272,0.171239754058837
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,41636,0.0170085392905597,0.012433264924748,-0.00736065996194647,0.0413777385430659,0.171339863151404
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,41740,0.015780546516651,0.011552676127902,-0.0068626986940369,0.038423791727339,0.171973455554036
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,39600,0.00366435173824179,0.00268267249399756,-0.00159368634999343,0.008922389826477,0.171987819793614
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,39241,0.00666129981906504,0.00488095025748536,-0.00290536268560626,0.0162279623237363,0.172359016770687
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BEX3,Protein BEX3,39241,-0.00708402000040844,0.00519134949819818,-0.0172590650168769,0.00309102501606,0.172413446519426
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSB,Lupus La protein,41466,-0.00891044419356326,0.0065447437803598,-0.0217381420030685,0.00391725361594194,0.173390405850734
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSR,Insulin receptor,39334,0.00258206097414332,0.00189984769654389,-0.0011416405110827,0.00630576245936934,0.174147130703394
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LARP1,La-related protein 1,39589,0.00940357996579547,0.00692378161452434,-0.00416703199867223,0.0229741919302632,0.17444186886992
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,39408,0.007532433332931,0.00555283313176071,-0.00335111960532,0.018415986271182,0.174967599497873
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MELTF,Melanotransferrin,39625,-0.00452347241033831,0.00334215310454885,-0.0110740924952541,0.00202714767457743,0.17593628952583
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCL2,Phosducin-like protein 2,39241,0.00782537621800485,0.00578453946969902,-0.00351232114260523,0.0191630735786149,0.176145445577565
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDK2,Protein sidekick-2,39408,0.00591966966581725,0.00438666814103666,-0.00267819989061459,0.0145175392222491,0.177214856616393
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBN2,Fibrillin-2,39328,0.00898859646844863,0.00668279628169943,-0.00410968424368225,0.0220868771805795,0.178642288298602
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,39589,0.00644986606915443,0.00480077158864943,-0.00295964624459845,0.0158593783829073,0.179135883401944
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PER3,Period circadian protein homolog 3,39334,0.0184115305480913,0.0137111187713588,-0.00846226224377204,0.0452853233399546,0.179359461575745
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGR2,Anterior gradient protein 2 homolog,41376,0.0148245012025602,0.0110788124063271,-0.00688997111384094,0.0365389735189613,0.180889352283091
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACYP1,Acylphosphatase-1,39373,0.0096771711383432,0.00724872822389114,-0.00453033618048343,0.0238846784571698,0.181899185360043
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,41466,0.00725430133025988,0.00544037774156855,-0.00340883904321448,0.0179174417037342,0.18241805108232
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",39600,0.00537275776649698,0.0040296342024313,-0.00252532527026836,0.0132708408032623,0.182457199890406
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,41805,0.00427533400825429,0.0032108698892778,-0.00201797097473019,0.0105686389912388,0.183041307977406
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPA33,Cell surface A33 antigen,41689,0.0196765535969743,0.0147898163216932,-0.0093114863935444,0.0486645935874931,0.183405641358317
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINE2,Glia-derived nexin,39625,0.00958092919784501,0.00720373649437226,-0.00453839433112463,0.0237002527268146,0.183547629308846
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,39334,0.00563049892270836,0.00424457694944046,-0.00268887189819493,0.0139498697436117,0.184697084394251
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,39259,-0.0106193821750427,0.00801665230239008,-0.0263320206877273,0.00509325633764181,0.185310542716466
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,41689,-0.00544608865801769,0.00411318631590521,-0.0135079338371919,0.00261575652115652,0.185507597581069
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROS1,Vitamin K-dependent protein S,39650,0.00371483285178756,0.00280900651652447,-0.00179081992060041,0.00922048562417552,0.186038351942307
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",39328,-0.0113645522775308,0.00859537561056484,-0.0282114884742379,0.0054823839191763,0.186139562504015
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSPN,Claspin,41447,0.0051728878286227,0.00391409591860446,-0.00249874017184204,0.0128445158290874,0.186323328790081
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,39589,0.0167470188232024,0.0126853687154334,-0.00811630385904707,0.041610341505452,0.186801142310263
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,41667,0.00379797884888169,0.00288083962858305,-0.00184846682314109,0.00944442452090447,0.187406839266842
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,39308,-0.00376366012889821,0.00285484097213309,-0.00935914843427906,0.00183182817648264,0.187416990015166
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EZR,Ezrin,41865,-0.00354639522433098,0.00269278266467663,-0.00882424924709717,0.00173145879843521,0.187861318212443
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINF1,Pigment epithelium-derived factor,39490,0.00384097202793154,0.00291800161827446,-0.0018783111438864,0.00956025519974948,0.188100327683384
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP164,Centrosomal protein of 164 kDa,41534,-0.0090980548340882,0.00691700095724666,-0.0226553767102917,0.00445926704211526,0.188426417728741
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RELB,Transcription factor RelB,39334,0.0068354466465127,0.00520318662932777,-0.00336279914696974,0.0170336924399951,0.188973939572301
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTOA,Otoancorin,39259,-0.00764191421892895,0.00582041430003092,-0.0190499262469895,0.00376609780913165,0.1892279892625
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,39308,0.00764671079117379,0.00582994671402168,-0.00377998476830871,0.0190734063506563,0.189674412840339
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,41625,0.0148376542156524,0.0113134420375511,-0.00733669217794779,0.0370120006092527,0.189709773288107
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATRN,"Attractin, Isoform 2",39650,0.002429535980958,0.00185343365842039,-0.00120319398954596,0.00606226595146196,0.189942530082
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP170,Centrosomal protein of 170 kDa,39308,0.0112559081104765,0.00859752501503428,-0.00559524091899068,0.0281070571399437,0.190493587414487
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,39600,0.00695394281726202,0.00531316322310527,-0.00345985710002431,0.0173677427345483,0.190624679627002
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP5,Microfibrillar-associated protein 5,41925,0.00583673688515673,0.00446641993402518,-0.00291744618553263,0.0145909199558461,0.191301728378948
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNST,Consortin,41765,0.0157923353355142,0.0120854997061963,-0.00789524408863059,0.0394799147596589,0.191331459953597
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KAZN,Kazrin,39600,0.0152082580068754,0.0116562073147655,-0.00763790833006493,0.0380544243438156,0.192010500536609
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,39259,-0.00465595993416326,0.00358916176189687,-0.0116907169874811,0.00237879711915461,0.194580940748949
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,39241,0.00693677067647796,0.00535834510338411,-0.00356558572615488,0.0174391270791108,0.195495547666704
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,41465,0.00813220514989191,0.00628711241434453,-0.00419053518222337,0.0204549454820072,0.195871015109082
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA12,Serpin A12,41383,-0.0154159302482406,0.0119650599703663,-0.0388674477901585,0.00803558729367742,0.197625803819507
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPN3,Calpain-3,39589,-0.00557914951829278,0.00433782451921788,-0.0140812855759598,0.00292298653937427,0.198413269115224
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRMD7,FERM domain-containing protein 7,39328,-0.00488365626020269,0.00380166029734431,-0.0123349104429975,0.00256759792259215,0.198955840714952
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2,Apoptosis regulator Bcl-2,39600,0.00759725297902514,0.00593410007478614,-0.00403358316755568,0.019228089125606,0.200477032730709
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN1,Nectin-1,39334,-0.00468710078413945,0.00366218624836798,-0.0118649858309407,0.00249078426266179,0.200620588243601
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRLF1,Cytokine receptor-like factor 1,41805,0.00351966404103567,0.00275391983296898,-0.00187801883158352,0.00891734691365486,0.201252111595086
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,41521,-0.00826771811496912,0.00647069098380207,-0.0209502724432212,0.00441483621328293,0.201371843819606
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,39589,-0.0101274618350432,0.00793253180351679,-0.0256752241699362,0.00542030049984967,0.201735226956909
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,41534,-0.00524437529630092,0.00410995411180911,-0.0132998853554468,0.00281113476284494,0.201972080952437
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,39334,0.00731423035744604,0.00573673194271767,-0.0039297642502806,0.0185582249651727,0.202343185019968
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGBL1,Integrin beta-like protein 1,39633,0.0055801776963128,0.00437983649914309,-0.00300430184200765,0.0141646572346332,0.202668729869522
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM26,Tripartite motif-containing protein 26,39241,-0.0081068018983285,0.00638256935257463,-0.0206166378293748,0.00440303403271777,0.204060012023523
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEPH,Hephaestin,39625,-0.0038962942975096,0.00307019532602156,-0.00991387713651187,0.00212128854149266,0.20444271358029
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YY1,Transcriptional repressor protein YY1,39334,0.00394160130146281,0.00310610271789283,-0.00214636002560714,0.0100295626285328,0.204473522819401
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,39334,-0.00584207793001297,0.00460784181143086,-0.0148734478804175,0.00318929202039152,0.204877031709644
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR15L,Protein GPR15L,39600,0.00874600433445858,0.0068994373019874,-0.00477689277743673,0.0222689014463539,0.204953288585643
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPHS1,Nephrin,39334,-0.00468219737015913,0.00369617915735216,-0.0119267085185694,0.00256231377825109,0.205266140586269
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNC79,Protein unc-79 homolog,39241,0.00784210146919229,0.00619555178525501,-0.00430118002990753,0.0199853829682921,0.205625584999109
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,39328,-0.0066239879892994,0.0052347039831891,-0.01688400779635,0.00363603181775124,0.20575589773901
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSAP,Gamma-secretase-activating protein,41465,-0.0118172317131125,0.00934626758231085,-0.0301359161744417,0.0065014527482168,0.20611665390785
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIM,Vimentin,41521,-0.0160213774148538,0.0126982987328335,-0.0409100429312074,0.00886728810149972,0.207081406336858
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,39241,-0.0108343356693009,0.00858885938604912,-0.0276685000659572,0.00599982872735534,0.207177811733926
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,39250,-0.00478019064910906,0.00378948685927609,-0.0122075848932902,0.00264720359507207,0.207179860753527
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARSA,Arylsulfatase A,41758,-0.00627451054396348,0.00497666669982521,-0.0160287772756209,0.00347975618769394,0.20740839823283
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",39250,-0.005675491632142,0.00450654701910848,-0.0145083237895946,0.00315734052531062,0.207917790058073
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",39224,0.00371307858153256,0.00295489210722499,-0.00207850994862842,0.00950466711169353,0.208930904844547
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,39427,-0.00957019771608355,0.00762224324291525,-0.0245097944721974,0.00536939904003035,0.209301971372256
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",39250,-0.0117254858992376,0.00934413401013298,-0.0300399885590983,0.00658901676062302,0.209560779379476
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,41465,0.010872318806434,0.00866823032997418,-0.00611741264031541,0.0278620502531834,0.209765936806503
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTD,Biotinidase,39650,-0.00284175154166978,0.00226922449943377,-0.00728943156055997,0.00160592847722041,0.210486799864747
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,39241,-0.00541139841909146,0.0043289696575508,-0.013896178947891,0.00307338210970812,0.211311313132578
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF2,TNF receptor-associated factor 2,41740,-0.00960862534916102,0.00769068148635247,-0.0246823610624119,0.00546511036408982,0.211546391532527
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF16,Fibroblast growth factor 16,39334,-0.00644007848419781,0.00516091085023347,-0.0165554637506554,0.00367530678225979,0.212110668280271
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,39625,0.00532733895853899,0.00427276373353292,-0.00304727795918554,0.0137019558762635,0.212492423705694
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,39334,0.00624440103287007,0.00500984770265546,-0.00357490046433462,0.0160637025300748,0.212635489830257
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,39250,0.00477692224448136,0.0038331571001023,-0.00273606567171916,0.0122899101606819,0.212714381629531
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSDE1,Cold shock domain-containing protein E1,39250,0.0166860010290424,0.0133924526738603,-0.00956320621172376,0.0429352082698085,0.212819079553246
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G15,Phospholipase A2 group XV,41802,-0.00375877054221817,0.0030477847075996,-0.00973242856911338,0.00221488748467704,0.21749344379561
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPO,Erythropoietin,41740,0.00993727633823372,0.00806915709045516,-0.0058782715590584,0.0257528242355258,0.218152889475954
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TK1,"Thymidine kinase, cytosolic",39427,-0.00646574121484423,0.00525491272473153,-0.016765370155318,0.00383388772562956,0.218567204508623
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,41805,-0.0059744251972553,0.00486119648707057,-0.0155023703119136,0.00355351991740302,0.219092571283289
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,39581,-0.0118148735915298,0.00961432498646106,-0.0306589505649935,0.00702920338193387,0.219142280612592
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",41534,0.00842076176898706,0.00685478386452768,-0.00501461460548719,0.0218561381434613,0.219300301600067
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",41617,0.00976602649118991,0.0079810209940217,-0.00587677465709263,0.0254088276394725,0.221104066547342
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFPI,Tissue factor pathway inhibitor,41774,-0.00422578305372607,0.00345774041914994,-0.0110029542752599,0.00255138816780781,0.221683096142422
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLINT1,Clathrin interactor 1,39241,0.00682147738276537,0.00558270009532811,-0.00412061480407772,0.0177635695696085,0.221774129208756
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COPE,Coatomer subunit epsilon,41466,0.00624975916684663,0.00511563425621556,-0.00377688397533587,0.0162764023090291,0.221844308547327
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGM2,Phosphoglucomutase-2,39328,0.00827814402739647,0.00678226300450307,-0.00501509146142955,0.0215713795162225,0.222280318424283
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,41614,-0.0054513202598669,0.00447188755760033,-0.0142162198727635,0.00331357935302975,0.222858705835336
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BECN1,Beclin-1,39308,0.00804657913141456,0.0066205103213417,-0.00492962109841518,0.0210227793612443,0.224239737268649
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,39600,-0.00456696808635103,0.00375865153564713,-0.0119339250962194,0.00279998892351735,0.224371220414778
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,39241,-0.00851567565129154,0.00702655674845818,-0.0222877268782696,0.0052563755756865,0.225567136468413
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,41744,0.00394486640012772,0.00326901214710396,-0.00246239740819604,0.0103521302084515,0.227551805399885
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD3,Extracellular superoxide dismutase,39655,-0.00809777327062304,0.0067402966935661,-0.0213087547900126,0.00511320824876651,0.229622916574683
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",39600,0.00897319485395442,0.00749792341751281,-0.00572273504437068,0.0236691247522795,0.231426943784484
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEDD9,Enhancer of filamentation 1,39334,0.00451070216419307,0.00377926323631897,-0.00289665377899211,0.0119180581073783,0.232684300909647
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,39589,0.0117910548986625,0.00990131565732654,-0.00761552378969749,0.0311976335870225,0.233735297565301
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLN4,Cerebellin-4,41877,-0.00418237285961768,0.00351327788964468,-0.0110683975233213,0.00270365180408589,0.233891839423008
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCC,Netrin receptor DCC,39328,-0.00295371710730535,0.00248677709139824,-0.00782780020644589,0.00192036599183519,0.234950668630791
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,39167,0.00402409410145938,0.00339539747669835,-0.00263088495286939,0.0106790731557882,0.235980281909487
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB9,Serpin B9,41636,0.00428246246890828,0.00362287880581916,-0.00281837999049728,0.0113833049283138,0.237203198385271
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,41521,0.00739742903813561,0.00625814504223305,-0.00486853524464118,0.0196633933209124,0.237208331823786
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,39633,0.00304408927014918,0.00257702762764552,-0.00200688488003604,0.00809506342033439,0.237532678804211
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",41667,0.00990277064866316,0.00838937195497062,-0.00654039838307926,0.0263459396804056,0.237864733857485
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC123,Cell division cycle protein 123 homolog,39241,-0.00824991130959565,0.00699458320261099,-0.0219592943867132,0.00545947176752188,0.238236861157592
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL25,Interleukin-25,39193,-0.00448361783910371,0.00381316123241416,-0.0119574138546355,0.00299017817642804,0.23969044967257
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,39241,-0.00385678699174594,0.00328040600723706,-0.0102863827659306,0.00257280878243869,0.239739419225159
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,39241,-0.0033873367509779,0.00288205448841104,-0.00903616354826354,0.00226149004630773,0.239892947927273
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",39250,0.00555024445959137,0.00473360894345595,-0.0037276290695823,0.014828117988765,0.241015141030721
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,41865,0.00840393422297664,0.00717005822725083,-0.00564937990243499,0.0224572483483883,0.241183056285021
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",41689,0.012691494641507,0.0108353338524725,-0.00854575970933913,0.0339287489923531,0.241497007904112
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,41736,0.00348550466811588,0.00297738908333787,-0.00235017793522634,0.0093211872714581,0.241757467059952
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,39250,-0.00717961175013353,0.00613974328818935,-0.0192135085949847,0.0048542850947176,0.242282064575592
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_DRA,,41683,0.00470115343904999,0.00403830116212386,-0.00321391683871278,0.0126162237168128,0.244387954915857
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,39241,0.00669414811278892,0.00578850738791233,-0.00465132636751924,0.0180396225930971,0.247521071795325
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH7B,Myosin-7B,39241,0.00551330770995722,0.00476942886883949,-0.00383477287296817,0.0148613882928826,0.247720151371856
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSNK1D,Casein kinase I isoform delta,39334,0.00826916235476999,0.00716360840928758,-0.00577151012743366,0.0223098348369736,0.248390928709142
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSNL1,Visinin-like protein 1,39598,0.00493853048448434,0.00427832353965577,-0.00344698365324096,0.0133240446222096,0.248396375061288
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,41465,-0.00497453427112379,0.00431532313503457,-0.0134325676157915,0.00348349907354397,0.249030099117768
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,41598,0.00377488883225511,0.00328182846089792,-0.00265749495110481,0.010207272615615,0.250066389716314
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNL1,Thioredoxin-like protein 1,39244,-0.0130167161001667,0.0113176023052176,-0.0351992166183932,0.00916578441805971,0.250116092520281
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,41838,0.00810164916355492,0.00705118210527401,-0.00571866776278213,0.021921966089892,0.250586042506181
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,39259,0.00901866128729144,0.00785632009498495,-0.00637972609887906,0.0244170486734619,0.251015040130591
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGN,Cingulin,39328,0.0047909512920331,0.0041740545154208,-0.00339019555819166,0.0129720981422579,0.251079549152099
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTA1,Glutathione S-transferase A1,41740,0.0107597257413756,0.00939269309744184,-0.00764995272961038,0.0291694042123617,0.252005512772123
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,39589,-0.00733196366310296,0.00642629087910697,-0.0199274937861526,0.0052635664599467,0.253922906355313
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POSTN,Periostin,39633,-0.00478353572902825,0.00419800723281838,-0.0130116299053523,0.00344455844729577,0.254528691938362
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL28,C-C motif chemokine 28,41697,0.00743610501424756,0.00653613510238678,-0.00537471978643052,0.0202469298149256,0.255270157613961
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NME3,Nucleoside diphosphate kinase 3,41764,-0.00299885891489219,0.00264158911590062,-0.0081763735820574,0.00217865575227302,0.256292067735502
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,39250,-0.00718761277988708,0.00634369380962423,-0.0196212526467506,0.00524602708697641,0.257226010861068
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEXIM1,Protein HEXIM1,41740,0.0101228998157371,0.00896319604670061,-0.00744496443579614,0.0276907640672703,0.258756044141692
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSD,Cathepsin D,40881,0.00518701332550743,0.00459705292813817,-0.00382321041364339,0.0141972370646583,0.259200728502534
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,39655,-0.00462795665993571,0.00411093544300394,-0.0126853901282234,0.00342947680835201,0.260288470830399
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,39334,0.00452883459138351,0.00403070332619434,-0.00337134392795739,0.0124290131107244,0.261214587841509
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,39334,0.00692782291511472,0.00616734045649247,-0.00516016437961051,0.0190158102098399,0.261331827023163
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KDM3A,Lysine-specific demethylase 3A,39334,-0.0110597788745416,0.00986218675811085,-0.0303896649204389,0.00827010717135566,0.2621288037274
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,39401,0.00605610638013692,0.0054124632239997,-0.00455232153890249,0.0166645342991763,0.263199702381886
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR3,Toll-like receptor 3,41911,0.00754698742777705,0.00676372196947144,-0.00570990763238697,0.0208038824879411,0.264526221891802
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASA1,Ras GTPase-activating protein 1,41466,-0.00402588643897154,0.00361657572843144,-0.0111143748666972,0.00306260198875408,0.265653510022294
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,41765,-0.00774228153096468,0.00695982064650321,-0.021383529998111,0.00589896693618161,0.265975584910888
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,39414,0.00663406956362737,0.00597685387455475,-0.00508056403049993,0.0183487031577547,0.267040883957096
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,39427,0.00746173251437772,0.00673788846952394,-0.00574452888588919,0.0206679939146446,0.268133132431053
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST1,Cystatin-SN,38213,0.0131521171873879,0.0118859893805115,-0.0101444219984146,0.0364486563731904,0.268528028758413
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,41819,-0.00356764569338979,0.00322546323582909,-0.00988955363561481,0.00275426224883523,0.268708626355667
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,39413,0.00564941739552551,0.00510769966466624,-0.00436167394722032,0.0156605087382713,0.268725572427001
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD1,Bromodomain-containing protein 1,39427,-0.00372159052142048,0.00336584341985711,-0.0103186436243404,0.00287546258149946,0.268883858791029
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAST,Gastrin,39598,-0.0160186890145699,0.0145084057615834,-0.0444551643072733,0.0124177862781336,0.269575166109684
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMNB1,Lamin-B1,39579,0.00746975710100677,0.00677465580976716,-0.00580856828613686,0.0207480824881504,0.270223693256316
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRR1B,Cornifin-B,39427,-0.0106137253609045,0.0096329375013832,-0.0294942828636155,0.00826683214180662,0.270566134016772
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDNRB,Endothelin receptor type B,39334,-0.00535978593102867,0.00486791836929154,-0.0149009059348401,0.00418133407278275,0.270902767567151
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,41521,0.00580347177291786,0.00529143214225878,-0.00456773522590934,0.0161746787717451,0.272763400358388
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,39410,0.0064440086179742,0.00587773932337523,-0.00507636045584125,0.0179643776917896,0.272953846433883
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,41466,-0.00809707266416174,0.0073926715413893,-0.0225867088852848,0.00639256355696128,0.273412867304111
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMP,Olfactory marker protein,39259,-0.00583027465982943,0.00532454629082849,-0.0162663853898533,0.00460583607019441,0.273549896332848
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP29,Dual specificity phosphatase 29,39328,-0.00819645111369384,0.00748585422396283,-0.022868725392661,0.0064758231652733,0.273573949249054
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL2A1,Collagen alpha-1(II) chain,39308,-0.00957113571527543,0.00876180703617231,-0.0267442775061732,0.0076020060756223,0.274695051268951
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,41689,0.00312328878181912,0.0028657540007716,-0.00249358905969321,0.00874016662333146,0.27579209632372
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",39250,-0.00562689540660691,0.00516646622237608,-0.015753169202464,0.0044993783892502,0.276126151423188
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,39427,0.0065686708195266,0.00603233080046638,-0.0052546975493875,0.0183920391884407,0.27621741142083
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,39259,-0.00418197051768318,0.00384523360153719,-0.0117186283766961,0.0033546873413297,0.276808445238125
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RUVBL1,RuvB-like 1,41465,0.0118793796698942,0.0109325900630417,-0.00954849685366763,0.033307256193456,0.277232879035317
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHP1,Calcineurin B homologous protein 1,39259,0.00889599095199014,0.00820445895743999,-0.00718474860459225,0.0249767305085725,0.278261942527593
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINI1,Neuroserpin,39385,0.00349642044032937,0.00322877172823669,-0.00283197214701455,0.00982481302767329,0.278879285103445
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL21R,Interleukin-21 receptor,39334,-0.00654714101381197,0.00604928305030664,-0.018403735792413,0.00530945376478903,0.279143413954275
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NBN,Nibrin,41534,-0.00652734645483452,0.00603685862295453,-0.0183595893558254,0.00530489644615636,0.279606592089344
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NLGN2,Neuroligin-2,39259,0.00561761546869835,0.00519849701985191,-0.00457143869021139,0.0158066696276081,0.279889294317073
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,39633,0.00441216565736128,0.00408453922716553,-0.00359353122788315,0.0124178625426057,0.280071684738797
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",41765,0.0088033822582342,0.00815090490469343,-0.00717239135496492,0.0247791558714333,0.280139842260809
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN7,Septin-7,39427,0.00638407708635832,0.00591139982313599,-0.00520226656698821,0.0179704207397049,0.280183918558396
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPP1,Tripeptidyl-peptidase 1,41679,0.00566420901858223,0.00524745323234023,-0.00462079931680463,0.0159492173539691,0.280420185291894
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL22,Interleukin-22,39589,-0.00843060752908795,0.00782950227697212,-0.0237764319919533,0.0069152169337774,0.28160470761992
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNU13,NHP2-like protein 1,39250,-0.00755051395636634,0.00701258374991068,-0.0212951781061913,0.0061941501934586,0.281634556932419
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,41744,-0.00698330253768556,0.00650517696954145,-0.0197334493979868,0.00576684432261567,0.283066886490638
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN2,Prefoldin subunit 2,41466,0.00657557418128619,0.00612887504954997,-0.00543702091583175,0.0185881692784041,0.283343127000817
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,39259,0.00597808966541705,0.0055807215253344,-0.00496012452423838,0.0169163038550725,0.284102092678382
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,41758,0.00531151171047463,0.00496221248081632,-0.00441442475192536,0.0150374481728746,0.284462608029979
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECM1,Extracellular matrix protein 1,39393,-0.00434682087942728,0.00406450183621404,-0.0123132444784068,0.00361960271955223,0.28488649950133
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSE,Cathepsin E,39408,-0.00629730908068003,0.00589737763434105,-0.0178561692439885,0.00526155108262843,0.285627760316751
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,39250,-0.00463611056138872,0.00434602076991299,-0.0131543112704182,0.00388209014764074,0.286109660774613
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,39250,-0.00429131254748742,0.00402283248255228,-0.0121760642132899,0.00359343911831504,0.28611386393511
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,41465,-0.00612207336957646,0.00575812484001586,-0.0174079980560075,0.00516385131685462,0.287708459542074
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFAP1,Actin filament-associated protein 1,39408,0.00989303375351789,0.00931093728634198,-0.00835640332771239,0.0281424708347482,0.288024560225428
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,39612,-0.00582059887780169,0.00548085813202631,-0.0165630808165733,0.00492188306096988,0.288264976111976
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBP1,Z-DNA-binding protein 1,39334,0.00489164829645723,0.00460665805160211,-0.0041374014846829,0.0139206980775974,0.288320930609473
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,39250,0.00309606174391616,0.00292004330254021,-0.00262722312906265,0.00881934661689498,0.289041555416534
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,41521,0.00713154797319332,0.00673433901408398,-0.00606775649441129,0.0203308524407979,0.289627491000446
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,39633,-0.00386008310303695,0.00364545523886673,-0.0110051753712157,0.00328500916514184,0.289679681660222
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HCG22,Protein PBMUCL2,39250,0.00681743579768023,0.00644807374915933,-0.00582078875067206,0.0194556603460325,0.290406639944508
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRK5,G protein-coupled receptor kinase 5,41521,0.00603846331467854,0.0057120539547618,-0.00515716243665459,0.0172340890660117,0.29046565667681
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD3,Bromodomain-containing protein 3,39250,0.00559020753022348,0.0052917969920882,-0.00478171457426939,0.0159621296347163,0.290813507933328
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,41465,0.00776786272809606,0.00736672684502393,-0.00667092188815083,0.022206647344343,0.291695649477419
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A4,Protein S100-A4,41802,0.00652978706119036,0.00621123406639323,-0.00564423170894038,0.0187038058313211,0.293146227871922
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHH,Sonic hedgehog protein,39334,0.00499786385151227,0.0047628804961985,-0.00433738192103679,0.0143331096240613,0.29404694557589
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,39476,-0.00654543104007826,0.00625003784254053,-0.0187955052114577,0.00570464313130117,0.295001741330328
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC25A,M-phase inducer phosphatase 1,39241,-0.00466041954797244,0.00445645136631361,-0.0133950642259471,0.00407422513000224,0.295691362353578
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSC1,Hamartin,39334,-0.00861306883722907,0.0082362128939708,-0.0247560461094118,0.00752990843495371,0.295697260818106
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RYR1,Ryanodine receptor 1,39250,0.00393655046222766,0.00376929023556927,-0.00345125839948811,0.0113243593239434,0.296335878462189
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,39328,0.0120249255121965,0.0115621353035129,-0.0106368596826888,0.0346867107070818,0.298351091656585
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL5,Interleukin-5,41534,-0.015876579177271,0.0152956980341733,-0.0458561473242507,0.0141029889697086,0.299300276139253
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,39600,-0.0135795167902982,0.0131022786907736,-0.0392599830242145,0.012100949443618,0.30002713631998
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MLLT1,Protein ENL,39241,-0.00760596271786173,0.00734722331985431,-0.0220065204247762,0.00679459498905272,0.30059159976706
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIF,Leukemia inhibitory factor,41466,0.00568585457698137,0.00550808690765816,-0.00510999576202862,0.0164817049159914,0.301963208670496
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1,Integrin beta-1,41787,-0.00241343126986291,0.00233810349990502,-0.00699611412967675,0.00216925158995093,0.301989184754813
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDAC8,Histone deacetylase 8,39334,-0.00686639507208964,0.00669129954994313,-0.0199813421899782,0.0062485520457989,0.304835695266998
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC16,Mucin-16,41689,0.0216903188179463,0.021138221003529,-0.0197405943489705,0.0631212319848631,0.304854711687512
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX5,Syntaxin-5,39334,-0.00452132182181128,0.00440688718054368,-0.0131588206956769,0.00411617705205432,0.304930151517624
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,39250,0.00237505969650709,0.00231714584478121,-0.00216654615926409,0.00691666555227827,0.305389480520202
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB2,Integrin beta-2,41703,0.00325048025871184,0.00317196321772517,-0.00296656764802949,0.00946752816545317,0.305498452377734
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGF,Beta-nerve growth factor,41636,-0.00137849546843903,0.00134804531080162,-0.00402066427761021,0.00126367334073214,0.306521482474706
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH1,Protocadherin-1,41879,0.00231932668970338,0.00227888837541701,-0.00214729452611396,0.00678594790552072,0.308817814735836
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL34,Interleukin-34,41447,0.00409875945800874,0.00403333597746209,-0.00380657905781696,0.0120040979738344,0.309543444791496
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,39250,0.00436443979254424,0.004301221314745,-0.00406595398435596,0.0127948335694445,0.310272955729819
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C7orf50,Uncharacterized protein C7orf50,39598,-0.00257765958777708,0.00254591965094642,-0.00756766210363206,0.0024123429280779,0.311337098947556
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,39427,0.00800000846652098,0.00791587395891023,-0.00751510449294308,0.023515121425985,0.31221681565391
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCLN,Nicalin,41534,-0.00573204120458735,0.00568880249352147,-0.0168820940918894,0.00541801168271474,0.313665056510788
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRN1,Neuritin,39600,-0.00389463101646577,0.00387634579485698,-0.0114922687743854,0.00370300674145391,0.31505517830988
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP4,Caspase-4,39427,0.0185373255041408,0.0184533930981562,-0.0176313249682453,0.0547059759765268,0.315136830450921
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAT1,Diamine acetyltransferase 1,39250,-0.00539162578355311,0.00538743776011222,-0.0159510037933731,0.00516775222626684,0.316957190711857
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTR,Methionine synthase,39250,-0.00724810782813875,0.00726913823023521,-0.0214956187593998,0.00699940310312225,0.318735281957499
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",39241,-0.00533626522676602,0.00537104332779913,-0.0158635101492523,0.00519097969572027,0.320476818680764
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMTN,Smoothelin,39566,0.010203517017816,0.010277370114671,-0.00994012840693924,0.0303471624425712,0.32082250793238
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,39328,0.00655392131577177,0.00664273028726287,-0.00646583004726346,0.019573672678807,0.323845988854129
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,41744,0.00256613859248139,0.00260453110361802,-0.00253874237060993,0.00767101955557271,0.32451483566279
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN2B,Sodium channel subunit beta-2,39328,-0.00309475868644213,0.00314516598186798,-0.00925928401090337,0.00306976663801912,0.325150935034586
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",39308,-0.0095852386063619,0.00974904943901583,-0.0286933755068329,0.00952289829410912,0.325532581468845
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,41466,0.00490666835305305,0.00499130138556616,-0.00487628236265662,0.0146896190687627,0.325604320732003
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK1,Kallikrein-1,41640,-0.0139247013009202,0.0141761197781583,-0.0417098960661104,0.0138604934642701,0.325987709781002
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL3,Myosin light chain 3,39308,-0.00854541640391365,0.008719835603899,-0.0256362941875557,0.0085454613797284,0.327109531948895
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOLGA3,Golgin subfamily A member 3,39600,0.00845358765398367,0.00864297876385781,-0.00848665072317765,0.025393826031145,0.328052664484395
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,41865,0.00257069834852403,0.00262942168351515,-0.00258296815116567,0.00772436484821373,0.3282569639993
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGR3,Anterior gradient protein 3,41449,-0.00640943239700557,0.00656305821693183,-0.019273026502192,0.00645416170818082,0.328789397398506
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D5,TBC1 domain family member 5,41740,-0.00843942488202617,0.00865673960554364,-0.0254066345088917,0.00852778474483936,0.329629563973353
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISM2,Isthmin-2,39633,-0.0046671237859512,0.00479000694948761,-0.0140555374069469,0.00472128983504451,0.329906167050377
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA14,Carbonic anhydrase 14,41877,0.00395976034646085,0.00406553246584038,-0.00400868328658629,0.011928203979508,0.330082622081894
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDUA,Alpha-L-iduronidase,41877,-0.00506365928590648,0.00521092545974413,-0.015277073187005,0.00514975461519201,0.331198131881908
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BDNF,Brain-derived neurotrophic factor,39633,0.0090263712344748,0.00930662594610212,-0.00921461561988535,0.0272673580888349,0.332124311257834
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSLNL,Mesothelin-like protein,39328,0.00408355210232085,0.00421322086859593,-0.00417436080012717,0.0123414650047689,0.332455606572322
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",39617,0.00423315744637059,0.00437123598233799,-0.00433446507901186,0.012800779971753,0.332859899849307
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTN,Titin,39250,-0.00743451670950812,0.0076795440643095,-0.0224864230755547,0.00761738965653849,0.333019658426515
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCNE1,G1/S-specific cyclin-E1,39334,-0.00985372146777395,0.010187890614613,-0.0298219870724154,0.0101145441368675,0.333466163930451
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX18,Sorting nexin-18,39600,0.0047039546251507,0.00486659324779035,-0.00483456814051838,0.0142424773908198,0.333774986226748
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F2,Prothrombin,39650,0.0015908548090401,0.00164816083068501,-0.00163954041910251,0.00482125003718272,0.33445058608333
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NINJ1,Ninjurin-1,41465,0.00579125088549086,0.00600015943474465,-0.00596906160660865,0.0175515633775904,0.334471385916615
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPMT,Thiopurine S-methyltransferase,41465,-0.00762444859709072,0.00794969983711702,-0.0232058602778401,0.00795696308365863,0.337533270209702
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,39250,0.00452610644917746,0.00473084962360654,-0.00474635881309135,0.0137985717114463,0.338729463532457
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR1,Cadherin-related family member 1,41466,-0.00438563289168117,0.00458466641777445,-0.0133715790705191,0.00460031328715675,0.338793660714462
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAP1,Antigen peptide transporter 1,39427,-0.00621682801375021,0.00650982716701722,-0.018976089261104,0.00654243323360354,0.339603440723241
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,39241,-0.00397191331992898,0.00417568070933057,-0.0121562475102169,0.00421242087035894,0.341523753952689
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTX2,Neuronal pentraxin-2,39633,0.00361380113472278,0.0038005547918864,-0.00383528625737457,0.0110628885268201,0.341695529429139
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA3,GDNF family receptor alpha-3,41609,0.00292573204116863,0.00307980337390065,-0.00311068257167665,0.00896214665401391,0.342143291258868
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,39328,0.00740125874683855,0.0077999245726169,-0.00788659341549058,0.0226891109091677,0.342698697145006
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCXR,L-xylulose reductase,41802,-0.00569260288203364,0.00601408372178865,-0.0174802069767394,0.0060950012126721,0.343887835398312
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,39334,-0.00516216606012099,0.00545951733814452,-0.0158628200428843,0.00553848792264227,0.344406969522612
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS3BP,Galectin-3-binding protein,39650,0.00326967653338057,0.00346035790276873,-0.00351262495604614,0.0100519780228073,0.344732900459972
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,41689,-0.00279454128420671,0.00295842967951542,-0.00859306345605694,0.00300398088764351,0.344879076735646
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSTN,Osteocrin,39328,0.00420553247633318,0.00446825499843616,-0.0045522473206017,0.0129633122732681,0.346622322599478
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,39589,0.00373483265845723,0.00397002340620125,-0.00404641321769723,0.0115160785346117,0.346849389561507
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH12,Protocadherin-12,39600,-0.002664400811167,0.00283346933108663,-0.0082180007000968,0.0028891990777628,0.3470681326107
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB118,Beta-defensin 118,39259,0.00589516877367225,0.00628727849171288,-0.006427897070085,0.0182182346174295,0.348453556514578
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,39250,-0.00686794592333246,0.0073325110777378,-0.0212396676356985,0.00750377578903363,0.348963411381726
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST13,Hsc70-interacting protein,39408,0.00565677665928226,0.00604532631621417,-0.00619206292049751,0.017505616239062,0.349434535419175
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,39598,0.00400609000777262,0.00428986915178135,-0.00440205352971883,0.0124142335452641,0.350402292284034
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGFAC,Hepatocyte growth factor activator,39562,0.00280954217080904,0.0030224141806163,-0.00311438962319891,0.00873347396481698,0.352614814275306
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",39250,-0.00696354028806821,0.00749596928840433,-0.0216556400933407,0.00772855951720427,0.35292501745743
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRG3,Proteoglycan 3,39633,0.00510359175706934,0.00549911164666984,-0.00567466707040356,0.0158818505845422,0.353388618658374
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD33,Myeloid cell surface antigen CD33,41802,0.00817883920124476,0.00882060409125542,-0.00910954481761587,0.0254672232201054,0.353817579394671
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TF,Serotransferrin,39650,0.00220497290622752,0.00237966560808146,-0.00245917168561215,0.00686911749806718,0.354160001961067
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",39250,0.00631511955515869,0.00681867187254892,-0.00704947731503719,0.0196797164253546,0.354388515802648
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,41521,0.00386385043482642,0.00417824795343044,-0.00432551555389723,0.0120532164235501,0.35511128673327
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,41465,0.00592553345817341,0.00640886585177831,-0.00663584361131208,0.0184869105276589,0.355199791432551
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXO3,Forkhead box protein O3,41465,0.00983195387930531,0.0106518595624297,-0.0110456908630568,0.0307095986216675,0.356010450074091
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1A,Protein phosphatase 1A,41465,0.00319345022715851,0.00347329717341695,-0.0036142122327387,0.0100011126870557,0.357888452746833
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2orf69,UPF0565 protein C2orf69,39328,0.00602123436438568,0.00655408979583848,-0.00682478163545774,0.0188672503642291,0.358273797401746
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF6,Fibroblast growth factor 6,39334,0.00399356571516298,0.00435154336230412,-0.00453545927495309,0.012522590705279,0.358777990140739
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,39250,0.00666307444884307,0.0072662223304882,-0.00757872131891381,0.0209048702165999,0.359167113267224
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRCAM,Neuronal cell adhesion molecule,41765,0.00292136595157987,0.00318802741747857,-0.00332716778667813,0.00916989968983788,0.359497335704252
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,39250,-0.00469124136479599,0.00512416461626336,-0.0147346040126722,0.00535212128308019,0.359942899947465
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH17,Cadherin-17,41765,0.00690964335347594,0.00755567226331004,-0.00789947428261174,0.0217187609895636,0.360472242406009
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,39250,0.00361717798713978,0.00396121111245795,-0.0041467957932778,0.0113811517675574,0.361184584964403
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCN,Decorin,41521,-0.00231955606379639,0.00254641987334736,-0.00731053901555721,0.00267142688796443,0.362360464294644
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",41466,0.00304734593698764,0.00334824524109439,-0.00351521473555736,0.00960990660953264,0.362769824217009
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,39576,0.00386744503802593,0.00425657998965069,-0.00447545174168943,0.0122103418177413,0.363591619072162
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,41750,0.0124621723204996,0.0137620802262267,-0.0145115049229047,0.0394358495639039,0.365193730634539
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHGA,Chromogranin-A,39633,0.00850815963952546,0.00940571251338341,-0.00992703688670601,0.0269433561657569,0.365711054707512
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,41521,0.00221705582799169,0.00245177867563986,-0.00258843037626243,0.00702254203224582,0.36587215264599
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGLON5,IgLON family member 5,39241,-0.00919615191424801,0.0102012367437057,-0.0291905759319111,0.0107982721034151,0.367356638827809
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD99L2,CD99 antigen-like protein 2,41758,0.00245040532361531,0.00272361013074761,-0.00288787053265001,0.00778868117988063,0.368301608571785
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,41911,0.00348811325180811,0.00389567086933644,-0.00414740165209132,0.0111236281557075,0.370599154397078
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,39589,-0.00608425118138731,0.00680227359333487,-0.0194167074243237,0.00724820506154904,0.371104096318414
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,39427,0.00715848527455871,0.00801833487649373,-0.00855745108336901,0.0228744216324864,0.372003106295845
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGR,Tyrosine-protein kinase Fgr,41466,0.00579676397952689,0.00650642214202,-0.00695582341883231,0.0185493513778861,0.372983607325209
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,39250,0.00350362988773203,0.0039380418840492,-0.00421493220500441,0.0112221919804685,0.373653360438096
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,39241,-0.00308446019550922,0.00346731189009479,-0.00988039150009501,0.00371147110907658,0.37371018305216
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD276,CD276 antigen,41744,0.00352874438914639,0.0039741774953342,-0.00426064350170863,0.0113181322800014,0.374601020182285
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,39408,-0.00303266314603353,0.00341768411705235,-0.00973132401545615,0.00366599772338908,0.374913208304335
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",41521,-0.00874824753580783,0.0098722545659268,-0.0280978664850244,0.0106013714134087,0.375555969554085
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,39259,0.0059751842546698,0.00674469000764012,-0.00724440816030484,0.0191947766696444,0.375686337815779
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,41466,-0.00408489206280523,0.00461874565131469,-0.013137633539382,0.00496784941377156,0.376488273160283
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,41802,0.0027103763118213,0.00306564224752811,-0.00329828249333379,0.00871903511697639,0.376650938282398
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL3,Fc receptor-like protein 3,41534,0.00523789360799298,0.0059330195979791,-0.00639082480404606,0.016866612020032,0.37734035467043
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REEP4,Receptor expression-enhancing protein 4,39600,0.00613328796755428,0.00694896892749063,-0.00748669113032735,0.0197532670654359,0.377461760711505
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A16,Protein S100-A16,41447,0.00592539281839026,0.00671588291072299,-0.0072377376866268,0.0190885233234073,0.377633573460812
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,39334,0.00453333867609532,0.00513884374348695,-0.00553879506113911,0.0146054724133297,0.377704122127314
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNNI3,"Troponin I, cardiac muscle",41521,0.0081828522285702,0.00928245664976826,-0.0100107628049756,0.026376467262116,0.37804228014397
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO2,Roundabout homolog 2,41865,-0.00220772630654436,0.00250828756515165,-0.0071239699342416,0.00270851732115288,0.378781690935601
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,41829,-0.00998728555507057,0.0113548948927091,-0.0322428795447804,0.0122683084346392,0.379114923683492
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCP11,T-complex protein 11 homolog,39427,-0.00562736183621912,0.00643358551266395,-0.0182371894410405,0.00698246576860222,0.381764633468905
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YJU2,Splicing factor YJU2,39589,0.00322240477115067,0.00368600535637281,-0.00400216572734003,0.0104469752696414,0.38201384337228
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIMAP8,GTPase IMAP family member 8,39241,0.00487064228574308,0.00557327834598244,-0.00605298327238251,0.0157942678438687,0.3821773546828
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,39241,0.00664920399291989,0.00761037671183654,-0.00826713436227972,0.0215655423481195,0.382300089169387
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPBGL,Trophoblast glycoprotein-like,39328,0.00396563187395794,0.004544370173108,-0.00494133366533374,0.0128725974132496,0.382874939816971
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GET3,ATPase GET3,39625,-0.00522145287975064,0.00600014741542434,-0.0169817418139823,0.00653883605448106,0.384198715842296
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAP1A,Ras-related protein Rap-1A,39334,-0.0067230871419254,0.00772613966630996,-0.0218663208878929,0.00842014660404211,0.384224690201701
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,39259,0.00595175120838652,0.00684248044495633,-0.00745951046372789,0.0193630128805009,0.384416380337058
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKKL1,Dickkopf-like protein 1,41689,0.00803898255072441,0.00925062903420508,-0.0100922503563176,0.0261702154577664,0.384852072222438
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,39328,-0.00751086409170674,0.00864574038821432,-0.0244565152526068,0.00943478706919332,0.385011095687258
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CENPJ,Centromere protein J,39427,0.0067641598202746,0.00779012484273213,-0.00850448487148038,0.0220328045120296,0.385249759842159
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYO6,Unconventional myosin-VI,39600,0.00360486621245845,0.00417699451038983,-0.00458204302790561,0.0117917754528225,0.388140493875415
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN3,Calsyntenin-3,39598,0.00289670923932997,0.00336190239466713,-0.0036926194542176,0.00948603793287753,0.388911042529502
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPT1,Translationally-controlled tumor protein,41534,0.00607557676315991,0.00705309136061419,-0.00774848230364391,0.0198996358299637,0.389030320741266
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,41465,0.0117823928116232,0.0137051057976485,-0.0150796145517679,0.0386444001750142,0.389965893596081
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL11,Eotaxin,41911,0.00354935794106563,0.00413296211717041,-0.00455124780858838,0.0116499636907196,0.39047032729101
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTSS1,Protein MTSS 1,39600,0.0106301879515127,0.0123791916313212,-0.0136330276458769,0.0348934035489024,0.390516911487353
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,39314,-0.00548867084215357,0.00639266986382867,-0.0180183037752578,0.00704096209095062,0.390586964124464
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRX,Cone-rod homeobox protein,41521,0.0101870187961153,0.0118748630000039,-0.0130877126838923,0.0334617502761229,0.390983415227684
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK7,Kallikrein-7,39158,-0.00377773455176837,0.00441758626198713,-0.0124362036252631,0.00488073452172641,0.392483048830343
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,39655,0.00628495877181305,0.00735571937329237,-0.00813225119984,0.0207021687434661,0.392884430839444
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BGLAP,Osteocalcin,39633,-0.00792136212091652,0.0093029172947184,-0.0261550800185646,0.0103123557767315,0.394514438770751
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RCC1,Regulator of chromosome condensation,39589,0.00494425688683627,0.00580795013747189,-0.00643932538260863,0.0163278391562812,0.394626157540878
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESR1,Estrogen receptor,39334,-0.00539984365418657,0.00635200532489045,-0.0178497740909719,0.00705008678259871,0.395288108679739
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,39427,0.00525873586116375,0.00619449602308974,-0.00688247634409214,0.0173999480664196,0.395935208921838
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN3,Neuronal-specific septin-3,39600,0.00735952002725938,0.00869252700126197,-0.00967783289521408,0.0243968729497328,0.397209164575341
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,39241,-0.00525596132655114,0.00621328008918138,-0.0174339903013466,0.00692206764824436,0.397614291878101
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADD1,Alpha-adducin,39408,-0.00656092667351037,0.00775654348166822,-0.0217637518975801,0.00864189855055935,0.397651243551585
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,41925,0.00620952140362203,0.00735435562720401,-0.00820501562569783,0.0206240584329419,0.398498793289492
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,39250,0.00525180890138387,0.00622893757341111,-0.00695690874250192,0.0174605265452696,0.399174249572742
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDAC9,Histone deacetylase 9,39259,-0.0062519208034338,0.00742328399537258,-0.0208015574343641,0.00829771582749646,0.3996925709088
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,41865,0.00432389819029155,0.00514077719873357,-0.00575202511922624,0.0143998214998093,0.400308112953654
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,39192,0.00497287116243908,0.00592007028416657,-0.0066304665945274,0.0165762089194056,0.400926197997186
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],41509,0.00439453212804139,0.00523442587971482,-0.00586494259619965,0.0146540068522824,0.401179518331093
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,41466,0.00635181555143456,0.00758395303388162,-0.00851273239497341,0.0212163634978425,0.4023082510302
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLN1,Cerebellin-1,39259,-0.00860415433471079,0.0102762223291752,-0.0287455500998942,0.0115372414304726,0.402449655855873
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,39308,-0.00370772233952732,0.00443184110349003,-0.0123941309023678,0.00497868622331315,0.402830523281453
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERI1,3'-5' exoribonuclease 1,39427,0.0031911391317024,0.00383304107805157,-0.00432162138127868,0.0107038996446835,0.405125647443414
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,39241,0.00591652009982767,0.00710698797338976,-0.00801317632801626,0.0198462165276716,0.405149223208175
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IKBKG,NF-kappa-B essential modulator,41740,-0.00840084018916449,0.0101417886046378,-0.0282787458542547,0.0114770654759257,0.407493522069603
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPY,Pancreatic prohormone,41712,-0.00944266308272845,0.0114050301616356,-0.0317965221995343,0.0129111960340774,0.407720422518844
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR4,Toll-like receptor 4,39334,0.00261588594801993,0.0031648713790095,-0.00358726195483868,0.00881903385087855,0.408517434752139
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGCR6,Protein DGCR6,39259,0.0038462766588788,0.0046539182849952,-0.00527540317971179,0.0129679564974694,0.408561777576037
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,39241,-0.00279472815457465,0.00338185154287075,-0.00942315717860132,0.00383370086945202,0.408601446658369
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPT1,Angiopoietin-1,41708,0.00763752972188957,0.00924721497829858,-0.0104870116355756,0.0257620710793548,0.408860216567214
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,39328,0.00711009579459228,0.00861667698681027,-0.00977859109955585,0.0239987826887404,0.409301833355619
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHPS,Deoxyhypusine synthase,39589,0.00370173241674785,0.00448671887717268,-0.0050922365825106,0.0124957014160063,0.409365541163167
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH5,Cadherin-5,41925,0.00276750298165174,0.00335720549099597,-0.00381261978070037,0.00934762574400384,0.409757055927156
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX16,Syntaxin-16,41465,0.00522127746229013,0.00634465369876179,-0.00721424378728298,0.0176567987118632,0.410556637526062
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,41802,-0.00213749831292672,0.00259868148198396,-0.00723091401761527,0.00295591739176184,0.410789117305062
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3GLB2,Endophilin-B2,39598,0.00598764131387486,0.00730212222314009,-0.00832451824347971,0.0202998008712294,0.412241599261789
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GJA8,Gap junction alpha-8 protein,39241,0.00567529028936666,0.00692409692145657,-0.00789593967668821,0.0192465202554215,0.412437786951988
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,39600,0.00603485380331496,0.0073659411003931,-0.00840239075345551,0.0204720983600854,0.412637803611979
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAPK2,Death-associated protein kinase 2,39334,0.00504524608601881,0.00616054632872815,-0.00702942471828836,0.017119916890326,0.412826948040525
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,39427,0.00469071101229049,0.00573011450899893,-0.00654031342534742,0.0159217354499284,0.413028771694016
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,39295,-0.00341490886925353,0.00417192748878101,-0.0115918867472643,0.00476206900875724,0.413064502572119
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA11,Serpin A11,41925,0.0037714810394509,0.00462567623905147,-0.00529484438908998,0.0128378064679918,0.414894496474241
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL3,Insulin-like 3,39598,0.00810214585389094,0.00999201176256325,-0.011482197200733,0.0276864889085149,0.417462286360076
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDRG1,Protein NDRG1,41466,0.00592152176333576,0.00731528435063666,-0.00841643556391209,0.0202594790905836,0.418258364465195
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,39334,0.00400685492090468,0.0049687070678184,-0.00573181093201938,0.0137455207738287,0.420019725254811
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,39600,0.00953877833464636,0.0118375461706502,-0.0136628121598279,0.0327403688291207,0.420371522605457
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TUBB3,Tubulin beta-3 chain,39259,0.00255662178106642,0.00318018754998943,-0.00367654581691287,0.00878978937904571,0.421460125040811
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,41447,-0.00590359603067448,0.00739062551515432,-0.0203892220403769,0.00858202997902798,0.4244239532236
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,41466,0.00667012904788931,0.00835786948263287,-0.00971129513807111,0.0230515532338497,0.424847088157783
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,39250,0.00386828600555044,0.00485300825348663,-0.00564361017128335,0.0133801821823842,0.425416334921517
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,41466,0.0035230180280535,0.00442272428822952,-0.00514552157687636,0.0121915576329834,0.425714382395886
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,39334,0.00568213727564369,0.0071415737079886,-0.00831534719201396,0.0196796217433013,0.426257636425724
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTA,Lymphotoxin-alpha,41740,-0.00352659024281919,0.00445154920590921,-0.0122516266864012,0.00519844620076285,0.428248814994855
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLHL41,Kelch-like protein 41,39600,-0.00462351764454869,0.00583931811178625,-0.0160685811436497,0.00682154585455236,0.428499812458013
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANSC4,MANSC domain-containing protein 4,39250,0.00597224344076177,0.00754275349245052,-0.00881155340444124,0.0207560402859648,0.428503346879939
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHD,SH2 domain-containing adapter protein D,39230,0.00722679886673753,0.00913111958256874,-0.0106701955150972,0.0251237932485723,0.428700745039055
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDAN1,Codanin-1,39598,-0.00191633925679813,0.00242232543472994,-0.00666409710886881,0.00283141859527255,0.42889364064392
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,41465,-0.00504371165560845,0.00637679151598152,-0.0175422230269322,0.00745479971571532,0.428988811059422
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,39408,-0.00193649975691387,0.00245113708630742,-0.00674072844607641,0.00286772893224867,0.429520928057914
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,39408,0.00614874683189091,0.00779010792467759,-0.00911986470047718,0.021417358364259,0.429952902293956
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,39250,-0.0038824349286967,0.0049269386162311,-0.0135392346165097,0.00577436475911626,0.430713377361628
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB6B,Ras-related protein Rab-6B,41466,0.00411191524321429,0.00522547261333547,-0.00613001107892323,0.0143538415653518,0.43135592745617
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PADI2,Protein-arginine deiminase type-2,41534,0.00489935108500333,0.00627128364511804,-0.00739236485942803,0.0171910670294347,0.434678140256686
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCF2,Neutrophil cytosol factor 2,41718,-0.00720646245654208,0.00923002594955099,-0.025297313317662,0.0108843884045779,0.43495600673496
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPESP1,Sperm equatorial segment protein 1,39625,-0.00288914915838912,0.00372776972562186,-0.010195577820608,0.00441727950382972,0.438336052144991
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,41689,0.00178430418950949,0.00230452791346406,-0.00273257052088008,0.00630117889989905,0.438790933328728
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",39334,0.00535032730792895,0.0069176840742461,-0.0082083334775934,0.0189089880934513,0.439286434236396
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,39600,0.00639222293126852,0.00827355071295092,-0.00982393646611528,0.0226083823286523,0.439770188175748
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,41740,0.00513332139931457,0.00664787812975059,-0.00789651973499659,0.0181631625336257,0.440025020682333
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,39259,0.00510063221652012,0.00660914136345015,-0.00785328485584217,0.0180545492888824,0.440277166548814
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,39259,0.00557872648393883,0.00723475322249503,-0.00860138983215143,0.0197588428000291,0.440664075162635
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZPR1,Zinc finger protein ZPR1,39259,0.00824765983629935,0.0107001846782236,-0.012724702133019,0.0292200218056177,0.440844927247108
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,39589,0.00856162195294325,0.0111194022551912,-0.0132324064672314,0.0303556503731179,0.441333396889792
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYGD,Gamma-crystallin D,39598,0.00837680141026089,0.0108840253039141,-0.0129558881854108,0.0297094910059326,0.441528900069767
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",39250,0.0042610819250808,0.00555014516336016,-0.00661720259510512,0.0151393664452667,0.442657245068713
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,39250,0.00411929916021096,0.00538190200703387,-0.00642922877357542,0.0146678270939973,0.44405130933818
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA4,Ephrin type-A receptor 4,39408,0.00248319271133546,0.00324715506646077,-0.00388123121892766,0.00884761664159857,0.444449801715987
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXK,Tyrosine-protein kinase TXK,39427,0.00624558746519067,0.00817567140755868,-0.00977872849362435,0.0222699034240057,0.444929482787971
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAS6,Growth arrest-specific protein 6,41855,0.00212421141271636,0.00278679039219682,-0.00333789775598941,0.00758632058142213,0.445928561586529
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,39600,0.00344670016029457,0.00452390504447149,-0.00542015372686956,0.0123135540474587,0.446144349104639
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM2,Intercellular adhesion molecule 2,41925,0.00275497912785259,0.00362304836667345,-0.00434619567082737,0.00985615392653256,0.447026808674151
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACE2,Angiotensin-converting enzyme 2,41521,-0.00460728495017059,0.00606407122140515,-0.0164928645441247,0.0072782946437835,0.447407363483594
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLASP1,CLIP-associating protein 1,39241,0.0063160221085991,0.00831802453763437,-0.00998730598516427,0.0226193502023625,0.447679434672509
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTF3,Neurotrophin-3,41740,0.0028955189130925,0.00381923785919546,-0.0045901872909306,0.0103812251171156,0.448380471224709
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOSB,Protein fosB,41466,0.00321519646243413,0.00425408216243127,-0.00512280457593116,0.0115531975007994,0.449788427646551
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,39259,0.00245863106637299,0.00325867089307248,-0.00392836388404907,0.00884562601679505,0.450572367303875
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,39250,-0.00262512878009874,0.00348266396651151,-0.00945115015446131,0.00420089259426382,0.451003804441839
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",41740,-0.00836909458634656,0.0111050626791643,-0.0301350174375086,0.0133968282648155,0.451085674837877
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPH3,Neurexophilin-3,39334,-0.00251186337521541,0.00333444097433131,-0.00904736768490479,0.00402364093447396,0.451280957528659
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",39427,0.00578715205209488,0.00770164876292557,-0.00930807952323925,0.020882383627429,0.452417891972253
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACY1,Aminoacylase-1,41765,-0.00523998182302833,0.00698443309102287,-0.0189294706814332,0.0084495070353765,0.453125239730355
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDZD2,PDZ domain-containing protein 2,39250,0.0049286030008938,0.00656977982438137,-0.00794816545489369,0.0178053714566813,0.453155031469825
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTNNA1,Catenin alpha-1,39259,0.00278081435239258,0.00372480406577544,-0.00451980161652728,0.0100814303213124,0.455341674392081
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERVV_1,,39250,0.0036077768605698,0.00484267539313852,-0.0058838669099817,0.0130994206311213,0.456290195205473
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,39308,0.0027723290161668,0.00373441125773436,-0.00454711704899256,0.0100917750813261,0.457877182657558
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP2BP,LRP2-binding protein,39328,0.00641634553947791,0.00864583696133767,-0.0105294949047439,0.0233621859836997,0.458024082717358
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK8,Kallikrein-8,41299,0.00301629633433372,0.00406509932530654,-0.0049512983432671,0.0109838910119345,0.458102156109396
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,39427,-0.00372436432964024,0.00503663268899281,-0.0135961644000661,0.00614743574078567,0.459646653675387
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PXDNL,Peroxidasin-like protein,39589,0.0046848521144101,0.0063454550532649,-0.00775223978998911,0.0171219440188093,0.460347679437655
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NME1,Nucleoside diphosphate kinase A,39334,0.0018012801951338,0.00244697076213,-0.00299478249864101,0.0065973428889086,0.461669760010236
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMG3,Proteasome assembly chaperone 3,41740,-0.00402271894993923,0.00547053340209928,-0.0147449644180538,0.00669952651817536,0.46214369447844
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,39598,0.00449057487782345,0.00611599691833494,-0.00749677908211303,0.0164779288377599,0.462821588919493
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMOD2,Leiomodin-2,39259,0.00500648237544678,0.00684387158736414,-0.00840750593578694,0.0184204706866805,0.464472907619987
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFD,Vascular endothelial growth factor D,41891,0.00312920662801002,0.0042783976238278,-0.00525645271469246,0.0115148659707125,0.464549671292815
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICOSLG,ICOS ligand,41689,-0.00154211868695497,0.00211515410437983,-0.00568782073153943,0.00260358335762949,0.465965156326763
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH9,Protocadherin-9,39600,0.00273079057086041,0.00375321557362827,-0.004625511953451,0.0100870930951718,0.466881973530627
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,41783,-0.0039866967282911,0.00550133617819078,-0.014769315637545,0.00679592218096283,0.468662519670157
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN2,Contactin-2,41877,-0.00351680268632821,0.00486724222009348,-0.0130565974377114,0.00602299206505501,0.469972049546159
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,41465,0.00485507031045803,0.00672138028495681,-0.00831883504805732,0.0180289756689734,0.47010330737356
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL9,Interleukin-9,39427,0.00448570687781842,0.00622751565746493,-0.00772022381081283,0.0166916375664497,0.471353151219109
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,41465,0.0041264276097619,0.00575549282240081,-0.0071543383221437,0.0154071935416675,0.473415066528833
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,39625,0.00593171624274056,0.00829452461383642,-0.0103255520003788,0.0221889844858599,0.474539923910256
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDHB15,Protocadherin beta-15,39589,0.00316013962798904,0.00442638916680041,-0.00551558313893976,0.0118358623949178,0.475284565228525
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,39250,0.00338171174128186,0.0047376140126478,-0.00590401172350783,0.0126674352060715,0.475366128628269
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,39427,-0.00378163175888585,0.00529931601811076,-0.0141682911543829,0.00660502763661123,0.475485288097063
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMMR,Hyaluronan mediated motility receptor,39224,0.00383485892820572,0.00538652683866438,-0.00672273367557646,0.0143924515319879,0.476520436789795
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,41925,0.00245609905750256,0.00345153052806915,-0.00430890077751297,0.00922109889251809,0.476726770611625
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,39250,0.00297500888050433,0.00419476992090089,-0.00524674016446141,0.0111967579254701,0.478204353523802
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,39633,-0.0027320445793969,0.00385612604387089,-0.0102900516253838,0.00482596246659004,0.478653116627633
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF9,Fibroblast growth factor 9,39221,0.0032327317361299,0.00457147072110609,-0.00572735087723804,0.0121928143494978,0.479486577304859
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,41521,0.00595158123504459,0.00844572216097644,-0.0106020342004692,0.0225051966705584,0.481018435475586
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD2,Sushi domain-containing protein 2,41758,-0.0022158701497739,0.00314479343658458,-0.00837966528547968,0.00394792498593188,0.48106203070294
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,39334,-0.00293100295113784,0.00416051562111421,-0.0110856135685217,0.00522360766624602,0.481148749691579
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALPP,"Alkaline phosphatase, placental type",41689,-0.00807805496052249,0.0115548881142872,-0.0307256356645253,0.0145695257434803,0.484500193391222
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCUN1D2,DCN1-like protein 2,39241,0.00615724258798104,0.00881789551868944,-0.0111258326286503,0.0234403178046124,0.485025694304959
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASAH2,Neutral ceramidase,41636,0.00410162752171813,0.0058801533008298,-0.00742347294790828,0.0156267279913445,0.48547891038668
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,41740,0.00470618789775531,0.00676095997941886,-0.00854529366190565,0.0179576694574163,0.48638929413714
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,39241,0.0041918109591982,0.00602609713085459,-0.0076193394172768,0.0160029613356732,0.48668854906549
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,41466,-0.00463989918374637,0.00668641709219965,-0.0177452766844577,0.00846547831696494,0.487739221329853
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB37,Ras-related protein Rab-37,41534,0.00622766924471157,0.00898968891429351,-0.0113921210273037,0.0238474595167269,0.488474546692256
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGS8,Regulator of G-protein signaling 8,41534,-0.00488283953881863,0.00705277996752207,-0.0187062882751619,0.00894060919752463,0.488743577330019
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UROD,Uroporphyrinogen decarboxylase,39408,0.00519046801053703,0.00754757201191534,-0.00960277313281703,0.0199837091538911,0.491656249037944
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCN15,Lipocalin-15,39600,0.00461283300538766,0.00671368061122085,-0.0085459809926052,0.0177716470033805,0.49204705185968
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASSF2,Ras association domain-containing protein 2,41465,0.00434729117419356,0.00633142856834306,-0.00806230881975884,0.016756891168146,0.492334030509304
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN2,Dynactin subunit 2,41689,-0.00722542940803522,0.010534602440099,-0.0278732501906293,0.0134223913745589,0.492803547959996
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOBR,Apolipoprotein B receptor,39308,-0.00325361534667445,0.00475927322891955,-0.0125817908753568,0.00607456018200786,0.494219197137598
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCUN1D1,DCN1-like protein 1,39259,0.0057014913803182,0.00834769641873429,-0.010659993600401,0.0220629763610374,0.494620572116253
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,39259,0.00282908829894577,0.00415269807953042,-0.00531019993693384,0.0109683765348254,0.495718558330042
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA10,Ephrin type-A receptor 10,41466,-0.00496199779827031,0.00728712988294965,-0.0192447723688516,0.009320776772311,0.495930431219475
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP6,Guanylate-binding protein 6,39250,-0.00338110404477121,0.0049748059015305,-0.013131723611771,0.00636951552222857,0.496743774683062
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,41465,-0.00362344096705181,0.00535001217352176,-0.0141094648271545,0.00686258289305083,0.498242307870891
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERC2,ERC protein 2,39328,-0.00553473488102675,0.00823205101613158,-0.0216695548726447,0.0106000851105911,0.501381928012136
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,39600,-0.00183448009039462,0.00273754860088043,-0.00720007534812027,0.00353111516733103,0.502796755429475
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,41740,0.00541292468124608,0.00807798655258263,-0.0104199289618159,0.021245778324308,0.502816402808301
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GASK1A,Golgi-associated kinase 1A,39250,-0.00319056333936795,0.00476368561200703,-0.0125273871389017,0.00614626046016583,0.50302032942727
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,39600,0.00225815173104914,0.00337490797863866,-0.00435666790708264,0.00887297136918091,0.503445580415119
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,39408,0.00390262806816752,0.00583313956937798,-0.00753032548781331,0.0153355816241484,0.503481587366809
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF75D,Zinc finger protein 75D,39427,0.00457570743081898,0.00684306958592979,-0.0088367089576034,0.0179881238192414,0.503724731195407
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,39334,-0.00777809109529952,0.0116338839948151,-0.0305805037251371,0.0150243215345381,0.503782805585307
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC44A4,Choline transporter-like protein 4,39328,-0.00507854677268997,0.00759647677860889,-0.0199676412587634,0.00981054771338346,0.503803493965539
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,39334,0.00403131404026425,0.00605025328290254,-0.00782718239422474,0.0158898104747532,0.505230487258489
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS15,Enteropeptidase,41689,-0.00647274514380138,0.00972621921066094,-0.0255361347966968,0.0125906445090941,0.505746003036736
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,41740,0.0110451775421529,0.0166033174991658,-0.021497324756212,0.0435876798405178,0.505909191648926
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA4,Kallistatin,39476,0.00171683223446302,0.00259665847220512,-0.00337261837105901,0.00680628283998506,0.50851741386506
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPARCL1,SPARC-like protein 1,41789,0.00200384451078292,0.00303159216247024,-0.00393807612765875,0.0079457651492246,0.508631878244086
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,39276,0.00306197118857284,0.0046357663959441,-0.0060241309474776,0.0121480733246233,0.508940698476403
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP3,Stromelysin-1,41758,0.0036323341800868,0.00550170427089332,-0.00715100619086411,0.0144156745510377,0.509124334642183
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,39266,-0.00251759993698366,0.00382802098532106,-0.010020521068213,0.00498532119424562,0.51076013581679
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,39600,-0.00355141358956908,0.00543612349073202,-0.0142062156314038,0.00710338845226569,0.513577244967277
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,39328,0.0030413951212111,0.00465878258013104,-0.00608981873584573,0.0121726089782679,0.513879580585501
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP9,Fatty acid-binding protein 9,41740,0.0040851306945736,0.00625977675869824,-0.00818403175247495,0.0163542931416221,0.514025562678436
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALLD,Palladin,39334,0.00277030050982416,0.00425698850221445,-0.00557339695451615,0.0111139979741645,0.515211915753366
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REST,RE1-silencing transcription factor,39241,0.00247604793545233,0.00380563172148976,-0.0049829902386676,0.00993508610957227,0.515301143294416
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD70,CD70 antigen,41740,0.00319744082859087,0.004918436859213,-0.00644269541546661,0.0128375770726483,0.515643587154702
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,39600,0.00777849591205426,0.0120263717934195,-0.015793192803048,0.0313501846271565,0.517783572593064
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA5,Protein disulfide-isomerase A5,39241,-0.00436456092920309,0.00678036326331572,-0.0176540729253019,0.00892495106689573,0.519779931485457
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL8,Interleukin-8,41655,0.0048280506811717,0.00751108226011943,-0.00989367054866238,0.0195497719110058,0.520371478666143
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORD,Sorbitol dehydrogenase,41820,0.00488570229598945,0.00761732213600717,-0.0100442490905846,0.0198156536825635,0.521278055848361
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,39427,-0.00461553417937437,0.00721653134742493,-0.0187599356203272,0.00952886726157849,0.522460566629612
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APLP1,Amyloid-like protein 1,41765,-0.00358590800550814,0.00563939581340517,-0.0146391237997823,0.00746730778876599,0.524873899691572
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAP18,Chromatin complexes subunit BAP18,39598,0.00482279544262566,0.00758500784439392,-0.0100438199323864,0.0196894108176377,0.524898751215348
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAX1BP1,Tax1-binding protein 1,39598,0.00438931928530567,0.006903595277094,-0.00914172745779857,0.0179203660284099,0.524918750915002
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NSFL1C,NSFL1 cofactor p47,41865,0.00442304783155006,0.00695980270579039,-0.00921816547179911,0.0180642611348992,0.525104597437768
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVPL,Envoplakin,39427,-0.0023614714499419,0.00371671808765164,-0.00964623890173913,0.00492329600185532,0.52520401677743
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAM,Integrin alpha-M,41758,-0.00221284725306744,0.00348505608049095,-0.0090435571708297,0.00461786266469483,0.525470027089437
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD2AP,CD2-associated protein,41765,-0.0044382856370356,0.00700207299256942,-0.0181623487024717,0.00928577742840046,0.526187711148333
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,41740,0.00744712459493243,0.0118126902729134,-0.0157057483399778,0.0305999975298426,0.528421468171527
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRC,Chymotrypsin-C,41743,0.00455436837763901,0.00722863957862522,-0.00961376519646641,0.0187225019517444,0.528676081792414
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSP1,Lymphocyte-specific protein 1,41740,0.00280521797380477,0.00448959005800392,-0.00599437853988291,0.0116048144874925,0.532095327688557
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,39334,0.00216490268674755,0.0034662005870356,-0.00462885046384222,0.00895865583733732,0.532263220702027
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,39427,0.00529557521396467,0.00848314682508568,-0.0113313925632033,0.0219225429911326,0.532478827242392
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,39427,-0.0030723198372593,0.0049410274976641,-0.0127567337326809,0.00661209405816233,0.534087950888939
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN4,Contactin-4,41758,-0.00161565417629067,0.00259954851452377,-0.00671076926475726,0.00347946091217592,0.534272662933954
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFL4,Insulin growth factor-like family member 4,39334,0.0049604868337457,0.00798483603169033,-0.0106897917883673,0.0206107654558587,0.534455963132503
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEPD,Xaa-Pro dipeptidase,39655,-0.00181929884451095,0.0029378389320943,-0.00757746315141578,0.00393886546239388,0.535755003138854
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",41534,-0.00794089139477827,0.0128307073564263,-0.0330890778133738,0.0172072950238172,0.535994852681526
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,41862,0.0046212062562933,0.00751170158648768,-0.0101017288532226,0.0193441413658092,0.538432549673182
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,39328,-0.00248450136913667,0.00404497338879561,-0.0104126492111761,0.00544364647290272,0.539083340781441
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM2,Myomesin-2,39250,-0.00379858313240358,0.0061865685562575,-0.0159242575026683,0.00832709123786112,0.53922523354616
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,39241,0.0022837006875125,0.0037211127393422,-0.00500968028159821,0.00957708165662321,0.53941715147697
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPR,Nucleoprotein TPR,39250,-0.00334070153901783,0.00544522622422226,-0.0140133449384935,0.0073319418604578,0.539552178299641
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,41802,0.00169909693966412,0.00276988236489883,-0.00372987249553759,0.00712806637486583,0.539610259373282
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFX1,Transcriptional repressor NF-X1,39250,0.00460922662501871,0.0075290823104359,-0.0101477747034356,0.0193662279534731,0.540425326386698
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,41534,0.0028639080849945,0.00470683208527417,-0.00636148280214288,0.0120892989721319,0.542894657300928
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B4,Protein ATP1B4,39241,0.00282663885856315,0.00465900094917134,-0.00630500300181269,0.011958280718939,0.544059691423312
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCARE,Photoreceptor cilium actin regulator,39259,0.00562855979898878,0.00929198892692063,-0.0125837384977757,0.0238408580957532,0.544698140820528
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,39259,0.00415156921265523,0.00687590346051307,-0.00932520156995039,0.0176283399952608,0.54599926427425
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LACRT,Extracellular glycoprotein lacritin,39565,-0.00304542300958389,0.00504827250890288,-0.0129400371270335,0.00684919110786577,0.546347934658136
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TJP3,Tight junction protein ZO-3,39259,0.00277886459181466,0.00461419697165547,-0.00626496147263005,0.0118226906562594,0.547025673797373
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RCOR1,REST corepressor 1,41521,0.00299839783531033,0.00497927694708806,-0.00676098498098225,0.0127577806516029,0.547067989036673
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,39583,-0.00268436942302435,0.00446144026161151,-0.0114287923357829,0.0060600534897342,0.547398085390017
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,41758,0.00160091671638498,0.0026623745309307,-0.0036173373642392,0.00681917079700916,0.547642816808766
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,39328,0.00487627031165096,0.00811763861207246,-0.0110343013680111,0.020786841991313,0.548052115430786
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F13B,Coagulation factor XIII B chain,39596,-0.00170245014330051,0.0028357533279745,-0.00726052666613054,0.00385562637952951,0.548284051628485
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCLRE1C,Protein artemis,39241,-0.00201693041822508,0.00336673614814252,-0.00861573326858442,0.00458187243213425,0.549135039085476
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR2,Toll-like receptor 2,39427,-0.00153866817770285,0.00258248407316746,-0.00660033696111107,0.00352300060570537,0.551315045846083
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,39600,0.00317044131437211,0.00533279637038942,-0.00728183957159116,0.0136227222003354,0.552178199860192
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",39250,-0.00252315971954459,0.00425477523797472,-0.010862519185975,0.00581619974688586,0.553181475189168
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,39406,-0.0033338062588724,0.00562348787182897,-0.0143558424876572,0.00768822996991238,0.553303294302862
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLO1,Lactoylglutathione lyase,41521,0.00370126921020708,0.00625670303131532,-0.00856186873117095,0.0159644071515851,0.554149838016064
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPPK1,Epiplakin,39308,0.00485226351032793,0.00823706294221565,-0.0112923798564148,0.0209969068770706,0.555822114691161
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",41466,0.00341641928310282,0.0058016363985252,-0.00795478805800656,0.0147876266242122,0.555957705268324
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,39259,-0.00495321121797867,0.00841430035852064,-0.0214452399206791,0.0115388174847218,0.556097928753001
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDM1,Nuclear protein MDM1,39328,0.00206714539520717,0.00351250283926501,-0.00481736016975225,0.0089516509601666,0.55620196448688
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",39259,-0.00295186189556663,0.00502798691198551,-0.0128067162430582,0.00690299245192496,0.557158227720001
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,41758,-0.00197016566884472,0.00335592747220513,-0.00854778351436677,0.00460745217667734,0.557166501867255
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF22,Kinesin-like protein KIF22,39250,0.00807208179222503,0.0138157533608585,-0.0190067947950577,0.0351509583795077,0.559053405615353
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",39328,-0.00556196988700135,0.00952004657424685,-0.0242212611725252,0.0130973213985225,0.559072701204341
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,39334,0.00446046513115593,0.00770309245930667,-0.0106375960890851,0.019558526351397,0.562568511418197
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,39408,0.00237082209255473,0.00409509879174334,-0.00565557153926221,0.0103972157243717,0.562640801247291
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,41765,0.00225734553858226,0.00391056765284522,-0.00540736706099438,0.0099220581381589,0.56378557501193
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",39241,-0.00344684790205415,0.00598090258328521,-0.0151694169652932,0.00827572116118486,0.564418539343516
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MATN3,Matrilin-3,41614,-0.00210125043102334,0.00365059145745733,-0.00925640968763971,0.00505390882559303,0.564901091250224
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,41689,0.00438345497703719,0.00762338614010882,-0.0105583818575761,0.0193252918116505,0.565300475236333
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NLGN1,Neuroligin-1,39328,0.00430294136433415,0.00750870381990442,-0.0104141181226785,0.0190200008513468,0.566615759885353
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA1,Annexin A1,39372,-0.00283722059289669,0.00495119849989356,-0.0125415696526881,0.00686712846689469,0.566631513226973
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAD1,Glutamate decarboxylase 1,39241,-0.00166565586542498,0.00291578987810738,-0.00738060402651545,0.00404929229566549,0.567839720912775
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,39598,-0.00178539394251965,0.00312590891816222,-0.0079121754221176,0.0043413875370783,0.567902902900804
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD209,CD209 antigen,41791,-0.00245279923270177,0.00429559396393385,-0.0108721634020121,0.00596656493660859,0.56800699061458
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FURIN,Furin,41802,0.00208333199038682,0.00365775645498888,-0.00508587066139137,0.00925253464216502,0.568982104619722
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",39259,-0.00532826869250416,0.00941861715723658,-0.0237887583206879,0.0131322209356795,0.571598312468286
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB116,Beta-defensin 116,39259,-0.00471422339576612,0.00834265252096454,-0.0210658223368566,0.0116373755453244,0.572034724242694
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,39650,0.0012090355335305,0.00214500220072293,-0.00299516877988645,0.00541323984694746,0.57300218931113
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,39259,0.00473881453280023,0.00842228575981493,-0.011768865556437,0.0212464946220375,0.57368382139616
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,39427,-0.00261900114382593,0.00466988440611014,-0.0117719745798018,0.00653397229214994,0.574926517432757
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,39241,0.00342240162655118,0.00610366386813187,-0.00854077955498729,0.0153855828080897,0.575005238325794
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP6,Bone morphogenetic protein 6,41508,-0.00246950535810705,0.00443120177178831,-0.0111546608308121,0.00621565011459804,0.577332661523878
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",39625,-0.00475570926177167,0.00853685867484343,-0.0214879522644648,0.0119765337409214,0.577484397740564
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,41740,0.00220057720424181,0.00395038927979368,-0.00554218578415381,0.00994334019263743,0.57750053230749
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,41832,0.00355783335393601,0.00639230730962451,-0.00897108897292802,0.0160867556808001,0.577823518625162
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",39334,-0.00264680218565196,0.00475656789104646,-0.011969675252103,0.00667607088079909,0.577913431734983
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,39328,-0.00226325008225504,0.00407144861244606,-0.0102432893626493,0.00571678919813924,0.578302262856621
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMOD4,Tropomodulin-4,39241,-0.0024664263376872,0.00443888693248202,-0.011166644725352,0.00623379204997756,0.578468169175368
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAX,Integrin alpha-X,39427,0.00317926052437506,0.00577872806926458,-0.00814704649138353,0.0145055675401336,0.582216773758802
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,39308,0.00263024055610778,0.00478758587467845,-0.00675342775826199,0.0120139088704775,0.58275090377607
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM19,Probable RNA-binding protein 19,39250,-0.00293758977245145,0.00536472843787654,-0.0134524575106895,0.00757727796578658,0.583995413672358
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNIP4,Kv channel-interacting protein 4,41466,-0.00308122387913122,0.0056550084999804,-0.0141650405390928,0.00800259278083036,0.585854880412201
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE3,Eosinophil cationic protein,41703,-0.00656507526419467,0.012084333658418,-0.0302503692346939,0.0171202187063046,0.586952057750663
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROCR,Endothelial protein C receptor,39250,-0.00209634462752447,0.00387466151901549,-0.00969068120479482,0.00549799194974588,0.58849172710688
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPS,Calcyphosin,39598,0.00569312340602896,0.010547950406194,-0.0149808593901113,0.0263671062021692,0.58938906594925
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,39250,0.00297181025478134,0.00551449898147798,-0.0078366077489155,0.0137802282584782,0.589961271178122
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM171A2,Protein FAM171A2,39600,-0.00934528299301061,0.0173797851983212,-0.0434096619817201,0.0247190959956989,0.590788204075426
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELOA,Elongin-A,41689,0.00316445092555823,0.00596583260957638,-0.00852858098921148,0.0148574828403279,0.595823487304266
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPGN,Epigen,39589,-0.00272750822348102,0.00514211291768142,-0.0128060495421366,0.00735103309517457,0.595827612818404
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRING1,SREBP regulating gene protein,39241,0.00363963142244689,0.00686945241659491,-0.00982449531407914,0.0171037581589729,0.596241922265467
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRLB,Fc receptor-like B,41465,0.00361069820285363,0.00682039417132422,-0.00975727437294185,0.0169786707786491,0.59653901107003
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QSOX1,Sulfhydryl oxidase 1,39440,0.00230429556556515,0.00435437566120399,-0.00623028073039468,0.010838871861525,0.596683930010358
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,39328,-0.00211002123774573,0.003991975380233,-0.00993429298300242,0.00571425050751095,0.597117697833102
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,39328,0.00300301475287446,0.00568189897091326,-0.00813350723011554,0.0141395367358645,0.597147264420762
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN7,Tetraspanin-7,39259,0.00568079425441792,0.0108011425499622,-0.015489445143508,0.0268510336523438,0.598938178100597
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TET2,Methylcytosine dioxygenase TET2,39420,0.00583095280986571,0.0111678614476,-0.0160580556274303,0.0277199612471617,0.601598156872508
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOL1,Apolipoprotein L1,39655,-0.00309217040482009,0.00593540120912153,-0.0147255567746983,0.00854121596505811,0.602397584105015
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,41465,0.00328219038113403,0.00630512145162397,-0.00907584766404895,0.015640228426317,0.602682681198098
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,41521,-0.00190855057311928,0.00366772825025353,-0.00909729794361619,0.00528019679737763,0.602819414578318
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTN2,Alpha-actinin-2,39250,0.00372417876552026,0.00715762037704402,-0.010304757173486,0.0177531147045265,0.6028586049154
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,39600,0.00436660461874427,0.00839298437042184,-0.0120836447472825,0.0208168539847711,0.602886982127138
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB39B,Ras-related protein Rab-39B,39250,-0.00531551787360269,0.0102435775646096,-0.0253929299002375,0.0147618941530321,0.603832717474676
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,41534,-0.00178024555364314,0.00343849001547344,-0.00851968598397109,0.00495919487668481,0.604648189075374
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EXOSC10,Exosome component 10,39250,0.00336702958115334,0.0065041055018911,-0.00938101720255322,0.0161150763648599,0.604693997444257
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH9,Myosin-9,39633,0.00647894191567393,0.0125914337034581,-0.018200268143104,0.0311581519744519,0.606876725397492
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF6,SLAM family member 6,41465,0.00220361806278143,0.00428637650939241,-0.00619767989562769,0.0106049160211906,0.607192228820359
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFB2,BPI fold-containing family B member 2,39595,0.00350043108029134,0.00681089159237143,-0.00984891644075667,0.0168497786013393,0.607300013178977
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAGLN3,Transgelin-3,39241,0.00341604669655858,0.00664884031119023,-0.00961568031337427,0.0164477737064914,0.607415899852217
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR2,Cadherin-related family member 2,41689,0.00373697406221604,0.00727885972765801,-0.0105295910039937,0.0180035391284257,0.60767949256191
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,39250,-0.00493802199460442,0.00968893143076115,-0.0239283275988963,0.0140522836096874,0.610303047258334
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,39589,-0.00335185967085901,0.00657783863405603,-0.0162444233936088,0.00954070405189081,0.610363997094776
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB5,Serpin B5,41521,-0.00275239802096429,0.00540186296429949,-0.0133400494309913,0.00783525338906272,0.610391191767481
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO4,Roundabout homolog 4,39308,-0.00102949006147064,0.00202306123152511,-0.00499469007525985,0.00293570995231857,0.610848673924034
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,39427,-0.00392715279597149,0.00771731054276578,-0.0190530814597924,0.0111987758678494,0.610849633223161
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARB1,Scavenger receptor class B member 1,41466,0.00313315217200285,0.0061653737781616,-0.00895098043319389,0.0152172847771996,0.611332128609104
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,39328,-0.00286264112215998,0.00565033757794273,-0.0139373027749277,0.00821202053060776,0.61242355071779
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,39334,-0.00229856755784744,0.00453773042156327,-0.0111925191841114,0.00659538406841656,0.612484063041722
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,39250,0.00259688960664749,0.00512927760835896,-0.00745649450573608,0.0126502737190311,0.612665252623736
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,39259,0.00345816082754071,0.00683661987043516,-0.0099416141185122,0.0168579357735936,0.612987134500153
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DENND2B,DENN domain-containing protein 2B,39250,0.00275320618016097,0.00544309036463551,-0.00791525093452462,0.0134216632948466,0.612995780212665
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP13,Collagenase 3,41466,0.00180098880641512,0.00356250951216829,-0.00518152983743473,0.00878350745026498,0.613188715484302
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SBSN,Suprabasin,39621,-0.00197980250359876,0.0039350682109205,-0.00969253619700295,0.00573293118980542,0.614891570896908
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,H2AP,Huntingtin-interacting protein M,39241,-0.00281335755159414,0.00560032646950007,-0.0137899974318143,0.00816328232862599,0.615427525666583
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MICALL2,MICAL-like protein 2,39328,-0.0038211853763486,0.00763843578702447,-0.0187925195189166,0.0111501487662194,0.616903982878217
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,39241,0.00185722816321197,0.00371629250036419,-0.00542670513750184,0.00914116146392579,0.617259372564898
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,41465,-0.0046654930008734,0.00935267295437791,-0.0229967319914541,0.0136657459897073,0.617900211078971
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,39250,0.00585303777965632,0.01174749310188,-0.0171720487000285,0.0288781242593411,0.618327171465826
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,41466,0.00297030809101159,0.00599564715177968,-0.00878116032647657,0.0147217765084998,0.620318664425194
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPM3,Tropomyosin alpha-3 chain,39250,-0.00254037876499398,0.00513633214305864,-0.0126075897653889,0.00752683223540095,0.620899730100022
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",39308,0.00171854960960677,0.00349208146921567,-0.00512593007005594,0.00856302928926947,0.622639243618628
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",39328,-0.00307473990608413,0.00626523214312806,-0.0153545949066151,0.00920511509444686,0.623604596101095
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,39308,-0.00338957964535312,0.00690909725352706,-0.0169314102622662,0.0101522509715599,0.623721842023532
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLK1,Protein delta homolog 1,41925,-0.00314462414606749,0.00641867354316996,-0.0157252242906806,0.00943597599854564,0.624199942260331
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KHDC3L,KH domain-containing protein 3,39241,-0.00364862624809617,0.00745704255366956,-0.0182644296532885,0.0109671771570962,0.624649342447962
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,39250,-0.00276936671916568,0.00566679136013135,-0.0138762777850231,0.00833754434669176,0.625063444163179
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,39328,0.00163743456887014,0.00335189377379797,-0.00493227722777389,0.00820714636551417,0.62519843054524
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DMD,Dystrophin,39308,0.00277875173402623,0.00573310827767006,-0.00845814049020708,0.0140156439582595,0.627909704049282
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,39259,-0.00217023550816016,0.00448072753489296,-0.0109524614765504,0.00661199046023004,0.628148220239092
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,39427,0.00240483722896544,0.00498350191605173,-0.00736282652649594,0.0121725009844268,0.62941814974053
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,39328,0.00441510300712672,0.00916065648512843,-0.013539783703725,0.0223699897179784,0.629841634094839
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,39427,0.00440498109636756,0.00914405995890218,-0.0135173764230807,0.0223273386158158,0.630006481171426
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,39334,-0.00455955803950275,0.00949728719386932,-0.0231742409394866,0.0140551248604811,0.631172774780787
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNL2,Interferon lambda-2,39259,0.00310490526225682,0.00647263276601699,-0.00958145495913648,0.0157912654836501,0.631452402503803
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,39308,0.00205639567060054,0.00429023979299811,-0.00635247432367576,0.0104652656648768,0.631721127378282
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,39259,-0.00312077975134247,0.00653287081582865,-0.0159252065503666,0.00968364704768168,0.632870558418024
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIFR,Leukemia inhibitory factor receptor,41740,0.00127093654930192,0.00266283196101701,-0.00394821409429141,0.00649008719289525,0.633165311642239
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,39427,-0.00423205132407622,0.00889890263014186,-0.0216739004791543,0.0132097978310018,0.634390330766999
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,39427,-0.00277294899545126,0.00584536158137948,-0.014229857694955,0.00868395970405251,0.635235303339606
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFR,Epidermal growth factor receptor,41925,-0.000837112131303763,0.00176910515749999,-0.00430455824000374,0.00263033397739622,0.636089712736467
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEBP1,Heme-binding protein 1,41521,-0.00271996705813357,0.00576923447883015,-0.0140276666366407,0.00858773252037352,0.637319771403288
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLF4,Krueppel-like factor 4,39259,-0.0021199743838252,0.00451056249967001,-0.0109606768831784,0.00672072811552802,0.638363047650398
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,38782,-0.00292558547323665,0.00629621071667648,-0.0152661584779225,0.00941498753144925,0.642186235203452
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",39308,-0.00294478631439773,0.00639812511124511,-0.0154851115324381,0.00959553890364269,0.645340608865097
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,41911,0.00129250983234418,0.00282131386259747,-0.00423726533834685,0.00682228500303522,0.646871283816034
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP85,Centrosomal protein of 85 kDa,41465,-0.00330450030475839,0.00721834220766006,-0.0174524510317721,0.0108434504222553,0.647109516826947
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",41764,0.0016634024792446,0.00364301193301618,-0.00547690090946711,0.00880370586795631,0.647965475119837
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,39427,-0.00321771802428023,0.00706067384969416,-0.0170566387696808,0.0106212027211203,0.648597652382328
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",41466,0.0021033552007826,0.00462711996818519,-0.00696579993686038,0.0111725103384256,0.649425469977824
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BSND,Barttin,39241,-0.00169304308485908,0.00373338331799426,-0.00901047438812783,0.00562438821840968,0.650206909262053
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,39427,-0.00330479148936187,0.00729336830743402,-0.0175997933719325,0.0109902103932088,0.650469396678671
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,39308,0.00284496791311627,0.00628368233068535,-0.00947104945502701,0.0151609852812595,0.650734421125225
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,41534,0.00298615895326409,0.00659944089211872,-0.00994874519528861,0.0159210631018168,0.650926019775996
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRMD4B,FERM domain-containing protein 4B,39250,0.00353768851148202,0.00782819329019087,-0.0118055703372921,0.0188809473602561,0.651338451176259
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSCA,Prostate stem cell antigen,39600,-0.0129820350925113,0.0288305170128329,-0.0694898484376638,0.0435257782526412,0.652511683365774
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASS1,Argininosuccinate synthase,39250,0.00386609901617736,0.0085876345270698,-0.0129656646568794,0.0206978626892342,0.652579937475911
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGT,Angiotensinogen,39655,0.00108783656498286,0.00241847911033514,-0.00365238249127402,0.00582805562123973,0.652862087124938
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,41521,-0.00147406519869942,0.00327795459828854,-0.00789885621134497,0.00495072581394613,0.652941131260995
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNW1,Interferon omega-1,39250,-0.00175949355733951,0.00392655057939587,-0.00945553269295541,0.00593654557827639,0.654088995921636
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA6,Corticosteroid-binding globulin,39650,0.000765954177013388,0.00171018734526405,-0.00258601301970415,0.00411792137373093,0.654250495701165
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPC5,Glypican-5,41636,0.00278671512711295,0.00623943966920438,-0.00944258662452764,0.0150160168787535,0.655150322999331
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMS1,PMS1 protein homolog 1,39328,-0.00242442163564652,0.00546960435329448,-0.0131448461681037,0.00829600289681066,0.657591275852013
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP1,Methionine aminopeptidase 1,41466,0.00142686811298521,0.0032294148967213,-0.00490278508458854,0.00775652131055896,0.658616128959583
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,39328,0.00339976251705463,0.00772527629618835,-0.0117417790234745,0.0185413040575838,0.659885883415291
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIL1,Nucleotide exchange factor SIL1,39308,0.00157468387690365,0.00360021762696094,-0.00548174267193978,0.00863111042574709,0.661840439691642
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRNN,Cornulin,41373,0.00325715324708363,0.00748253953224199,-0.0114086242361107,0.0179229307302779,0.663351672446027
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAGE2A,G antigen 2A,39241,0.0031563722212933,0.00725369908520952,-0.0110608779857174,0.017373622428304,0.663469875684074
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENAH,Protein enabled homolog,41534,0.00231627479128057,0.00532745903557156,-0.0081255449184397,0.0127580945010008,0.66372908383569
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD109,CD109 antigen,41758,-0.00163745243479706,0.00377713159034368,-0.00904063035187068,0.00576572548227656,0.664646002467213
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,39334,-0.00422068944519299,0.00974339958386834,-0.0233177526295749,0.014876373739189,0.664889459913818
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,41838,0.00196763521276851,0.004553563150355,-0.00695734856192729,0.0108926189874643,0.665669296660828
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CR1,Complement receptor type 1,39636,-0.0016789390551877,0.00394341100849431,-0.00940802463183654,0.00605014652146115,0.670292446594882
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FMNL1,Formin-like protein 1,41466,0.00296988464301093,0.00700648516728979,-0.0107628262848771,0.0167025955708989,0.671662945367721
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",41598,-0.00191190134974056,0.00451780500085407,-0.0107667991514145,0.00694299645193341,0.672161794581947
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,39334,-0.0040588505913943,0.00960646195528902,-0.0228875160237608,0.0147698148409722,0.672659416356144
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EXTL1,Exostosin-like 1,39250,-0.00222473516036444,0.00528286592813406,-0.0125791523795072,0.00812968205877832,0.673673929732399
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,39334,-0.00140342475357305,0.00333284693189721,-0.00793580474009158,0.00512895523294548,0.673698618391492
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN1,Contactin-1,41925,0.00123819521014574,0.00295369216800117,-0.00455104143913656,0.00702743185942803,0.675074885498035
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,39427,0.00263500956911568,0.00630489767171002,-0.00972258986743597,0.0149926090056673,0.676006158388501
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD82,CD82 antigen,39427,0.00191844722355268,0.00459421349537588,-0.00708621122738404,0.0109231056744894,0.676263210312144
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL36A,Interleukin-36 alpha,39334,-0.00266888758695219,0.00640000470213186,-0.0152128968031306,0.00987512162922625,0.676676961050947
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF7,SLAM family member 7,41740,0.00274682371445511,0.0066257915906258,-0.0102397278031715,0.0157333752320817,0.678466874143642
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,39250,0.00234254894432398,0.00566684660321257,-0.00876447039797266,0.0134495682866206,0.679338113134643
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL32,Interleukin-32,41740,-0.00204043381030076,0.00493723738384652,-0.0117174190826399,0.00763655146203841,0.679412328667167
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMIGO1,Amphoterin-induced protein 1,39328,-0.00233305443083577,0.0056456107292071,-0.0133984514600817,0.00873234259841016,0.679430966008475
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP73,Tumor protein p73,39328,-0.00157139219369306,0.00380575999551352,-0.00903068178489955,0.00588789739751343,0.679689308800817
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POMC,Pro-opiomelanocortin,39308,0.00335624119732623,0.00816465577798549,-0.0126464841275253,0.0193589665221778,0.681029779245537
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",39334,-0.00157580163365632,0.00383567318424445,-0.00909372107477545,0.0059421178074628,0.681206920177841
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,39308,0.00192685478932506,0.00470703004155502,-0.00729892409212278,0.0111526336707729,0.682286020097705
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3GL3,Endophilin-A3,39361,-0.00386762792941497,0.00951016887219394,-0.0225075589189151,0.0147723030600851,0.684248612904943
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,39328,-0.00364914091124974,0.00901469349322332,-0.0213179401579675,0.014019658335468,0.68563317159243
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGR,Progesterone receptor,39334,-0.00449783650769518,0.0111364863823115,-0.0263253498170258,0.0173296768016354,0.686306871289991
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IKZF2,Zinc finger protein Helios,41465,-0.00396784011705058,0.0098735321721889,-0.0233199631745408,0.0153842829404397,0.687789080598384
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,39328,0.00211908553206162,0.00527634183779124,-0.00822254447000921,0.0124607155341324,0.687971551864252
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,39241,0.00118125122438824,0.00295126576458018,-0.00460322967418892,0.00696573212296539,0.688978653380202
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,39633,0.00283956105553908,0.00709820914668173,-0.0110729288719571,0.0167520509830353,0.689135477793692
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,41465,0.00232858481045216,0.00582247545257405,-0.00908346707659297,0.0137406366974973,0.689214436480215
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,39600,-0.00249078966363489,0.00623411900130765,-0.0147096629061979,0.0097280835789281,0.689501960519359
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,41765,-0.00142649298656464,0.00357514235767886,-0.0084337720076152,0.00558078603448593,0.689897370592096
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA11,Carbonic anhydrase-related protein 11,41465,-0.00134982270620512,0.00338379250069252,-0.00798205600756245,0.00528241059515221,0.689967439361994
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,39241,0.00259938787261621,0.00651879016828372,-0.0101774408572199,0.0153762166024523,0.690083129273127
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,39427,0.00176821361408081,0.00445114466829058,-0.00695602993576873,0.0104924571639304,0.691191542323222
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,39250,0.00159238355151037,0.00400875593242723,-0.006264778076047,0.00944954517906775,0.691208501221658
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEP1A,Meprin A subunit alpha,39600,-0.0033360516200699,0.00843717071874644,-0.0198729062288129,0.0132008029886731,0.692555873510687
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",39334,0.00128370584678598,0.00327135165187219,-0.0051281433908835,0.00769555508445547,0.694764276514168
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NIT1,Deaminated glutathione amidase,39308,0.00192199201682746,0.00492222109974665,-0.00772556133867599,0.0115695453723309,0.696194948124884
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,39589,-0.00282202325490596,0.00723839843615623,-0.0170092841897722,0.0113652376799603,0.69664137279402
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,39589,-0.00210261408063383,0.00544536858547878,-0.0127755365081722,0.00857030834690457,0.699408696432196
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,39259,0.00234709000210125,0.00609273383050059,-0.00959466830567991,0.0142888483098824,0.700076389488664
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL5,Insulin-like peptide INSL5,39600,-0.00436758805514544,0.0113612902506377,-0.0266357169463953,0.0179005408361045,0.70066933668148
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEPR,Leptin receptor,41765,0.0013337786070855,0.00347205773130275,-0.00547145454626789,0.00813901176043889,0.700876119282446
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1B,Protein phosphatase 1B,39334,0.00263399866832763,0.00686384542457894,-0.0108191383638471,0.0160871357005024,0.70117156798389
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPEP1,Dipeptidase 1,41617,-0.00193636799070035,0.00507568577863835,-0.0118847121168315,0.00801197613543081,0.702839394551286
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFLAM,Pikachurin,39600,0.00129878952263775,0.00341573597388757,-0.00539605298618189,0.00799363203145739,0.703776767462256
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",39598,-0.00107121047066324,0.00281900775103764,-0.00659646566269701,0.00445404472137053,0.703956037740722
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,39250,-0.00151553185899407,0.00400588194001545,-0.00936706046142435,0.00633599674343622,0.705195497500902
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,41689,0.00337659820474162,0.00893376486774463,-0.0141335809360379,0.0208867773455211,0.705467066983422
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,39259,-0.00187099059244223,0.00495143110294522,-0.0115757955542149,0.0078338143693304,0.705535695712983
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,41829,-0.00349240652595065,0.00925629175063525,-0.0216347383571957,0.0146499253052944,0.705956110561906
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,39250,-0.00197051926793612,0.00523955334264125,-0.012240043819513,0.00829900528364073,0.706860934235969
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,41521,-0.00148499724559926,0.00395719993640823,-0.00924110912095939,0.00627111462976088,0.707469813831396
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG4,Desmoglein-4,41637,-0.00199188375245585,0.00531281832149812,-0.0124050076625922,0.00842124015768046,0.707725796001623
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA7,Carbonic anhydrase 7,39427,-0.00140276039984821,0.00374625270585546,-0.00874541570332491,0.00593989490362849,0.708081633353061
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,39259,-0.00309363860119806,0.00828253939750341,-0.0193274158203048,0.0131401386179086,0.708773878669461
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAS2,Growth arrest-specific protein 2,39427,0.00216891418005757,0.00581202547711223,-0.00922265575508241,0.0135604841151975,0.709024025429601
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTN,Neuroplastin,41465,-0.00324761606305047,0.00871937074222753,-0.0203375827178164,0.0138423505917155,0.70955658898977
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMCH,Pro-MCH,39250,0.00342335948765476,0.00919821477283338,-0.0146051414670987,0.0214518604424082,0.709768838129866
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PYDC1,Pyrin domain-containing protein 1,39308,0.00168971571047413,0.00455909914509001,-0.00724611861390229,0.0106255500348506,0.710924257033895
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD86,T-lymphocyte activation antigen CD86,39600,-0.00124447207116709,0.00337015937158352,-0.00784998443947078,0.0053610402971366,0.711939492116994
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,39241,0.00274433554784597,0.00744311623707011,-0.0118441722768115,0.0173328433725034,0.71235281583109
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C19orf12,Protein C19orf12,41466,-0.0027243687225374,0.00742122714580527,-0.0172699739283157,0.0118212364832409,0.713546822751823
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BACH1,Transcription regulator protein BACH1,41740,-0.00304660553972733,0.00832725999154891,-0.0193680351231632,0.0132748240437085,0.714475954857723
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,41786,-0.00316386803226641,0.0087072198092104,-0.0202300188583188,0.013902282793786,0.716340718514141
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,41466,-0.00155450081724432,0.00430211144609119,-0.00998663925158305,0.00687763761709441,0.717855421121167
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNAS,Neuroendocrine secretory protein 55,39600,-0.00346860508346234,0.00964632866541674,-0.0223754092676791,0.0154381991007545,0.719169833282317
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,39259,-0.00131352216782158,0.00366674038989743,-0.00850033333202055,0.00587328899637739,0.720181198577748
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD101,Immunoglobulin superfamily member 2,39600,0.00171535823663652,0.004797823843897,-0.0076883764974016,0.0111190929706746,0.720703135525333
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEG1,Protein LEG1 homolog,39082,-0.00276311959385436,0.0078477412205159,-0.0181446923860655,0.0126184531983568,0.724777044320637
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CADPS,Calcium-dependent secretion activator 1,39328,0.00160494914616359,0.00456026943209621,-0.00733317894074498,0.0105430772330722,0.724888869954547
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FH,"Fumarate hydratase, mitochondrial",39259,-0.00322311738812245,0.00917403876962374,-0.021204233376585,0.0147579986003401,0.725347543104718
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,39427,-0.00259444715335313,0.00740072425378073,-0.0170998666907634,0.0119109723840571,0.72592029557083
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,41534,0.00121967066595977,0.00348401606788321,-0.00560900082709132,0.00804834215901086,0.72628730684931
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,41911,-0.0013667489673653,0.00391099038849203,-0.00903229012880967,0.00629879219407907,0.726746785710379
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,39308,-0.00202188495960507,0.00584806238899131,-0.013484087242028,0.00944031732281789,0.729548013498723
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,39259,0.00352340085671233,0.0102078341169317,-0.0164839540124739,0.0235307557258985,0.729976124613627
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,41925,0.000890049950801715,0.00258103125148116,-0.00416877130210135,0.00594887120370478,0.73021802428644
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCNA,Proliferating cell nuclear antigen,39241,0.00245725429211318,0.00715726774487848,-0.0115709904878486,0.016485499072075,0.731362298137799
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,41877,-0.00202102698128639,0.00589675568532643,-0.0135786681245262,0.00953661416195341,0.73180294637701
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM4,Intercellular adhesion molecule 4,41740,0.00199158134570175,0.0058247614139778,-0.00942495102569473,0.0134081137170982,0.73241928921255
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,39600,-0.00234442010251136,0.00687585982492511,-0.0158211053593646,0.0111322651543419,0.733137257340243
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',39598,0.00168008594858733,0.00493279762482097,-0.00798819739606176,0.0113483692932364,0.733415038915439
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,39334,0.00215060874657312,0.00633651845843513,-0.0102689674319597,0.014570184925106,0.734315726300098
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCIN,Adseverin,39259,0.00278153976002718,0.00820891982575882,-0.0133079430984601,0.0188710226185145,0.734734245806954
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,39328,-0.00150343908479555,0.00445369791414406,-0.0102326869965179,0.00722580882692681,0.735693133167207
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,39259,-0.00213068406729499,0.00634910198696686,-0.01457492396175,0.0103135558271601,0.737187985517822
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAND5,DAN domain family member 5,39334,0.00204482831111221,0.00609473727363277,-0.00990085674520802,0.0139905133674324,0.737249062096011
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRUNE2,Protein prune homolog 2,39427,-0.00107670603915713,0.0032205530862491,-0.00738899008820536,0.0052355780098911,0.738142061434591
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,39625,0.00113984243790287,0.00343961532321504,-0.00560180359559862,0.00788148847140435,0.740358781435821
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL33,Interleukin-33,41534,-0.00144773397744943,0.00437663362952696,-0.0100259358913223,0.00713046793642341,0.740810658471292
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIPF,Gastric triacylglycerol lipase,39308,-0.00230781741351822,0.00699183584699937,-0.016011815673637,0.0113961808466005,0.741351133353379
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTX1,Neuronal pentraxin-1,41758,-0.00152062491088103,0.0046284370419467,-0.0105923615130966,0.00755111169133449,0.742508926838634
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHI3L1,Chitinase-3-like protein 1,41540,-0.00303680189564349,0.00925401594195079,-0.021174673141867,0.01510106935058,0.742795670821528
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,39250,-0.0024875371200221,0.00761151897940133,-0.0174061143196487,0.0124310400796045,0.743816368099746
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,39328,-0.00165942913847531,0.00508613692496787,-0.0116282575114123,0.00830939923446172,0.744230130387617
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",41466,-0.00192859816567722,0.00591224639421488,-0.0135166010983384,0.00965940476698393,0.744275353667681
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYBB2,Beta-crystallin B2,39598,0.00250603683796285,0.00769611551672971,-0.0125783495748274,0.0175904232507531,0.7447153492825
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,39259,0.00205232879679077,0.00636156582612383,-0.0104163402224119,0.0145209978159935,0.746994084148891
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRC1,Protein regulator of cytokinesis 1,39589,-0.00157182597988675,0.00490718523448651,-0.0111899090394803,0.00804625707970681,0.748738587355978
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17F,Interleukin-17F,41534,0.00259254794489576,0.00810130382963037,-0.0132860075611798,0.0184711034509713,0.748961267970214
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,39600,0.000912868920773252,0.00285618997750825,-0.00468526343514291,0.00651100127668942,0.749269520390499
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,39598,0.00312634740867788,0.00982616856845994,-0.0161329429855036,0.0223856378028594,0.750365475019089
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,39241,0.00170994064232394,0.00543511974214561,-0.00894289405228146,0.0123627753369293,0.753064286276301
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,41636,0.000830271825707675,0.00265338623409114,-0.00437036519311097,0.00603090884452632,0.754353833883278
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLGAP5,Disks large-associated protein 5,39600,0.00171565539297363,0.00548636135196062,-0.00903761285686919,0.0124689236428165,0.754504801791869
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,41465,-0.00150449703878206,0.00482351559103913,-0.0109585875972188,0.00794959351965465,0.755114876649506
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF21,Fibroblast growth factor 21,41862,-0.00414196375362441,0.0132988557341234,-0.0302077209925064,0.0219237934852575,0.7554614354691
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,41465,0.00162200511189648,0.00520816213598519,-0.00858599267463449,0.0118300028984275,0.755474830151573
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,41521,-0.00175996529884826,0.00566150605548086,-0.0128565171675907,0.00933658656989423,0.75590810387721
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGKZ,Diacylglycerol kinase zeta,41534,0.00124142192052444,0.00400916517520523,-0.0066165418228778,0.00909938566392669,0.756835167123724
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDGF,Hepatoma-derived growth factor,41858,-0.00312474844177422,0.0101283176208438,-0.0229762509786281,0.0167267540950797,0.757694544361474
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DENR,Density-regulated protein,39334,0.0019775600514997,0.00642165258705119,-0.0106088790191206,0.01456399912212,0.758124915744208
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,39542,0.00213170587115477,0.00695804803611815,-0.0115060682796368,0.0157694800219463,0.759332201688414
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PITHD1,PITH domain-containing protein 1,39221,0.0026148382455311,0.00855284739213976,-0.0141487426430628,0.019378419134125,0.759818339153339
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,39334,0.00155658469830607,0.00512353901645898,-0.00848555177395353,0.0115987211705657,0.761278192914119
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,39328,-0.00123120784956489,0.00408974108909755,-0.00924710038419608,0.00678468468506631,0.763383824899046
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHC1,SHC-transforming protein 1,39241,0.00385696621220679,0.012967651132001,-0.0215596300065153,0.0292735624309288,0.766144182064946
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STC1,Stanniocalcin-1,41865,0.00150851013449147,0.00508651023315206,-0.00846104992248656,0.0114780701914695,0.766798890934703
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN3B,Sodium channel subunit beta-3,39259,-0.00152973396261231,0.00518180959033883,-0.0116860807596764,0.0086266128344518,0.767837451124198
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,39328,0.00164932761320793,0.00559790839134598,-0.00932257283383018,0.012621228060246,0.768280078011561
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,39250,-0.001521619469722,0.00522691210622985,-0.0117663671979325,0.00872312825848852,0.770970946394709
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINI2,Serpin I2,39600,-0.0018631503593311,0.00640101790075642,-0.0144091454448137,0.0106828447261515,0.771002545106598
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM1,Myomesin-1,39259,-0.00157668883465346,0.00543361358755851,-0.0122265714662681,0.00907319379696121,0.771689411815788
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL3A1,Collagen alpha-1(III) chain,39633,-0.000752109112367925,0.00260930926237015,-0.00586635526661342,0.00436213704187757,0.773167915232003
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,39427,0.00182331014659244,0.00633563040096584,-0.0105945254393006,0.0142411457324855,0.773515529228226
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,39427,-0.00217351582939794,0.00759978595924629,-0.0170690963095207,0.0127220646507248,0.774885906530384
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOP56,Nucleolar protein 56,39250,0.00355271007274196,0.0124312190831257,-0.0208124793301844,0.0279178994756683,0.7750450205769
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,39241,-0.00261185654125543,0.00931584695927686,-0.0208709165814381,0.0156472034989272,0.779201363283158
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,39427,-0.0012792481649087,0.00456316709857981,-0.0102230556781251,0.00766455934830772,0.779220356673139
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF20B,Kinesin-like protein KIF20B,39259,0.00232019923377806,0.00833111225943012,-0.014008780794705,0.0186491792622611,0.780635398159927
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A3,Protein S100-A3,39589,-0.00130456320098621,0.00473586653866713,-0.0105868616167738,0.00797773521480136,0.782964560276616
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GKN1,Gastrokine-1,41173,0.000860807743788618,0.00313748925293085,-0.00528867119195584,0.00701028667953308,0.783810970251536
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM5,Intercellular adhesion molecule 5,41765,0.00139922121041976,0.00510588947094498,-0.00860832215263241,0.0114067645734719,0.784057691074938
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,39259,0.00178849897135369,0.00655488160391582,-0.0110590689723213,0.0146360669150287,0.784973864082804
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,39313,0.0011741777689805,0.00436048011819232,-0.00737236326267644,0.00972071880063745,0.787721581044231
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,39589,0.00130205069866569,0.00488294074699843,-0.00826851316545123,0.0108726145627826,0.789741363570868
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN4,Prefoldin subunit 4,39241,-0.00155025852406622,0.00582357588849265,-0.0129644672655118,0.00986395021737937,0.790087349085734
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM3,Paralemmin-3,39250,0.00221439225684005,0.00838960253369151,-0.0142292287091953,0.0186580132228754,0.791827533818722
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDSN,Corneodesmosin,41861,-0.00128004606122232,0.00485540631083076,-0.0107966424304506,0.00823655030800596,0.792066708038906
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,39241,-0.00171611639720478,0.00657389271625045,-0.0146009461210557,0.0111687133266461,0.794058801209909
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLI2,Zinc finger protein GLI2,39334,-0.00095971926353084,0.00368260978373415,-0.00817763443964978,0.0062581959125881,0.794399464242188
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAU,Urokinase-type plasminogen activator,41758,0.000824311774972449,0.00317403823467581,-0.00539680316499213,0.00704542671493703,0.79509584217744
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,39600,0.00144993903470092,0.00558575554035585,-0.00949814182439655,0.0123980198937984,0.795194195952303
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,39427,0.00304298059676521,0.0117371640928085,-0.0199618610251395,0.0260478222186699,0.795439343120653
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,39600,-0.000900807964040554,0.00347621095569499,-0.00771418143720274,0.00591256550912163,0.795535921339231
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPT,Microtubule-associated protein tau,41466,-0.00151534182519053,0.00587295556643509,-0.0130263347354033,0.00999565108502224,0.79639535833401
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,39259,0.000870912739716803,0.0033801706553214,-0.00575422174471314,0.00749604722414675,0.796679323839523
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVI2B,Protein EVI2B,39241,-0.00114142071042501,0.00443403228080332,-0.00983212398079952,0.0075492825599495,0.796857432771058
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSP90B1,Endoplasmin,41408,0.0018120740661982,0.00704355987539198,-0.0119933032895701,0.0156174514219665,0.796976957350596
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDT,D-dopachrome decarboxylase,39633,0.00115261555556894,0.00449150849109063,-0.0076507410869687,0.00995597219810657,0.797476120339025
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,41810,-0.000849120812322877,0.00331923199250049,-0.00735481551762384,0.00565657389297809,0.798095003226264
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOS,Proto-oncogene c-Fos,39221,0.00102054534757082,0.00401487507508226,-0.0068486097995904,0.00888970049473205,0.799352878345813
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,39334,-0.001027665855521,0.00404751960464109,-0.00896080428061753,0.00690547256957554,0.799577557993964
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL24,Interleukin-24,41534,0.00135182318831445,0.00533341857236224,-0.00910167721351554,0.0118053235901444,0.79991463501757
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LHB,Lutropin subunit beta,41465,-0.00247428216114941,0.0097685077976236,-0.0216205574444917,0.0166719931221929,0.800046839757897
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,41521,-0.0015986592279372,0.00632625019517838,-0.0139981096104868,0.0108007911546124,0.800502137138651
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,41750,0.00133008689891245,0.00526977902659184,-0.00899867999320756,0.0116588537910325,0.800736626270571
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBQLN3,Ubiquilin-3,39250,-0.00156226218509337,0.00626434658656159,-0.0138403814947541,0.0107158571245673,0.803064325554917
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPB1,Beta-ureidopropionase,39625,0.00250006146020729,0.0100667767137782,-0.017230820898798,0.0222309438192126,0.803869973516096
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INHBC,Inhibin beta C chain,41758,0.00108406277101696,0.00438492521803981,-0.00751039065634108,0.00967851619837499,0.804738020277088
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS27,Serine protease 27,41728,-0.00110059796453867,0.00445221223575033,-0.00982693394660932,0.00762573801753198,0.804755381579324
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORN4,MORN repeat-containing protein 4,39241,-0.00214146725505747,0.00867024067930894,-0.019135138986503,0.0148522044763881,0.804920325454199
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,41865,0.00127131010709064,0.00518004284723227,-0.00888157387348461,0.0114241940876659,0.806131455618054
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,39334,-0.000669509578634111,0.00273821560655083,-0.00603641216747374,0.00469739301020552,0.806843789292544
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,39259,-0.00111235028750009,0.0045631824221996,-0.0100561878350113,0.00783148726001113,0.807416480516376
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,39328,-0.00180882773656434,0.00744401738028527,-0.0163991018019235,0.0127814463287948,0.808017170202637
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,39250,-0.00156791085515604,0.00645886606667328,-0.0142272883458357,0.0110914666355236,0.808201213085419
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STEAP4,Metalloreductase STEAP4,39259,0.00196200816020188,0.00809621931080702,-0.0139065816889799,0.0178305980093836,0.808524219492433
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAG,S-arrestin,39259,0.00140527069507342,0.0058089890340776,-0.00998034781171867,0.0127908892018655,0.808852133057837
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEX33,Testis-expressed protein 33,39427,-0.00103637076509551,0.00431942540214029,-0.00950244455329049,0.00742970302309946,0.810387086197538
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",39250,0.00103002076391701,0.0043263893754824,-0.00744970241202849,0.00950974393986251,0.811824705600879
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,39427,0.000719982210585297,0.00302742518447174,-0.0052137711509793,0.0066537355721499,0.812025218027831
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,41534,-0.00116920282631903,0.00492509920204808,-0.0108223972623333,0.0084839916096952,0.812352726362083
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPACT,Protein IMPACT,39598,0.00140409343376847,0.00602429260991908,-0.0104035200816729,0.0132117069492099,0.815709897953817
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCP2,Non-specific lipid-transfer protein,41465,-0.00189385515841499,0.00820400733558419,-0.01797370953616,0.01418599921933,0.817438788353126
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,39589,-0.00116895032075124,0.00509781381395655,-0.0111606653961061,0.0088227647546036,0.81863672589207
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,39328,0.00162735511330074,0.00723265771640299,-0.0125486540108491,0.0158033642374506,0.821982793111673
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAFB2,Scaffold attachment factor B2,39600,-0.000676327201762208,0.00302559631432327,-0.00660649597783581,0.00525384157431139,0.823123160902813
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,39259,-0.00174940069042328,0.00788427054998742,-0.0172025709683986,0.0137037695875521,0.824407725724345
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,39250,0.00171621923992917,0.007740222666642,-0.0134546171866892,0.0168870556665475,0.824530370922136
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,39385,-0.00120352965526753,0.00545666899833356,-0.0118986008920013,0.00949154158146624,0.825438262320725
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,39589,0.00109768133594409,0.00498467721052609,-0.00867228599668705,0.0108676486685752,0.825710829731292
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRH,Corticoliberin,41454,0.00208877483439795,0.00950330846802397,-0.016537709762929,0.0207152594317249,0.826034701577631
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,39328,-0.00256347982730574,0.0117331383577512,-0.025560431008498,0.0204334713538866,0.82705771789003
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,41465,-0.0012566051056952,0.00578972490885156,-0.0126044659270443,0.0100912557156539,0.828180181739223
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,39241,0.00351759830456104,0.0162906893127363,-0.0284121527484022,0.0354473493575243,0.829048854670017
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,39328,0.00129747713751319,0.00606413751043281,-0.0105882323829351,0.0131831866579615,0.830583052489797
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,39600,0.00142022114101834,0.00666568640997045,-0.0116445242225237,0.0144849665045604,0.83128060224304
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,39589,-0.000960152063248203,0.00451803867107213,-0.00981550785854958,0.00789520373205317,0.83170903281057
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTBS,Di-N-acetylchitobiase,39530,-0.000644774899859289,0.00305174873952133,-0.0066262024293211,0.00533665262960252,0.832672362723612
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYB5A,Cytochrome b5,39241,-0.0016653205511926,0.0078968037080159,-0.0171430558189038,0.0138124147165186,0.83298074084615
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,39427,-0.00167838251335312,0.00796001161616149,-0.0172800052810296,0.0139232402543234,0.833006910470787
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDK1,Cyclin-dependent kinase 1,39241,0.000853091858322844,0.00404879943723158,-0.00708255503865106,0.00878873875529675,0.833123516959059
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",39334,0.000650908590502337,0.00311873104617955,-0.00546180426000959,0.00676362144101426,0.834679035465366
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,39334,0.00145659375150961,0.0069813717747446,-0.0122268949269898,0.015140082430009,0.834733202489464
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA4,Carboxypeptidase A4,39195,-0.00101658534106079,0.0048845528240911,-0.0105903088762793,0.00855713819415777,0.835137320382194
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,41888,0.00109708472242831,0.00527576986273496,-0.0092434242085322,0.0114375936533888,0.835272914788221
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH22,Cadherin-22,39427,-0.000633269611796943,0.00307129584732216,-0.00665300947254838,0.0053864702489545,0.836646599301423
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",39400,0.00142021503063819,0.00689423145417637,-0.0120924786195475,0.0149329086808239,0.83679441449976
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,39334,0.00134777963303665,0.00655097838330762,-0.0114921379982463,0.0141876972643196,0.837000138057437
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEX101,Testis-expressed protein 101,39328,0.00140740880083834,0.00685917668870746,-0.0120365775090283,0.014851395110705,0.837430498094331
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL31,Interleukin-31,39334,-0.00126970314492632,0.00619510515872153,-0.0134121092560205,0.0108727029661679,0.837613014965916
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,39589,0.00121280291082671,0.00594652214582526,-0.0104423804949908,0.0128679863166442,0.838395071235809
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAA4,Serum amyloid A-4 protein,39650,-0.000733391459014874,0.0036064814860772,-0.00780209517172618,0.00633531225369644,0.838862307396803
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",39328,0.000890339492262629,0.00438979782451784,-0.00771366424379233,0.00949434322831759,0.839279447174291
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,41465,-0.00071244104129684,0.00352205991098028,-0.00761567846681818,0.0061907963842245,0.839701307664534
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,39562,0.00101854976754512,0.00503741306215043,-0.00885477983426972,0.01089187936936,0.839766476955938
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PVR,Poliovirus receptor,41865,0.000836504665566632,0.00415275175555581,-0.00730288877532276,0.00897589810645603,0.840362458218838
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,39250,-0.00222505519082417,0.011223007072067,-0.0242221490520755,0.0197720386704272,0.842846698058852
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,39633,-0.000664701019232969,0.00335803905331519,-0.00724645756373074,0.00591705552526481,0.843093145430223
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSLP,Thymic stromal lymphopoietin,41521,0.00130212270714594,0.00666499863212417,-0.0117612746118174,0.0143655200261093,0.845108495490799
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,39250,-0.00103522401383193,0.0053393330521624,-0.0115003167960702,0.00942986876840637,0.846268537938498
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,39427,-0.000836622387484714,0.00439030204060476,-0.00944161438707004,0.00776836961210061,0.848872756340722
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMPR,GMP reductase 1,41911,-0.0010012977197825,0.00526948370468045,-0.0113294857809562,0.00932689034139118,0.849297779516035
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA6C,Semaphorin-6C,39334,0.000541501436787263,0.00287418468875372,-0.00509190055317003,0.00617490342674456,0.850565286343359
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,39259,0.0010867691206219,0.00581236834290249,-0.010305472831467,0.0124790110727108,0.851683583885896
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS5,Transmembrane protease serine 5,41570,0.000788736707242216,0.00426220265272154,-0.00756518049209201,0.00914265390657644,0.853189747966567
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,41465,0.00254819559566149,0.0140054622731055,-0.0249025104596252,0.0299989016509482,0.855630337760131
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F10,Coagulation factor X,39655,-0.000587891953736027,0.0032335522941264,-0.00692565445022378,0.00574987054275172,0.855735215631708
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MKI67,Proliferation marker protein Ki-67,39334,-0.000816121623745545,0.00451762424347085,-0.0096706651409484,0.00803842189345731,0.85664349284145
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALMS1,Alstrom syndrome protein 1,39427,0.000896511154789108,0.00496718924386011,-0.0088391797631767,0.0106322020727549,0.856773942359174
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",39259,0.000630823465418443,0.00352973462131204,-0.00628745639235315,0.00754910332319003,0.858163342616059
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK12,Kallikrein-12,41465,-0.00261432132090687,0.0147612567591694,-0.031546384568879,0.0263177419270652,0.859427162570472
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,39250,0.00075738481009609,0.00429086984203754,-0.00765272008029749,0.00916748970048967,0.859896031671629
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,39328,-0.000794137257725807,0.00452266627836246,-0.00965856316331623,0.00807028864786462,0.860618976005008
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA2,Integrin alpha-2,39408,-0.000671171945718621,0.00385114139136226,-0.00821940907278865,0.00687706518135141,0.86164969595428
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",39259,0.00103505382653189,0.00597052375205661,-0.0106671727274991,0.0127372803805628,0.862371252197808
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,41765,0.000828965263540221,0.0048055821989243,-0.00858997584635141,0.0102479063734319,0.863046731188271
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUMF1,Formylglycine-generating enzyme,39334,0.00125576227532612,0.00729018733191589,-0.013033004895229,0.0155445294458813,0.863241272109367
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,39250,-0.00112482901439346,0.00655380343456095,-0.0139702837461329,0.011720625717346,0.863731713943691
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK3,Prostate-specific antigen,39633,-0.00211764137841633,0.0126560945377618,-0.0269235866724294,0.0226883039155967,0.867119865111485
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOB,Apolipoprotein B-100,39655,0.000418606447361661,0.00253356990698335,-0.00454719057032571,0.00538440346504903,0.868770729876822
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,41559,-0.00305744149169469,0.0186873653013356,-0.0396846774823126,0.0335697944989232,0.870040653593443
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL11,Interleukin-11,41534,0.00108874396988114,0.00676447081779359,-0.0121696188329943,0.0143471067727566,0.872135016551325
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,39259,0.000888888390473604,0.00555606567711075,-0.0100010003366635,0.0117787771176107,0.872895748359628
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBZ,Hemoglobin subunit zeta,39625,-0.00188865012531442,0.0118913661388629,-0.0251957277574857,0.0214184275068568,0.873809402470572
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AZI2,5-azacytidine-induced protein 2,39600,0.000980948354051206,0.00619708209225133,-0.0111653325467614,0.0131272292548638,0.874229638342919
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,39250,0.000649816102202006,0.00410804423271478,-0.00740195059391897,0.00870158279832298,0.874316875356625
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,39259,0.00121946908927314,0.00771252762486413,-0.0138970850554606,0.0163360232340068,0.874368891795085
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKN3,Serine/threonine-protein kinase N3,39427,0.00129292703825522,0.00821779818089214,-0.0148139573962934,0.0173998114728038,0.874985712365146
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAM,Signal transducing adapter molecule 1,39589,0.000630681143252344,0.00401694564353954,-0.00724253231808516,0.00850389460458984,0.875243675690622
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,41765,-0.00116205149132505,0.00750430707842023,-0.0158704933650287,0.0135463903823786,0.87694094386695
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,41765,-0.000569125380422639,0.00377414747353546,-0.00796645442855213,0.00682820366770685,0.880139153111728
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,41328,0.00139962345967584,0.00936044662217791,-0.0169468519197929,0.0197460988391445,0.881141527255591
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,41698,0.000583518862877871,0.00392519417276023,-0.00710986171573219,0.00827689944148793,0.881824315440076
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,39589,-0.00084558423975899,0.00577262939371035,-0.0121599378514313,0.0104687693719133,0.883543867088889
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN6,Prefoldin subunit 6,39328,-0.00103378371957415,0.00719455117133751,-0.0151351040153957,0.0130675365762474,0.885748113803427
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,39250,0.000987605415880873,0.00695745848897043,-0.0126490132225012,0.0146242240542629,0.887122845242758
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYTH3,Cytohesin-3,39241,0.00113561426769256,0.00811081564121957,-0.0147615843890978,0.0170328129244829,0.888652891372114
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",39259,-0.000839072908369687,0.00607404456691612,-0.0127442002595253,0.0110660544427859,0.890131811365844
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,39259,0.0016231033875383,0.0120460290394973,-0.0219871135298763,0.0252333203049529,0.892818583281373
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEO1,Neogenin,39600,0.000333523664794849,0.00251988276593666,-0.00460544655644101,0.0052724938860307,0.89470448915128
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTNL10,Butyrophilin-like protein 10,39241,0.000565003141715746,0.00444203251384796,-0.00814138058542625,0.00927138686885774,0.898788676957587
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,39259,-0.000781110160782551,0.00621245423496523,-0.0129575204613144,0.0113953001397493,0.899945694512193
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH4,Myosin-4,39250,-0.000636452913642682,0.00509640466537978,-0.010625406057787,0.00935250023050168,0.900618750002912
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,39600,0.000362579522119658,0.00291576181894765,-0.00535231364301774,0.00607747268725706,0.901039199604833
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,39328,-0.000508990258808033,0.00409639021323321,-0.00853791507674512,0.00751993455912905,0.90111700016237
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,39250,-0.00101735128217087,0.00829403349869555,-0.0172736569396141,0.0152389543752724,0.902378164323103
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSD1,Tryptase delta,39600,-0.000494115839785787,0.0040716065879147,-0.0084744647520986,0.00748623307252702,0.903410903330127
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACRV1,Acrosomal protein SP-10,39334,0.00141966987863041,0.0118223574793947,-0.0217521507809832,0.024591490538244,0.904419262755412
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPLX2,Complexin-2,39241,-0.000401650574699514,0.00334585969393271,-0.00695953557480763,0.00615623442540861,0.904450513457322
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,41465,0.000705695040827434,0.00590074499526728,-0.0108597651498964,0.0122711552315513,0.904806459900538
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOX2,Transcription factor SOX-2,39583,-0.000326501910254289,0.0027308588585505,-0.00567898527301327,0.00502598145250469,0.904833771167566
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRTN,Neurturin,41534,0.000654778803477943,0.00549679274401117,-0.010118934974784,0.0114284925817398,0.905182013055896
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,39633,0.000342788967167596,0.00288425106219213,-0.00531034311472897,0.00599592104906416,0.905397532168677
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,41636,0.000372759522812166,0.00317458659875109,-0.00584943021073996,0.0065949492563643,0.9065291536733
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,39625,-0.000390871104224532,0.00334642831713545,-0.00694987060581001,0.00616812839736094,0.907018711252214
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,39250,0.000510042150132023,0.00436752568370068,-0.0080503081899213,0.00907039249018535,0.907036141229246
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,41689,0.000533231844598877,0.00457330289087441,-0.00843044182151497,0.00949690551071272,0.907181473023076
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,41689,0.000529981543277766,0.00454718179478263,-0.0083824947744962,0.00944245786105173,0.907217141932236
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,41636,0.000460618115077613,0.00403437979667987,-0.00744676628641494,0.00836800251657016,0.909102242041393
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MBL2,Mannose-binding protein C,39498,-0.0013867024131028,0.0122064346626221,-0.0253113143518421,0.0225379095256365,0.909553639468841
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLGN,Calmegin,39328,-0.000570551726822291,0.0050704662556866,-0.010508665587968,0.00936756213432344,0.910409642939954
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TERF1,Telomeric repeat-binding factor 1,39334,0.000356694806439002,0.00323976737560404,-0.00599324924974492,0.00670663886262293,0.912333003146844
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,39308,-0.000287740768237423,0.00261695525868949,-0.00541697307526883,0.00484149153879399,0.912449107864289
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL6B,Myosin light chain 6B,39328,0.0011084068306206,0.0101481493637277,-0.0187819659222857,0.0209987795835269,0.913028011603564
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRP15,RRP15-like protein,39259,-0.00110766831380961,0.0101519394157791,-0.0210054695687366,0.0187901329411174,0.913118062595689
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,39565,0.000464461346303915,0.0042611579746331,-0.00788740828397697,0.0088163309765848,0.913205391885692
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,39598,-0.000461242413622663,0.00426845380981255,-0.00882741188085526,0.00790492705360994,0.913951314908155
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,41740,-0.000437816504229846,0.00405914006196157,-0.00839373102567453,0.00751809801721484,0.914108851959617
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXN,Thioredoxin,39522,0.000515405765217649,0.00479513287195225,-0.00888305466380875,0.00991386619424405,0.914406048598675
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPE4,NXPE family member 4,39250,-0.000381697773244703,0.00356639565406416,-0.00737183325521045,0.00660843770872105,0.914770210751881
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,41750,-0.000887247978258611,0.00847449896474934,-0.0174972659491673,0.0157227699926501,0.916618461011585
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHODH,Dihydroorotate dehydrogenase,39250,0.000535254440260254,0.00517362100404286,-0.00960504272766375,0.0106755516081843,0.917601129297106
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP15,Matrix metalloproteinase-15,39625,0.000542119329078278,0.00537449102822203,-0.0099918830862369,0.0110761217443935,0.91965631665032
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPN1,Epsin-1,39427,0.000483567720330471,0.00483070284379578,-0.00898460985350926,0.0099517452941702,0.920264427818116
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSG1,Tryptase gamma,39334,0.000288268459128536,0.00291247859739723,-0.00542018959177003,0.0059967265100271,0.92115836226459
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAD2,Glutamate decarboxylase 2,39334,0.000501821475658799,0.00507718695181596,-0.00944946494990048,0.0104531079012181,0.921268355630543
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,41560,-0.000263071018838497,0.00266514925840318,-0.00548676356530872,0.00496062152763173,0.921371802518959
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL4,Interleukin-4,41534,-0.000992501891561541,0.010443346366576,-0.0214614607700506,0.0194764569869275,0.924287094235964
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF7,Fibroblast growth factor 7,39241,-0.000810165064252259,0.00861066214946734,-0.0176870628772082,0.0160667327487037,0.925040555171289
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX3,Syntaxin-3,39598,-0.000383976301102071,0.00423191703418623,-0.00867853368810709,0.00791058108590294,0.927706068032665
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,41534,0.000648903274133115,0.00725729293687276,-0.0135753908821375,0.0148731974304037,0.928754316734793
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6,Seizure protein 6 homolog,39328,0.000308128246640901,0.00349274592272958,-0.00653765376190907,0.00715391025519088,0.929703877517675
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,39427,-0.00052089610702404,0.00590988076644442,-0.0121042624092551,0.011062470195207,0.929767140168004
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAC1,Cartilage acidic protein 1,41925,0.00029800430120973,0.00343472243530273,-0.00643405167198362,0.00703006027440308,0.930861785581565
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPHS2,Podocin,39334,0.000972634241223302,0.0113572725064081,-0.0212876198713366,0.0232328883537832,0.931754377411355
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,39600,-0.000372704343679867,0.0043524353274497,-0.00890347758548128,0.00815806889812155,0.931761138709261
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNLZ,DNL-type zinc finger protein,39259,0.000798552320886006,0.00934359243171817,-0.0175148888452816,0.0191119934870536,0.931893138116873
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF20,Fibroblast growth factor 20,39334,0.000401557019556446,0.00481169498334079,-0.0090293651477915,0.00983247918690439,0.933491806815413
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,39250,-0.000908249796979959,0.0108987228529813,-0.0222697465888233,0.0204532469948634,0.933586392381974
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA8,Carbonic anhydrase-related protein,39334,-0.000243340903067573,0.00297390045998213,-0.00607218580463254,0.0055855039984974,0.934787000680803
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,39427,-0.000713017308723022,0.00879630792540701,-0.0179537808425208,0.0165277462250747,0.93539676631183
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,39334,0.000265497336890492,0.00328168929000502,-0.00616661367151935,0.00669760834530033,0.935520886391863
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",41124,0.000262048895767217,0.00328746801351085,-0.00618138841071404,0.00670548620224847,0.936468013262066
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,41465,0.0006484580183079,0.00814197161008317,-0.0153098063374551,0.0166067223740709,0.936521752320471
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTKN2,Rhotekin-2,39250,0.000449485130734049,0.00565139616484358,-0.0106272513523594,0.0115262216138275,0.936608400012362
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,41534,0.000511685258172794,0.00660648234477257,-0.0124370201375814,0.013460390653927,0.938265174492687
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBR1,T-box brain protein 1,39328,0.000415434278413474,0.00537572816922318,-0.010120992933264,0.0109518614900909,0.938402537310142
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRXN3,Neurexin-3,39328,0.000301615335796429,0.00398747414402971,-0.0075138339865018,0.00811706465809466,0.939706365635398
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",39250,-0.000338265308584544,0.00450696946191881,-0.0091719254539454,0.00849539483677631,0.940173294124503
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,39589,0.000616701366261073,0.00840732273881016,-0.0158616512018068,0.017095053934329,0.941526645022534
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RFC4,Replication factor C subunit 4,39589,-0.000179486357168023,0.00246933018874798,-0.00501937352711407,0.00466040081277802,0.94205711151599
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",39334,-0.000398679874909809,0.00548872283907713,-0.011156576639501,0.0103592168896814,0.942096986464337
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,39259,-0.000350789290928985,0.00484824060760648,-0.00985334088183769,0.00915176229997972,0.942321599899067
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPO,Lactoperoxidase,41274,0.000485863348145078,0.00679176025069186,-0.012825986743211,0.0137977134395011,0.942971366950556
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,39250,0.000216353689871504,0.00314221182005122,-0.00594238147742889,0.00637508885717189,0.945107168135518
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,39259,0.000352750410778997,0.00539012899703414,-0.0102119024234079,0.0109174032449659,0.947821895483837
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH6,Cadherin-6,41765,-0.000277882439137106,0.00431623916824373,-0.00873771120889482,0.00818194633062061,0.948668085834862
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRAS,GTPase Hras,39420,0.000708589491124441,0.011024000761135,-0.0208984520007001,0.022315630982949,0.948750869180909
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,39408,0.000266885470914174,0.00416686457992038,-0.00790016910572977,0.00843394004755812,0.948932020194999
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,41534,0.000496342195818196,0.00785689261447487,-0.0149031673285525,0.0158958517201889,0.949629850757885
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD36,Platelet glycoprotein 4,39334,0.000324087093767456,0.00518299595461388,-0.00983458497727575,0.0104827591648107,0.950142803410109
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFHD1,EF-hand domain-containing protein D1,39600,-0.000249491599937629,0.00400761417560232,-0.00810441538411818,0.00760543218424292,0.950361375778914
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,41466,-0.000262461904274331,0.00423756935092718,-0.0085680978320916,0.00804317402354294,0.950614044937604
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,39328,-0.000214083374384795,0.00349081154196429,-0.0070560739966348,0.00662790724786521,0.951099388982183
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,39221,0.000362200031400447,0.0059618363589972,-0.0113229992322341,0.012047399295035,0.951556986355921
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOX9,Transcription factor SOX-9,39328,-0.000182991869303297,0.0030774902355623,-0.0062148727310054,0.00584888899239881,0.952585719144786
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMB1,Laminin subunit beta-1,39308,-0.000198799966079715,0.00348170867686289,-0.00702294897273097,0.00662534904057154,0.954467882871798
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL36G,Interleukin-36 gamma,39301,0.000412733447064871,0.00742192675185563,-0.0141342429865722,0.0149597098807019,0.955653525391255
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMA1,Proteasome subunit alpha type-1,41465,-0.000274750401069114,0.00512878012398762,-0.0103271594440848,0.00977765864194662,0.957278334200547
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PYY,Peptide YY,39250,-0.000583068553943185,0.0111355829033133,-0.0224088110444372,0.0212426739365508,0.958242152806287
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKCQ,Protein kinase C theta type,41534,-0.000240246738829356,0.00472109017670771,-0.00949358348517647,0.00901309000751776,0.959415570101876
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUCL3,Mucin-like protein 3,39241,0.000239357844908488,0.00471378653582222,-0.00899966376530307,0.00947837945512005,0.959503173254658
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC1A4,Neutral amino acid transporter A,39328,-0.000285675444914469,0.00563290141820345,-0.0113261622245932,0.0107548113347643,0.959553164834179
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFM,Afamin,39650,0.000113539008379683,0.00224351906275456,-0.00428375835461924,0.00451083637137861,0.95963915935598
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OLFM4,Olfactomedin-4,39035,0.000693723185202451,0.0138085059526731,-0.0263709484820368,0.0277583948524417,0.95993303016345
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,41465,-0.000247139732529753,0.00501921038157494,-0.0100847920804166,0.00959051261535713,0.960729781160274
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MN1,Transcriptional activator MN1,39328,0.000313972467414729,0.00655784062130893,-0.0125393951503508,0.0131673400851802,0.961814828906855
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NENF,Neudesin,39589,0.000592828808436658,0.0124585773548018,-0.0238259828069749,0.0250116404238482,0.962048657166912
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,39328,0.00018545447687395,0.00404030970572517,-0.00773355254634739,0.00810446150009529,0.963389967872043
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HK2,Hexokinase-2,41521,-0.000137412977350174,0.0030325754140139,-0.00608126078881743,0.00580643483411708,0.963859081018989
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,39408,0.000205398125557497,0.00456053167387989,-0.00873324395524709,0.00914404020636209,0.964077694798668
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,39589,-0.000141200750919872,0.00316227750949922,-0.00633926466953834,0.00605686316769859,0.964385823981066
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,39427,0.000209231617837918,0.00469993560275904,-0.0090026421635698,0.00942110539924563,0.964492344812629
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY75,Lymphocyte antigen 75,41740,-0.000181281557724704,0.00429494437323829,-0.00859937252927176,0.00823680941382235,0.966333425198769
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",39334,0.000206959476214154,0.00494228379576601,-0.00947991676348723,0.00989383571591554,0.966598908360917
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUK1,Guanylate kinase,39250,0.000185161760865389,0.00446761543957226,-0.00857136450069623,0.00894168802242701,0.966941658928193
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTO1,Protein LTO1 homolog,41534,0.000177480529086991,0.00457439885800726,-0.00878834123260724,0.00914330229078123,0.969051514949814
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIT,Citron Rho-interacting kinase,39328,0.000192492230486969,0.00508412753056904,-0.00977239772942835,0.0101573821904023,0.969798886814466
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,41925,0.000125090900464842,0.00331970788588414,-0.00638153655586808,0.00663171835679776,0.969942352309857
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,39655,-0.000118172024674795,0.00317211183507712,-0.00633551122142596,0.00609916717207637,0.970283615222864
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,41758,-0.000141853500677137,0.00392867238341611,-0.00784205137217271,0.00755834437081844,0.971197400371943
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WDR46,WD repeat-containing protein 46,39589,0.000143801516301839,0.00408240303687,-0.00785770843596337,0.00814531146856705,0.971901188112364
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,41636,-0.000269752528144772,0.00770315860223138,-0.0153679433885183,0.0148284383322287,0.972065580217591
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHNAK2,Protein AHNAK2,39308,0.000118569512786004,0.0034513976291121,-0.00664616984027371,0.00688330886584572,0.972595458914441
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,39328,0.000151884918297721,0.0046351031861552,-0.00893291732656647,0.00923668716316191,0.973859886894191
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNPO1,Transportin-1,39427,-0.000128561668391876,0.00395316902196643,-0.00787677295144608,0.00761964961466233,0.974057035907169
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FST,Follistatin,41786,-0.000167270233666543,0.00540201282821215,-0.0107552153769624,0.0104206749096293,0.975298377571479
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,41521,-0.000268208199714091,0.00905080724463241,-0.0180077903991936,0.0174713739997654,0.976359708360963
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,39328,-0.000227118908664906,0.00778862344760047,-0.0154928208659618,0.015038583048632,0.976737254202212
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAEP,Glycodelin,41636,0.000316848094679794,0.0115848726382998,-0.0223895022763879,0.0230231984657474,0.978180870330708
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,41465,-0.000114920253004334,0.00445262392679078,-0.00884206314951426,0.00861222264350559,0.979409638958527
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,39600,-0.000489135078025882,0.0190868967072908,-0.0378994526243158,0.0369211824682641,0.979555516695092
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENOPH1,Enolase-phosphatase E1,39589,-0.000147567803049983,0.00593764296713148,-0.0117853480186277,0.0114902124125277,0.980172726256639
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,41689,-5.42502766251237e-05,0.00220111235680507,-0.00436843049596306,0.00425992994271281,0.980337101363316
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTLA,B- and T-lymphocyte attenuator,39241,0.000224773509850497,0.0094939739208637,-0.0183834153750424,0.0188329623947433,0.981111982496352
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,41534,0.00014337427164946,0.00621332548627361,-0.0120347436814468,0.0123214922247457,0.981590574154151
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL3,Interleukin-3,39241,0.000154273472994428,0.00678782937813612,-0.0131498721081524,0.0134584190541412,0.981867703779271
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,39259,0.000139039795583259,0.0061520713571471,-0.0119190200644251,0.0121970996555916,0.981969380108214
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,39259,-0.000113952701456492,0.00599876636093407,-0.0118715347688873,0.0116436293659743,0.984844633880601
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1A,Interleukin-1 alpha,41534,-0.000108671377485118,0.00640980068049613,-0.0126718807112575,0.0124545379562873,0.986473622376022
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",39241,0.000167524019639882,0.0105146452608786,-0.0204411806916821,0.0207762287309619,0.987288583678346
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSH,Pro-cathepsin H,41488,-0.000129248223639716,0.00826846745336659,-0.0163354444322382,0.0160769479849588,0.987528648735815
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAP,Cartilage-associated protein,39328,7.93221065444676e-05,0.00547558776747469,-0.0106528299177059,0.0108114741307949,0.98844211832041
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN15,Tetraspanin-15,39250,7.92172980926267e-05,0.00558189783292603,-0.0108613024544424,0.0110197370506276,0.988677210601144
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB5,Integrin beta-5,41802,-5.76663279556356e-05,0.00427642199888106,-0.00843945344576252,0.00832412078985125,0.989241284648682
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD2,Bromodomain-containing protein 2,39259,4.68219153863578e-05,0.00388818189561529,-0.0075740146000196,0.00766765843079232,0.990392243666398
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA2,Protein disulfide-isomerase A2,39241,-5.20578176017747e-05,0.00443181524414203,-0.00873841569612016,0.00863430006091661,0.990628174781151
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,41362,-2.00923208128574e-05,0.00229266823964828,-0.00451372207052348,0.00447353742889777,0.993007783232821
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLKB1,Plasma kallikrein,39433,2.31726741139973e-05,0.00272300016634083,-0.00531390765191404,0.00536025300014203,0.993210257832321
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,39250,-7.0326587045494e-05,0.0110698497164955,-0.0217672320313767,0.0216265788572857,0.994931204596539
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM25,RNA-binding protein 25,39241,3.14507338083117e-05,0.00519098175093074,-0.0101428734980159,0.0102057749656326,0.995165979568816
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,39600,-2.95649317178404e-05,0.00496205537394578,-0.00975519346465156,0.00969606360121588,0.995246178229709
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,41925,1.54769508166843e-05,0.00384986461662779,-0.00753025769777379,0.00756121159940716,0.996792470284704
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,41636,-1.77202699636384e-05,0.00566638922940475,-0.011123843159597,0.0110884026196697,0.99750485978763
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKAP12,A-kinase anchor protein 12,39408,6.99233473289544e-06,0.00236723584430326,-0.0046327899201015,0.00464677458956729,0.997643268718157
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLL4,Delta-like protein 4,39308,1.21582879928523e-05,0.00983643434050732,-0.0192672530194015,0.0192915695953872,0.999013801039653
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN4B,Sodium channel subunit beta-4,39308,4.86339377532736e-06,0.00483179860574829,-0.00946546187349132,0.00947518866104197,0.999196916951139
